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Obesity is extremely prevalent in the U.S., associated with numerous chronic 
diseases and an economic burden on the health care system. Exercise results in beneficial 
health outcomes, protects against a variety of chronic diseases and can reduce body mass 
and fat. U.S. exercise guidelines recommend identical exercise programs for everyone 
regardless of age, sex or genetic background. Furthermore, individual variation in 
responses to recommend exercise programs occurs across a variety of responses with 
some individuals experiencing adverse responses, including fat gain. In order to establish 
effective exercise guidelines, dissection of underlying physiological mechanisms and 
driving factors as well as the evaluation of potential interventions needs to occur. 
Experimental mouse models of exercise-induced adverse outcomes will be valuable in 
identification of mechanisms and evaluation of interventions while overcoming limitations in 
human studies. Several studies have identified individual mice exhibiting adverse fat gain 
following exercise, but no systematic effort has been conducted to identify and characterize 
models of adverse response. Strains from the Collaborative Cross (CC) genetic reference 
population were used due to its high levels of genetic variation, its reproducible nature, and 
the observation that the CC is a rich source of novel disease models, to assess the impact 
genetic background has on exercise responses. This thesis work aimed to identify and 
develop mouse models of exercise-induced adverse body composition response and to 
determine the effect of different factors, including age, sex, exercise program and genetic 
background, on body composition response. In an initial study, we assessed body 
composition responses to voluntary exercise in aged females from 42 CC strains. We
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observed significant variation in body composition responses due to genetic background. 
Some strains, in particular CC027/GeniUnc, had an adverse body composition response. 
An additional study identified CC002/Unc as a model of voluntary exercise-induced adverse 
body composition response in old females. Unlike the initial screen, this study took 
advantage of age matched females with a case – control experimental design to account 
for body composition changes due to aging. Additionally, we measured body composition 
and metabolic responses to different forced exercise programs (HIIT and MICT) in a subset 
of four CC strains. We found body composition responses to different exercise programs 
varied by sex and further by genetic background. Overall, females had more beneficial 
body composition responses to HIIT than MICT programs. Across these studies we have 
demonstrated that genetic background has a significant effect on responses to exercise 
and further genetic background interacts with other factors to influence these responses. 
Additionally, we evaluated body composition and metabolism responses to long-term 
exercise during aging in C57BL/6J mice. We observed body mass and composition 
response trajectories to long-term exercise vary dependent on sex. Overall, exercise was 
protective against age related changes in body mass and composition.  
This work provides novel models for studies to determine the mechanisms behind 
adverse metabolic responses to exercise and enables development of more rational 
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CHAPTER 1: INTRODUCTION 
This work details the development of mouse models for exercise-induced adverse 
fat response1 and the exploration of exercise-induced body composition responses across 
different genetic backgrounds, sexes, exercise types and ages. The primary aim of these 
studies was to identify genetically stable mouse models of exercise-induced adverse fat 
response in the Collaborative Cross (CC) mouse population. The secondary aim of these 
studies was to determine the contributions of genetic background, sex, type of exercise and 
all their interactions on exercise-induced body composition responses. Lastly, the tertiary 
aim of these studies and future studies was to identify potential mechanisms driving 
adverse fat responses within our established CC model strains. In this chapter, I give an 
introduction to obesity, exercise, the observations of adverse responses, the lack of mouse 
models for exercise-induced adverse fat responders and the CC mouse population. 
1.1  Obesity 
1.1.1 Prevalence and economic burden of obesity 
Obesity2 is an important health issue that requires additional study because it is a 
large economic and burden to society and is predicted to only increase in severity in 
subsequent decades. Obesity is prevalent in the U.S with ~36% of adults and 17% of youth
                                               
1A gain of body fat in response to exercise is an adverse response. In this work, adverse fat 
response is defined as a gain of body fat.  
2Obesity is medically defined as a BMI (body mass index) ratio equal to or greater than 30 
in adults. (Overweight is a BMI greater than or equal to 25 and less than 30; Normal weight 
is a BMI less than 25). In youth, obesity is classified as BMI greater or equal to an age- and 
sex- specific BMI in the 95th percentile. BMI is calculated as the squared product of weight 
(kg) divided by height (m) (1). 
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classified as obese from 2011-2014. The prevalence of adult obesity was greater in 
females (38.3%) than males (34.3%). Additionally, obesity in U.S. adults increased from 
30.5% in 1999 to 37.7% in 2014 (1, 2). Projections estimate an additional 65 million obese 
US adults by 2030 (20% of the 323.1 million U.S. population today) (3).  
Not only is obesity prevalent in the U.S., but it also is a large economic burden. The 
enormous economic burden of obesity is driven by the cost of increased health liability 
associated with obesity. In 2008, the estimated annual medical cost of obesity was ~$147 
billion. Annual medical costs for obese individuals were ~$1,429 (42%) greater than 
individuals of normal weight in 2006. Furthermore, the health care costs attributed to 
obesity and overweight are expected to double with each decade due to the increasing 
population of obese individuals. Obesity is expected to account for 16-18% of total U.S. 
healthcare expenditure by 2030. In addition, economic costs of obesity extend past medical 
costs and include loss of productivity incurred by associated morbidity and mortality. It has 
been estimated that obesity resulted in a loss of 1.7-3 million in productive person working 
years in U.S. adults, equivalent to a $390-580 billion loss, based on 2008 data (3, 4). The 
economic burden of the growing obesity epidemic is due to the medical costs of diseases 
linked to obesity. 
1.1.2 Obesity and chronic disease risk 
Obesity results from excess fat storage due to an imbalance between energy intake 
and expenditure. This is primarily driven by excessive food intake and/or insufficient 
physical activity. Obesity is associated with an increased risk for chronic diseases such as 
type 2 diabetes, cardiovascular diseases, early death, metabolic disorders, musculoskeletal 
disorders and cancer (2, 3, 5-11). 
Although the majority of obese individuals are at greater risk for chronic diseases, 
some obese individuals have no metabolic abnormalities and can be “healthy”. The location 
of adipose tissue, not the presence of adipose itself, is responsible for determining 
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dysmetabolic consequences (12). In particular elevated amounts of visceral fat have a 
higher association with metabolic disease and chronic disease risk compared to 
subcutaneous fat which has little to no associated risks. Subcutaneous fat is located in 
peripheral regions (e.g. hips, thighs); whereas, visceral fat is located in intra-abdominal 
regions. Both subcutaneous and visceral fat are composed of white adipose tissue. White 
adipocytes3 store lipids and release hormones (functioning as endocrine cells). Visceral 
white adipocytes are susceptible to lipid overload and tend to develop a stressed state 
resulting in hypertrophy, death, metainflammation and other complications associated with 
metabolic syndrome (12, 13). Infiltration of visceral adipocytes into muscle or liver tissue 
can further alter metabolism and result in metabolic dysfunction. For example, visceral fat 
accumulation is associated with insulin resistance and is likely caused by the excessive 
release of fatty acids into the liver from surrounding visceral fat (14). In conclusion, obesity 
and specifically visceral fat are associated with metabolic dysregulation and chronic 
diseases. 
1.2 Exercise 
1.2.1 Exercise benefits and adaptations 
Physical inactivity or sedentary lifestyle results in weight and visceral fat gain, 
metabolic deterioration and increased risk for chronic diseases (8, 12). Exercise has 
numerous positive health benefits including the reduction of chronic disease risks and 
weight and fat loss. Chronic diseases, which can be delayed or prevented by exercise, 
include but are not limited to psychiatric diseases, neurological diseases, metabolic 
diseases, cardiovascular diseases, pulmonary diseases, musculo-skeletal disorders and 
cancer. In addition to preventing diseases, exercise is also used as a treatment option for a 
                                               
3White adipocytes are cells that form white adipose tissue (fat). White adipocytes are large 
spherical cells that store energy in lipid (triglycerides) droplets. These lipid droplets 
consume ~90% of the cell volume and can grow with increases in available lipids (13). 
 4 
variety for diseases (e.g. coronary heart disease, osteoporosis, anxiety disorders, etc) (8, 
15-18). 
The ability of regular exercise to protect against chronic diseases arises from 
subsequent physiological and metabolic adaptations acquired in response to exercise. 
Exercise improves insulin sensitivity, HDL levels, cardiovascular fitness, dyslipidemia and 
reduces blood pressure, triglyceride and LDL levels (12, 19). Furthermore, exercise alters 
muscular and cellular metabolism, substrate oxidation, blood flow, hormone and 
neurotransmitter secretion, and peptides regulating appetite, satiety and gastric emptying 
(16). In both animals and humans, changes in metabolites in response to exercise have 
been observed in blood and skeletal muscles biopsies (20). Overall, engaging in physical 
activity reduces chronic disease risk and elicits beneficial physiological adaptations. 
Exercise can not only prevent weight gain, but can also reduce fat and maintain or 
increase muscle mass (15). Multiple studies in humans have shown that exercise prevents 
obesity and in particular, exercise prevents obesity due to increased visceral adipose tissue 
(8). The exercise-induced reduction of fat mass occurs from the increased energy 
expenditure and activation of lipolysis. This assumes energy expenditure is not 
compensated for through increased energy intake or other compensatory behaviors (15). 
Thus, exercise has been shown to reverse obesity and many of its associated diseases 
(16). While aerobic exercise is historically well studied and recommended to adults as the 
primary exercise program, there are multiple forms of aerobic exercise and other types of 
exercise, such as muscle-strengthening exercise.  
1.2.2 Emergence of exercise programs and exercise-induced adaptations 
In the 2008 Physical Activity Guidelines for Americans, the U.S. Department of 
Health recommended 150 minutes (2.5 hours) of moderate intensity exercise (e.g. walking 
3mph or faster) weekly to maintain and improve health (21). Public health guidelines 
generally recommend traditional exercise programs, such as moderate intensity interval 
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training (MICT; exercising at a continuous moderate intensity), as a method of weight 
management and health benefit for the whole population (22). Surprisingly, only ~21% of 
U.S. adults achieve the 2008 Physical Activity Guidelines. The most common reason for 
individuals not completing traditional exercise training programs is lack of time (23, 24). 
Alternative exercise programs that focus on strategies reducing amount of exercise time 
necessary to see health benefits may enable many more adults to meet the weekly 
exercise recommendations with the same health benefits. 
High intensity interval training (HIIT) programs have been used as a time efficient 
form of exercise and involve exercising at short intense intervals alternated with brief 
intervals of lower intensity for recovery. Studies have demonstrated that HIIT programs are 
not only a time efficient and effective alternative to traditional endurance-based training 
programs such as MICT, but they may also elicit physiological responses through distinct 
mechanisms (22, 25). HIIT has been shown to induce similar or better results than MICT for 
a range of responses (e.g. physiological adaptations, performance, health-related markers) 
in the general population, physically inactive individuals, individuals suffering from chronic 
diseases and athletes. Recent human studies have demonstrated extensive benefits from 
HIIT include improvements in aerobic fitness, anaerobic fitness, cardiorespiratory markers, 
skeletal muscle oxidative capacity, aerobic energy metabolism, insulin action, physiological 
remodeling and reduction in risk factors for metabolic syndrome (22-29). Initial studies have 
explored the metabolic mechanism behind HIIT-induced adaptations. In particular, HIIT has 
been shown to increase lactate concentrations and adenine nucleotide catabolism products 
in both plasma and skeletal muscle indicating increased anaerobic metabolism and ATP 
turnover (20). 
Preliminary studies have demonstrated HIIT can efficiently and effectively reduce 
body mass and body fat (29-33) and increase lean mass (6, 34, 35). However, individual 
variability in body composition responses with the presence of responders and non-
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responders has been observed in HIIT, MICT and other exercise programs making it 
difficult to determine effective personalized exercise programs (29). These observations 
demonstrate different exercise programs can elicit distinct physiological responses and 
exercise programs should be designed using scientific evidence for particular desired 
outcomes. 
Recently, mouse populations have been used to assess physiological adaptations to 
HIIT programs (25, 36-39). HIIT had beneficial effects on cardiac remodeling, physical 
performance, insulin sensitivity and metabolic markers in mice with diet-induced obesity 
and reversed changes in gut microbiota associated with diet-induced obesity (25, 36-39). 
Seldeen et al. demonstrated HIIT improved physical performance and reduced markers for 
frailty compared to sedentary controls in aged C57BL/6J mice (25). HIIT was shown to have 
superior metabolic adaptations (reduced body weight, body fat percentage, adipocyte size) 
compared to MICT in male ICR (outbred) mice with high-fat diet induced obesity (37). While 
studies in mouse populations have supported human findings and demonstrated HIIT is a 
physiologically effective exercise program, these studies have been limited to standard 
laboratory inbred strains, in particular C57BL/6J. These studies are informative but limited 
in genetic diversity. It is likely physiological adaptations to both HIIT and MICT exercise 
programs will vary significantly across genetic backgrounds. Studies utilizing mouse multi-
parental populations are necessary to evaluate the physiological effectiveness of HIIT and 
MICT in different genetic backgrounds. 
1.2.3 Sex and exercise induced responses 
Previous studies have shown sex affects physical activity traits and that sex differences 
regulate body composition traits in both human and mouse populations (40-42). Initial data 
suggests that males and females vary in physiological responses when exposed to the 
same exercise program, including interval training (22). The presence of sex differences 
varies depending on physiological response. For example, recent human evidence suggests 
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that men and women have similar cardiovascular response to HIIT, but men have significantly 
greater benefits to muscle protein synthesis and mitochondrial biogenesis compared to women 
(43). For body mass response to exercise, the prevailing view is that women lose less weight 
in response to exercise than men. Recently, human studies have shown when exercise-induced 
energy expenditure is held equal there are no sex effects on exercise induced weight loss (44). 
However, the effects of sex within the context of genetic backgrounds on body composition 
response to HIIT and MICT training are not clear. Specifically, it is unknown whether both sexes 
demonstrate the same or different body composition responses when receiving the same varied 
intensity training (10, 22). Identifying sex-based responses and intensity-based responses to 
exercise in genetically characterized and reproducible mice can help address unanswered 
questions.  
1.3 Adverse responders 
1.3.1 Individual variability to exercise 
Engaging in cardiovascular exercise activity is typically believed to result in weight 
and fat reduction, but this is not always the case. Some individuals even experience an 
adverse response to exercise. There is large inter-individual variation in both direction and 
magnitude of exercise-induced responses. Interestingly, exercise-induced weight loss is 
often less than expected (16, 18). Individual variability in responses to exercise are 
observed in both human and rodent populations (19). It is important to note, most studies 
focus on the group mean for a response to a standardized exercise intervention rather than 
reporting individual responses. Individual variation to exercise has been observed in 
numerous responses including but not limited to VO2 max, resting heart rate, heart rate 
during exercise, aerobic and anaerobic threshold, resting muscle glycogen and muscle 
enzyme activity (45). It is well established numerous variables contribute to individual 
variation in exercise-induced responses. 
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Multiple studies have demonstrated individual variability in exercise-induced 
responses is in part explained by exercise factors, compensatory behaviors and 
environment. In particular, insufficient exercise dose (frequency, duration, intensity), lack of 
program adherence and physiological and behavioral compensatory adaptations (e.g. 
alterations in energy intake, reductions in non-exercise or habitual physical activity) 
contribute to individual variation in exercise-induced responses and can affect exercise-
induced health benefits. Furthermore, compensatory adaptations vary by exercise type 
(e.g. intensity, duration, etc) and individual factors (e.g. sex, age, and body weight) (16, 19). 
Even when energy expenditure and energy intake are controlled, there still is variability in 
weight response to exercise (19). Individual variability in responses after controlling for 
energy expenditure and intake indicates exercise factors and compensatory factors are not 
the sole contributors to variability in exercise-induced responses. 
Some variability in exercise-induced responses can be explained by accounting for a 
baseline level of activity in untrained individuals. In one study, baseline phenotypes 
accounted for ~1% of exercise-induced response for HDL cholesterol levels and VO2max. 
Whereas, other baseline phenotypes contributed more to exercise-induced responses (e.g. 
heart rate during activity) (46). In some cases there is little relationship between the pre-
training trait and the magnitude of the resulting training response (45). Other factors 
contributing to exercise-induced responses include: variability in recovery ability, prior 
training status, nutritional status and measurement error (45). 
Finally, exercise-induced responses vary not only by training background and 
environmental factors but also by genetic background (8). This is not surprising, as 
numerous exercise-related phenotypes prior to exercise exposure are also heritable. Prior 
twin and family studies have established different exercise-induced responses are heritable 
and particular gene variants are associated with certain exercise response phenotypes 
(45). In particular, the role of genetics in regulating weight and fat response to exercise is 
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becoming evident (19). Twin studies have demonstrated shared familial factors (e.g. 
environment and genetics) are likely significant regulators in markers of body composition 
response (e.g. fat mass, body fat percentage change) to exercise. The extent to which 
familial factors influence body composition responses to exercise are likely to vary by sex 
with factors having a greater influence on fat mass response in females and fat-free mass 
(e.g. muscle mass) response in males (18). While exercise variables, compensatory 
behaviors and baseline phenotypes contribute to variability in exercise-induced responses, 
it is becoming evident genetics and other factors are likely driving contributors. 
1.3.2 Observations of adverse responses 
While some individuals are high positive responders to exercise training, there are a 
small proportion of individuals who are non responders (no improvement) or adverse 
responders (deterioration) in response to exercise. Thus, particular individuals do not obtain 
health benefits of exercise training (45). Adverse responders have been observed across a 
variety of traits and risk factors for chronic diseases including plasma fasting insulin, HDL 
cholesterol levels, triglycerides, resting systolic blood pressure (47), VO2 max (45), body 
weight (48) in humans. Bouchard et al. (2012) identified 31% of individuals across six 
separate studies had one exercise-induced adverse response in four possible traits (fasting 
insulin, HDL-cholesterol, triglycerides, resting systolic blood pressure) (47). Adverse 
responders have been observed across numerous traits, but we are particularly interested 
in adverse fat responders to exercise due to the health risks associated with obesity. 
1.3.3 Adverse fat responses to exercise in humans and mice 
Multiple studies have demonstrated that weight and fat response to exercise varies 
by individual even when controlling for compliance, energy intake and energy expenditure 
(49, 50). Barwell et al. (2009) measured fat loss in response to a seven week aerobic (at 
65-80% max heart rate) exercise program with 55 women and observed ~25% of the 
women were adverse fat responders. During the seven week intervention food weights 
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were self reported and used to calculate energy intake. After adjusting for energy 
expenditure and energy intake, ~45% of the women had an adverse fat response (49). 
Human studies of exercise induced responses are limited in numerous ways including 
accurate measurement of phenotypes (e.g. self reported food intake). Animal systems offer 
an improved way to measure body composition responses to exercise since they enable 
accurate measurements and the ability to standardize and control variables (e.g. energy 
intake). 
Exercise-induced adverse fat response has only previously been observed in 
outbred and partially inbred mouse populations. Kelly et al. (2011) measured body 
composition responses to six days of voluntary exercise in outbred mice (generation four of 
an advanced intercross line created from reciprocal cross between high running selection 
line and C57BL/6J). They observed exercise-induced fat response ranged from -69.1 to 
88.3% and lean mass response ranged from -17.2 to 26.3% across the whole population (n 
= 797) (19). Thus, a subset of outbred mice had exercise-induced adverse fat response. 
While exercise-induced adverse fat responders have been observed in outbred and 
partially inbred mouse populations, these mice are genetically unique individuals making it 
difficult to determine if genetics, experimental error or other variables are driving the 
adverse response. Additionally, developing mouse models by selective breeding of outbred 
mice is a long process. 
1.4 Mouse model development 
1.4.1 Need for mouse model 
Complex phenotypes are often influenced by multiple genetic loci and the 
modification of each loci by genetic background, sex, age and environmental factors (51). 
Given the complex interactions between physical activity, energy intake, body composition, 
as well as other factors, it is difficult to determine successful exercise regimes that result in 
healthy body composition. Animal models are critical towards this success, as human 
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studies often suffer from many confounding variables (e.g. food consumption, 
environmental and genetic differences) and prove difficult to measure and study 
mechanisms associated with exercise-related phenotypes (41), (52). Inbred mouse models 
in particular are excellent tools to dissect complex traits while controlling and manipulating 
environments. Furthermore, genetically distinct mouse strains can be used to assess the 
magnitude of genetic responses for all of these traits (51, 53, 54). Even though it is common 
in human studies, especially in women, to observe exercise-induced adverse fat (gain) 
responses, no inbred mouse models exist which recapitulate these phenotypes. 
1.4.2 Collaborative Cross 
The CC is a multi-parental population of ~75 recombinant inbred mouse strains. The 
CC is derived from eight founder laboratory strains (A/J, C57BL/6J, 129S1/SvImJ, 
NOD/ShiLtJ, NZO/HILtJ, CAST/EiJ, PWK/PhJ, WSB/EiJ) representing the three Mus 
musculus subspecies of mouse (M. m. musculus, M. m. domesticus, and M. m. 
castaneous). The CC was initially conceived as an improved resource for systems genetics 
enabling data integration across 
a platform of stable and 
reproducible sets of unique 
genotypes. CC strains are inbred 
which enables repeatability and 
reproducibility of experiments 
along with the ability to modulate 
variables (e.g. diet, sex, exercise 
type, etc) in the same genetic 
background (55-58) (53, 59). 

















genomic tools designed for the CC enable dissection of genetic and molecular mechanisms 
driving phenotypes and analyzing new models (59). The CC population is ideal for 
identifying stable research models. Each strain is inbred and reproducible, but across 
strains there exists a high level of genetic and phenotypic diversity. The CC has expansive 
phenotypic diversity, phenotypic range beyond other laboratory mice and continuous 
distribution for numerous traits (60-63). The CC has been a rich source of models of human 
disease especially disease traits that do not exist or are underrepresented in standard 
laboratory mouse strains (53, 64, 65). The expansive phenotypic diversity and presence of 
outlier strains make the CC ideal for identifying strains that accurately model human 
disease traits. For example, Rogala et al. (2014) identified CC011/Unc as a new model for 
spontaneous colitis. Unlike existing murine models for colitis, CC011/Unc developed colitis 
in the absence of chemical treatment, an infectious agent or direct mutagenesis (64). This 
illustrates the potential for development of animal models with genetic disorders as 
opposed to animal models with environmentally controlled disease status. Finally, a prior 
study tested exercise-related traits in the pre-CC4. The pre-CC captured phenotypic 
variation often beyond variation observed in the CC founder inbred strains in exercise-
related traits. Seventeen percent of 176 pre-CC mice had an adverse fat response to 
twelve days of voluntary exercise (Figure 1.1) (66). This observation of exercise-induced 
adverse fat response in the pre-CC suggests the CC might be a rich source of mouse 
models of exercise-induced adverse body composition response. 
1.5 Thesis purpose 
The main objectives of my thesis research are: 1) to demonstrate that the CC is a 
useful systems genetics resource for modeling human exercise and exercise-related traits 
2) to identify model strains for exercise-induced adverse fat response and 3) to determine 
                                               
4 The pre-CC is defined as mice from CC strains during the inbreeding process but prior to 
the strains becoming fully inbred. Thus, pre-CC mice are partially inbred or outbred. 
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the contribution of genetic background, sex and exercise type to fat response. My thesis 
work will also provide a better understanding of the effect of different exercise programs 
(HIIT vs MICT) has on body composition response and whether males and females elicit 
similar body composition responses to HIIT and MICT programs in the context of different 
genetic background. Identifying a stable mouse model(s) of exercise-induced adverse fat 
response will enable genetic and mechanistic dissection of adverse fat response to 
exercise. These findings and the development of mouse models will enable ongoing and 
future studies to determine personalized exercise programs or other treatment options to 





CHAPTER 2: LONG-TERM EXERCISE IN MICE HAS SEX-DEPENDENT BENEFITS ON 
BODY COMPOSITION AND METABOLISM DURING AGING5 
2.1 Overview 
Aging is associated with declining exercise and unhealthy changes in body composition. 
Exercise ameliorates certain adverse age‐related physiological changes and protects against 
many chronic diseases. Despite these benefits, willingness to exercise and physiological 
responses to exercise vary widely, and long‐term exercise and its benefits are difficult and 
costly to measure in humans. Furthermore, physiological effects of aging in humans are 
confounded with changes in lifestyle and environment. We used C57BL/6J mice to examine 
long‐term patterns of exercise during aging and its physiological effects in a well‐controlled 
environment. One‐year‐old male (n = 30) and female (n = 30) mice were divided into equal size 
cohorts and aged for an additional year. One cohort was given access to voluntary running 
wheels while another was denied exercise other than home cage movement. Body mass, 
composition, and metabolic traits were measured before, throughout, and after 1 year of 
treatment. Long‐term exercise significantly prevented gains in body mass and body fat, while 
preventing loss of lean mass. We observed sex‐dependent differences in body mass and 
composition trajectories during aging. Wheel running (distance, speed, duration) was greater in 
females than males and declined with age. We conclude that long‐term exercise may serve as a 
preventive measure against age‐related weight gain and body composition changes, and that 
mouse inbred strains can be used to characterize effects of long‐term exercise and factors (e.g.
                                               
5 The following work was previously published: McMullan RC, Kelly SA, Hua K, Buckley 
BK, Faber JE, Pardo-Manuel de Villena F and D Pomp. 2016. Long-term exercise in mice 
has sex-dependent benefits on body composition and meatoblism during aging. 
Physiological Reports: 4, e13011. Supporting figures are located in Appendix A.  
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sex, age) modulating these effects. These findings will facilitate studies on relationships 
between exercise and health in aging populations, including genetic predisposition and 
genotype‐by‐environment interactions. 
2.2 Introduction 
It has been estimated that Americans older than 65 years‐age will double in number 
from 40 million in 2010 to 81 million by 2040 (67). During the aging process, individuals 
generally experience a gain in body fat, redistribution of body fat, increase in intramuscular fat, 
and a decrease in lean mass and bone density (5, 19, 68). These concomitant changes in body 
composition and body mass are thought to be due to alterations in resting metabolic rate 
StOnge:2010ba}. It is common for energy expenditure to decline due to slower metabolism, 
decreased lean mass, and less physical activity (69). Further, the loss of lean mass during 
aging may cause dysregulation of energy expenditure via decreased basal metabolic rate 
(BMR) (70, 71), reduced physical fitness, and lower quality of life (72). Accompanying 
alterations in body composition and metabolism, physical activity levels decline with aging in 
both rodents (73-75) and humans (76, 77) in part due to the changes in skeletal muscle 
structure and function (67). Meanwhile, chronic health issues, such as obesity and other 
metabolic and cardiac conditions, increase with age in humans (7). 
It is well established that regular aerobic exercise results in beneficial health outcomes including 
among others, prevention or delay of diseases such as heart disease, stroke, certain forms of 
cancer, and dementia. In addition, physical activity is effective in weight management, 
regulation of obesity risk (8, 78, 79), and mitigation of physiological changes (e.g. muscle loss) 
that contribute to decline in exercise capacity with aging (67, 80, 81). Even though much 
literature suggests that regular exercise in elderly individuals mitigates age‐related decline in 
health, three‐fourths of older adults do not meet the recommended levels of exercise (82). 
Despite the benefits of exercise some individuals do not exercise or fail to experience positive 
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response to exercise treatments (8, 19, 78, 79, 83). Thus, developing a better understanding of 
the physiological effects of exercise during aging is vital for application to the growing aged 
human population (67). 
Exercise traits (e.g. amount, intensity) vary depending on sex in both humans and 
rodents. In humans, physical activity traits are greater in males compared to females, whereas, 
females run further and at greater speeds than males in multiple mouse strains (40, 84). Sex 
differences exist in body weight, composition, and energy metabolism in both humans and 
rodents. In both humans and rodents, females tend to maintain white adipose tissue and resist 
loss of these energy stores, compared to males. Human females have greater adipose mass, 
greater brown adipose mass, store adipose in different regions, have lower lean mass and 
greater circulating free fatty acids (FFA) than males. Even with these sex differences, females 
maintain glucose homeostasis in part because estrogen (E2) concentrations are tightly 
regulated between puberty and menopause (85). In both sexes, E2 regulates adipose 
development and deposition, body composition, energy balance, mitochondrial function, fatty 
acid transport and oxidation, and glucose metabolism. Postmenopausal women display a loss of 
E2, which leads to alterations in metabolism, body weight gain, and increased visceral fat in 
both humans and rodents (86-89). 
Habitual low‐intensity exercise (over 100 days) results in cardiorespiratory and metabolic 
adaptations, specifically the loss of fat mass and maintenance of fat‐free mass (77). However, 
there is a relative lack of knowledge regarding the effects of long‐term exercise (exercise > 3 
months) or the effects of exercise initiated during midlife. Animal models provide a time‐efficient 
alternative to longitudinal human studies, which are difficult and expensive to conduct. However, 
most rodent studies have examined the impact of habitual exercise for short periods [6 to 
~60 days (90)] in young mice (typically 60 days old). Previous studies on long‐term exercise in 
mice demonstrated positive outcomes on median lifespan, maintenance of motor coordination, 
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and altered expression of genes involved in heart and immune function (74, 91, 92). However, 
there is a gap in knowledge regarding long‐term exercise patterns during aging, the metabolic 
response to long‐term exercise, and the effect of sex on these traits in a controlled environment. 
In this report, we examined long‐term voluntary exercise patterns in an aging mouse 
population of C57BL/6J mice. The present results represent data collected within a larger 
experiment aiming to understand the impact of exercise, beginning at mid‐life and extending 
through the aging process, in protection against disease. The C57BL/6J strain was selected 
because it is the most widely used in biomedical research, is the mouse reference genome (93), 
and is commercially available at mid‐age. The median lifespan for C57BL/6J males is 901 days 
(30 months) and 866 days (28.8 months) for females (94). We examined physiological response 
to voluntary exercise in both sexes of C57BL/6J mice starting at ~1 year‐age until ~2 years‐age, 
which is equivalent to ~40–70 years in humans (95). We demonstrate that long‐term exercise 
even with decreasing physical workload provides beneficial outcomes on body weight and 
composition during aging, and that it does so in a sex‐dependent manner. In addition, our 
findings on metabolic response to physical activity during aging may aid establishing guidelines 
for exercise in the aging human population. 
2.3 Methods 
2.3.1 Animals 
Thirty male and 30 female C57BL/6J mice were purchased from the National Institute of 
Aging at 1 year of age and after arrival at University of North Carolina‐Chapel Hill were allowed 
to acclimate to the vivarium for 1 week. Mice were then assessed by Echo MRI for body weight 
and composition (EchoMRI‐100, Echo Medical Systems, Houston, TX) and placed into 
individual indirect calorimetry cages (Phenomaster/Labmaster, TSE SYSTEMS, Chesterfield, 
MO) for 48 h with O2 consumption and CO2 production, energy expenditure and food and water 




Following initial body composition and metabolic measures, animals in the experimental 
cohort were individually housed with access to running wheels (Lafayette Instruments, 
Lafayette, IN; model 80850L), while animals in the control cohort were single‐housed with 
access to ordinary lab‐animal enrichment (mouse huts) but no access to running wheels. 
Voluntary running was recorded at 1‐min intervals for 23–24 h a day for 12 months. The 
following daily exercise parameters were obtained: distance (total revolutions), time spent 
running (cumulative 1‐min intervals in which at least 1 revolution was recorded), average speed 
(total revolutions/time spent running), and maximum speed (highest number of revolutions in 
any 1‐min interval within a 24‐h period) (96). 
Body weight and composition were measured by MRI every 60 days; these 
measurements were conducted for all mice on the same day, except as noted below. Animals in 
both groups were removed from their respective cages for 48 h of indirect calorimetry 
assessment after 6 months and again after 1 year. At both time points, and again due to 
limitations in the number of indirect calorimetry cages, MRI measurement of body weight and 
body composition (obtained just prior to placement in the indirect calorimeters) for all 60 mice 
required 26 days; the initial 30 mice measured were from the experimental cohort, while the final 
30 mice measured were from the control group. Throughout the paper, we refer to the age of 
the mice as either ~1, ~1.1, ~1.4, ~1.5, ~1.6, ~1.8 or ~2 years representing an approximate age 
of 372, 423, 520, 549, 606, 669, or 731 days. The approximate age at each phenotype time 
point was calculated as the mean age in days from the actual age in days of each individual 
mouse at the time of data collection. 
Four mice in the experimental group died during the first 3 months of the experiment. 
Three of these mice died prior to the measures at ~1.1 years (~423 days) of age and the fourth 
prior to the measures at ~1.4 years (~520 days) of age. These mice were included in statistical 
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analyses of all measures prior to their death. Upon death, each of these four mice was replaced 
with an individual previously placed into the control group. Upon replacement and granting of 
wheel access these mice were placed in the experimental group for all subsequent statistical 
analyses. This was done to maintain sample size in the experimental cohort, and had no impact 
on results relative to removal of these mice from the analyses (data not shown). All procedures 
were approved by and conducted in accordance with the guidelines set forth by the Institutional 
Animal Care and Use Committee at the University of North Carolina at Chapel Hill. 
2.3.2 Statistical analysis 
Estimated marginal means and standard errors of body mass (g), percent body fat and 
percent lean mass were calculated at the beginning of the experiment at a mean age of ~1 year, 
and every other month over the next year. Percent body fat (and lean) was calculated as (fat 
mass/body mass) × 100. Percent change in variables [(pre–post/pre) × 100] was calculated 
relative to the prior measurement. Estimated marginal means and standard errors of RER were 
calculated at a mean age of ~1, ~1.5, and ~2 years of age. Measures represent diurnal (lights 
on) means on day‐2 of a 2‐day trial. Home cage activity was monitored for two consecutive 
days and mean activity levels were analyzed. General Linear Models (GLM) [Univariate GLM 
analysis of variance (ANOVA) (SPSS, Chicago, IL)] were utilized to examine the effects of 
sex (fixed effect), wheel access (fixed effect), and the sex‐by‐wheel access interaction on all 
phenotypic measurements. Statistical significance was defined as P < 0.05, and all P‐values 
presented are two‐tailed. GLM for data collected from TSE equipment also included the 
following covariates in the analysis: Activity, mean of the diurnal home cage activity on day‐2 of 
the 2‐day trial; Batch, reflects group that individuals were tested in within a given time point; 
VO2 (mL/kg/h), VCO2 (mL/kg/h), and RER values represent the diurnal (lights on) means on 
day‐2 of the 2‐day trial. Additionally, for a subset of the phenotypes, repeated measures 
ANOVAs [GLM (SPSS, Chicago, IL)] were utilized to investigate the effects of age across all 
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groups (sex and experimental vs. control). 
Estimated marginal means and standard errors were calculated for the physical activity 
traits (mean revolutions per day, mean time spent running per day, mean running speed per 
day). Measures were represented as means across 57 weeks. Comparisons between sexes 
were analyzed, using GLM (SPSS, Chicago, IL). Wheel freeness was included in models as a 
covariate. Wheel freeness was calculated as the number of wheel revolutions following 
acceleration to a given velocity. Pearson partial correlations (r; controlling for sex) were 
calculated for revolutions/day (distance), 1‐min intervals/day (time, cumulative 1‐min intervals in 
which at least one revolution was recorded), and average running speed (total revolutions/time 
spent running) and metabolic traits at ~1, ~1.5, and ~2 years. Pearson partial correlations (r; 
controlling for sex and wheel access) were calculated for physical activity traits and body 
composition traits at ~1, ~1.1, ~1.4, ~1.5, ~1.6, ~1.8, ~2 years. Pearson partial correlations (r; 
controlling for sex and wheel access) were calculated for body composition and metabolic traits 
at ~1, ~1.5, ~2 years. Degrees of freedom ranged from 20 to 54. 
2.4 Results 
For simplicity, we first summarize data for metabolic changes across aging in control 
mice (no wheel access) to establish “baseline” phenotypes, and then describe experimental 
data across time for mice provided wheel access in the following sections: (1) patterns of 
exercise, (2) impact of exercise on metabolic changes, and (3) exercise‐by‐sex interactions on 
metabolic changes. 
2.4.1 Age and sex contribute to metabolic changes in control mice 
The body mass of control C57BL6/J mice increased during aging from ~1 to ~2 years, 
and body mass changes occurred in a sex‐dependent manner (Fig. 2.1A). Over the entire 
period studied, males weighed significantly (P < 0.001) more than females (Table 2.1, Table S1, 
Fig. 2.1A). Additionally, there were significant sex effects on body mass changes between 
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measurement time points except from ~1.5 to ~1.8 years (P < 0.05, Fig. 2.1A, Table 2.1). In 
control male mice, we observed an initial increase in body mass (~1 to ~1.4 years), stable body 
mass levels in the midsection of our study (~1.4 to ~1.6 years) and a decline in body mass at 
older ages (~1.6 to ~2 years). In contrast, in control female mice, body mass remained stable 
early (~1 to ~1.1 years) and then increased for the remainder of the study (~1.1 to ~2 years) 
(Fig. 2.1A, Table S1).  
Body composition also changed during aging in control mice (Fig. 2.1B, C). One‐year‐
old females had lower body fat and higher lean mass than males, but the situation reversed 
itself as the mice aged. Males had greater percent body fat and lower percent lean mass than 
females until ~1.6 years of age when females had greater percent body fat and lower percent 
lean mass than males. Overall the pattern of increase in body fat in both sexes closely followed 
the changes in body mass (compare Fig. 2.1A and B). In females increases occurred over the 
length of the study, while in males there was initial increase in body fat, followed by a period of 
stabilization and a final decrease (Fig. 2.1B). The patterns for lean mass are similar but inverted 
(Fig. 2.1A, C). Significant (P < 0.05) sex effects on body fat (Table 2.1, Fig. 2.1B), lean mass 
(Table 2.1, Fig. 2.1C) and changes in percent fat and lean mass between consecutive 
measurements were observed for most time points (Table 2.1). The changes in both percent 
body fat and percent lean mass during aging in control mice occurred in a sex‐dependent 
manner (Fig. 2.1B, C, Table S1). 
Indirect calorimetry was performed three times on all mice: at the beginning of the 
experiment (~1 year) at ~1.5 years and at ~2 years of age (Table 2.2, Table S2). Over the 
period of study, RER levels ranged from 0.78 to 0.88 in control mice (Fig. 2.2, Table S2). In 
control males, VO2, VCO2, and RER levels were lower at ~1 year compared to ~1.5 years and 
greater at ~1.5 years compared to ~2 years (Table S2, Fig. 2.2). Female control mice had lower 
VO2, VCO2 and RER levels at ~1 year compared to ~1.5 years; whereas, females had greater 
VCO2 and RER levels and reduced VO2 levels at ~1.5 years compared to ~2 years (Table S2, 
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Fig. 2.2). We observed significant sex effects on VO2 and VCO2 at all three time points, with 
females having greater values (P < 0.05, Table S2). There was only a significant sex effect on 
RER levels at ~2 years (P = 0.025, Table S2). Finally, there was a significant difference in RER 
levels at ~2 years compared to ~1 and ~1.5 years in both males and females (P < 0.01, Fig. 
2.2). 
Food intake (as measured in the indirect calorimeters) was lower at ~1.5 years 
compared to ~1 year and greater at ~2 years compared to ~1.5 years in aging control mice. 
Water intake increased during aging in both sexes in the control cohorts. There were significant 
sex effects on food and water consumption at ~1 year and ~1.5 years (P < 0.005) and 
significant sex effects on water consumption at ~2 years (P = 0.001, Table 2.3). There were 
significant sex effects on home cage activity levels at all time points (P < 0.05). Female mice 
had greater levels of home cage activity compared to male mice (Table 2.3, Table S2). 
2.4.2 Long‐term physical activity varies during aging in a sex‐dependent manner 
In the experimental cohorts of both sexes, we observed an increase in mean revolutions 
per day (distance) after mice gained wheel access (weeks 1 through 5 in Fig. 2.3A). 
Subsequently, distance run declined over the 57 weeks of wheel access. During weeks 25 and 
51, mice were removed from their home cage and placed in metabolic cages (no wheel access) 
for 48 h and returned to their home cage after the metabolic measurements. After both 
metabolic analysis time points, there was an increase in distance run for several weeks, 
followed by a stabilization and decline (Fig. 2.3A). Exercise duration followed similar patterns as 
daily distance except there was no initial increase in duration over the first few weeks of wheel 
access (Fig. 2.3B). Mean average running speed (rpm) also followed similar patterns as 
distance (Fig. 2.3C). Thus, we observed an age‐related decline in all aspects of physical activity 
over the one‐year experimental period. 
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Females ran longer distances, for longer duration, and at higher speeds than males 
throughout the 57 weeks of wheel access. The sex effects were significant (P < 0.05) for 
distance from weeks 1–45 (~1 to ~1.85 years of age) of voluntary exercise. Similarly, significant 
sex effects on duration were observed during weeks 1–48 and week 54 (P < 0.05, Fig. 2.3B). 
There were very few weeks with significant sex effects on speed, although females had higher 
rpm than males and rpm slightly decreased with age in both sexes (Fig. 2.3C). Females 
demonstrated slightly different patterns of exercise in the early part of the study compared to 
males. Females had a sharper increase in distance (weeks 1–5) and a sharper decrease in 
distance (weeks 5–12) compared to male mice (Fig. 2.3A). 
2.4.3 Physical activity protects from age‐related metabolic changes 
Overall body mass was significantly lower in experimental mice compared to control 
mice at all time points, with experimental mice having ~16% less body mass during ~ 1.1 to ~2 
years (P < 0.05, Table 2.1, Fig. 2.1A, Table S1). Specifically, experimental mice followed similar 
temporal patterns of body mass changes as control mice but at significantly lower body mass. 
Female experimental mice had from 6 to 22 percent less body mass than female control mice. 
Male experimental mice had 11–19 percent less body mass than male control mice during aging 
(Table 2.1, Fig. 2.1A, Table S1). 
Wheel access had a significant effect on body composition. Experimental mice had 
~50% less body fat and ~15% more lean mass than control mice throughout the study. There 
were significant effects of exercise on percent fat and lean mass and on change in percent lean 
between experimental time points throughout the experiment (P < 0.001). Female experimental 
mice had 34–59% less percent body fat and 6–20% more percent lean mass than female 
control mice during aging from ~1.1 to ~2 years‐old. Thus, female mice with wheel access had 
~52% less fat and ~16% more lean mass than control female mice from ~1.1 to 2 years. Male 
experimental mice had 44–55% less percent body fat and 9–17% more percent lean mass than 
male control mice during aging from ~1.1 to ~2 years. Male mice with wheel access had on 
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average ~49% less body fat and ~15% more lean mass than control male mice from ~1.1 to ~2 
years. There was only a significant wheel effect on change in percent fat observed between ~1 
and ~1.1 years (P < 0.001). In the experimental cohort, female mice retained greater 
percentage lean mass than males until ~1.6 years old (Fig. 2.1C, B, Table 2.1, Table S1). 
Wheel access only had a significant effect on VCO2 and RER at ~1.5 years (P < 0.04, Table 
2.2, Table S2). RER levels in the experimental cohort increased with aging. RER levels in the 
experimental females increased from ~1 to ~1.5 years then remained stable from ~1.5 to ~2 
years (Fig. 2.2). 
Both food and water intake increased during aging in both sexes in the experimental 
cohort (Table S2). There was a significant wheel access effect on food and water consumption 
at ~1.5 years (P < 0.005) and on food consumption at ~2 years (P = 0.025, Table 2.3). Food 
and water intake was greater in experimental females than in experimental males. Both 
experimental males and females had greater food and water intake at both ~1.5 and ~2 years 
than control mice (Table S2). There was a slight decline in activity levels in control mice access 
during aging; whereas, experimental mice had an increase in home cage activity levels during 
aging but these effects were not significant except at ~2 years (P = 0.004, Table 2.3, Table S2). 
2.4.4 Exercise‐by‐sex interactions on metabolic changes during aging 
We only observed a few significant exercise‐by‐sex interactions on metabolic changes 
during the aging process. The majority of the significant interactions on metabolic phenotypes 
collected by indirect calorimetry were observed at ~1.5 years. Significant interactions on percent 
change in mass and percent change in percent lean mass existed at ~1.4 and ~1.6 years (P < 
0.05, Table 2.1, Fig. 2.1A). There was a significant exercise‐by‐sex interaction on RER levels 
observed at ~1.5 years and on VCO2 levels at ~1.5 and ~2 years. Females with wheel access 
had greater RER levels than control females at ~1.5 years; whereas males in both cohorts had 
the same RER levels at ~1.5 years (Fig. 2.1C, Table 2.2, Table S2). 
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2.4.5 Phenotypic correlations between exercise and metabolic traits during aging 
As expected, all physical activity phenotypes (distance, speed, time) were significantly 
and positively correlated at each time point during aging (Tables 2.4, 2.5). Body mass was 
significantly and positively correlated with percent fat and percent lean mass during aging. 
Distance and speed were significantly and negatively correlated with change in mass and 
change in percent lean mass at ~1.1 years (Table 2.5). VCO2 was significantly and positively 
correlated with VO2 and RER during aging. Exercise distance and time were significantly and 
positively correlated with RER levels at ~2 years but not at ~1 and ~1.5 years (Table 2.4). Body 
mass, percent fat, and percent lean mass were significantly correlated with RER at ~1 and ~1.5 
years but not at ~2nyears (Table 2.6). For a complete list of correlational analyses results see 
Tables 2.4, 2.5, 2.6. 
2.5 Discussion 
2.5.1 Physical activity prevents age‐related, sex‐dependent changes in body mass and 
composition 
The most interesting conclusion of this study is that regular long‐term exercise starting in 
midlife prevents body mass and body composition alterations observed during aging in both 
male and female mice. Mice that exercised had 16% lower body mass, 50% lower body fat, and 
15% higher lean mass than mice who were not exposed to running wheels. The changes in 
body mass were not significantly correlated with specific physical activity measurements 
(distance, time, speed) indicating that engaging in exercise, and not the specific workout load, is 
potentially sufficient for maintenance of body weight and composition throughout aging. This 
may aid formulating recommendations of exercise in the aging human population, since it 
demonstrates that exercise even in reduced amount may be sufficient to alleviate age‐related 
changes in body mass and composition, at least in mice, although there could be a threshold of 
activity below which benefits are not achieved. 
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Changes in body mass and body composition during aging followed sex‐dependent 
trajectories in both experimental and control mice. It has been established that sex differences 
exist in physical activity levels, body mass, body composition, and metabolism in both humans 
and rodents (40, 84, 97, 98). In humans, cross‐sectional studies have suggested there are 
different trajectories of changes in body fat depending on sex (99). Both longitudinal and cross‐
sectional studies in humans have shown men and women gain weight specifically due to greater 
amount of fat than lean mass when less than 60 years old. Men older than 60 years display loss 
of weight and body fat. The trajectory for body composition changes in women after the age of 
60 years has not been established (99). Our findings demonstrate that there are sex differences 
in the trajectories of body mass and body composition changes during aging long‐term. In both 
sexes, introducing exercise midlife prevented accumulation of age‐related changes in body 
mass and composition. Even though work load declined during aging, participating in physical 
activity was still sufficient to protect against age‐related changes in body mass and composition 
in a sex‐dependent manner. There were significant exercise‐by‐sex interactions on changes in 
body mass and composition during aging, indicating exercise alters body mass and composition 
in a sex‐dependent manner. Interestingly, similar sex‐dependent trajectories of body mass and 
composition were observed in the experimental and control mice and could be attributed to the 
regulation of food intake in conjunction with increased activity. Food consumption is typically 
positively correlated with wheel running, but the extent of the effects can be sex dependent and 
contingent on initial body composition differences (19). Future experiments, monitoring food 
consumption more regularly, are needed to determine the underlying causes of sex‐dependent 
trajectories of body mass and composition during aging. 
2.5.2 Physical activity levels change during aging in a sex‐dependent manner 
Physical activity levels decline as humans age (76). The CDC surveillance data have 
found that 17% of adults 45–64 years‐old, 23% of adults 65–74 years‐old, and 36% of adults 
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75+ years‐old remain physically inactive (100). In the current experiment, we observed a 
decline in exercise levels during voluntary participation over 12 months. There was an initial 
increase in distance and speed for the first 5 weeks of exercise followed by a decrease in 
physical activity. This also occurred after each indirect calorimetry measurement wherein mice 
were removed from the wheels for 48 h. These observations may extend from behavioral 
responses to a novel environment (new home cage, wheel access), adaption to the wheel, and 
potentially trained exercise ability. Novel environments induce stress response‐eliciting 
behavioral responses, such as increased activity to rewarding stimuli (101-103). In particular, 
C57BL/6J mice respond to novel cage environment (with wheel access) by increased wheel 
activity (101). 
We observed a sex effect on physical activity, in which females ran greater distance and 
duration than males, consistent with previous reports (104). These sex effects disappeared 
around ~46–49 weeks of exercise or ~23 months of age. However, after the initial 5 weeks of 
wheel access, females showed a sharp decline in physical activity and males showed a gradual 
decline in physical activity. There are several possible explanations for these declines. The 
decrease could be due to aging. Another possible explanation is loss of environmental novelty 
and habituation (105). Lastly, decline in physical activity could result from reduced E2 levels. 
Acyclicity in rodents has been established as the menopausal transition, which occurs in human 
females during aging (106). Although we do not have data for acyclicity, we would expect 
female mice to begin acyclicity at ~390–480 days (13–16 m) (86, 107, 108). E2 contributes to 
regulating adipose development, exercise levels, and age‐related changes in body composition. 
Both human and animal studies have shown a decline in of E2 production causes insulin 
resistance, and exercise mitigates the resulting glucose intolerance and composition changes 
(40, 85, 87, 88, 109). Estrogen deficiency in postmenopausal women and ovariectomized 
rodents leads to higher RER levels, reduced lipid oxidation, and greater carbohydrate oxidation 
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during rest and exercise (85, 86). 
The decrease in physical activity levels, body mass changes, and percent fat changes in 
males that we observed during aging could also be due to hormonal changes. Reduction in 
testosterone levels during aging in males decreases fat‐free mass and increases body fat (110). 
Additionally, physical activity levels are reduced in male rodents, including C57BL/6J, after 
castration (40). Hormonal changes during aging may also explain the sex‐dependent changes 
in physical activity levels, body mass, body composition, and metabolism that we observed. 
2.5.3 Changes in metabolism in response to aging and exercise 
RER (ratio of CO2 production to O2 consumption) is used to indirectly determine relative 
use of carbohydrates or lipids for energy expenditure. Higher RER values (e.g. 1.0) indicate 
greater carbohydrate use; whereas lower RER values (e.g. 0.7) indicate greater lipid oxidation. 
Individuals, both rodents and humans, with sedentary lifestyles normally have higher RER 
values and lower fat oxidation. Physically active individuals tend to demonstrate lower RER 
values than untrained individuals in response to exercise (66, 111). Previous studies have 
shown that older C57BL/6J mice (660 days, ~1.8 years), compared to young mice (90 days), 
have greater body mass, reduced lean mass, VO2 and RER, greater FFAs, and lower 
triglycerides (112). Sex differences in RER also exist. Females tend to store FFAs as 
triglycerides, which in turn assists in fat storage; whereas males oxidize circulating FFAs. Under 
increased energy demands from exercise, women oxidize a greater proportion of lipids versus 
carbohydrates than men, thus exercise results in lower RER in females (86). We found that 
aging C57BL/6J mice had higher resting RER levels, especially at ~2 years, indicating a 
preference toward carbohydrate utilization in aged individuals. Most interestingly, female mice 
with wheel access had greater resting RER levels than control females. Thus, females utilize 
more carbohydrates as an energy source in response to exercise; whereas, male mice had no 
difference in RER levels in response to exercise. 
We observed a decrease in both oxygen consumption (VO2) and carbon dioxide 
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production (VCO2) during aging. Both VO2 consumption and VCO2 production are thought to 
be a proxy for the amount of metabolism occurring (e.g. more VO2 consumed and the more 
VCO2 produced the more metabolism occurring). We expected both VO2 and VCO2 to 
decrease during aging since metabolism and BMR are reduced with age (69-71). Although VO2 
and VCO2 are used as proxies for metabolism, we cannot determine the efficiency of 
metabolism (e.g. the amount of ATP produced relative to oxygen intake) with only those 
measurements. We would expect VO2 to be positively correlated with running distance since we 
would expect a higher metabolism with greater running distance. It is possible the observed 
nonsignificant negative correlation of VO2 and running distance at 2 years of age could be due 
to a more efficient utilization of VO2 consumed in exercise‐trained mice. 
In conclusion, this study demonstrates that exercise in mice protects against age‐related 
alterations in body mass, body composition and metabolism in both sexes. We showed that 
patterns of physiological changes during aging vary by sex. Additionally, sex impacts exercise 
abilities and physiological responses to exercise during aging. However, the benefits occur 
despite the significant differences in physiological and exercise ability between the sexes. We 
conclude that exposure to exercise from midlife on has significant benefits in mice that may 
extend to humans. Further studies need to determine if the benefits from long‐term exercise 
during aging occur due to exposure to exercise at a specific time and/or for specific duration of 
time. Future studies should investigate the effect of exercise in other outcomes such as 
cognitive function, cancer, heart disease, etc. Our results support the contention that laboratory 
mice are a valuable model to study the effects of age and exercise. In particular, the mouse 
could be used to add a genetic dimension to these studies, given the plethora of existing genetic 







Estimated marginal means and standard errors of (A) body mass (g), (B) percent body fat, and 
(C) percent lean mass beginning at approximately one year of age and extending over the 
course of the following year. Wheel access (experimental) or no wheel access (control) was 
granted after the measurement at ~1 year of age. (A) At all time points, General Linear Models 
(GLM) revealed that males weighed significantly more than females (P < 0.05) and, with the 
exception of age ~1 year (immediately prior to wheel access), wheel access significantly 
reduced mass (P < 0.05). No significant sex‐by‐wheel access interactions were detected. 
However, at ~1.1 years of age, following the first 51 days of wheel access, the sex‐by‐wheel 
access interaction (F1, 52 = 3.354; P = 0.073) suggested that wheel access reduced body mass 
to a greater extent among male mice. For panels (B) and (C), at a given mean age, an “i” 
indicates a significant (P < 0.05) interaction, a “s” indicates a significant effect of sex, and a “w” 





Respiratory exchange ratio during aging and across experimental groups (sex; treatment). 
Repeated measure analysis of variance (ANOVAs) [GLM (SPSS, Chicago, IL)] revealed a 
significant effect of age across all groups (sex and experimental vs. control) (P < 0.05). Pairwise 
comparisons indicated that RER at ~ 2 years was significantly higher compared to ~1 year (P < 
0.001) or ~1.5 years (P < 0.001). Additionally, within each treatment group a similar trend was 




Figure 2.3 Estimated marginal means and standard errors of mean (A) revolutions per day, (B) 
time (i.e., cumulative 1 min intervals in which at least 1 revolution was recorded) spent running, 
and (C) running speed (mean revolutions/mean running time) across 57 weeks. (A) 
Comparisons between sexes by General Linear Models (GLM) revealed females ran 
significantly more than males during weeks 1–45. During weeks 46–57 there was no significant 
difference between the sexes. (C) Comparisons between sexes by GLM revealed females ran 





Effects of sex (male vs. female) and exercise (wheel vs. no wheel) on body composition. 
Measures were taken beginning at approximately one year of age and extended over the course 
of the following year. 
 
Trait N Sex Wheel Access Interaction 
~Day 372     
Body mass (g) 59 F1, 55 = 199.689 p < 0.001 
F1, 55 = 2.127 
p = 0.150 
F1, 55 = 0.094 
p = 0.760 
% Fat 59 F1, 55 = 3.092 p = 0.084 
F1, 55 = 0.767 
p = 0.385 
F1, 55 = 0.749 
p = 0.390 
% Lean 59 F1, 55 = 2.174 p = 0.146 
F1, 55 = 1.400 
p = 0.242 
F1, 55 = 1.349 
p = 0.250 
~Day 423     
Body mass (g) 56 F1, 52 = 213.576 p < 0.001 
F1, 52 = 20.102 
p < 0.001 
F1, 52 = 2.911 
p = 0.094 
% Fat 56 F1, 52 = 25.098 p < 0.001 
F1, 52 = 33.781 
p < 0.001 
F1, 52 = 5.575 
p = 0.022 
% Lean 56 F1, 52 = 22.356 p < 0.001 
F1, 52 = 30.530 
p < 0.001 
F1, 52 = 2.750 
p = 0.103 
% Change in Mass 55 F1, 51 = 7.896 p = 0.007 
F1, 51 = 25.754 
p < 0.001 
F1, 51 = 1.769 
p = 0.189 
% Change in % Fat 55 F1, 51 = 10.332 p = 0.002 
F1, 51 = 32.134 
p < 0.001 
F1, 51 = 1.313 
p = 0.257 
% Change in % Lean 55 F1, 51 = 18.918 p < 0.001 
F1, 51 = 24.674 
p < 0.001 
F1, 51 = 1.840 
p = 0.181 
~Day 520     
Body mass (g) 54 F1, 50 = 97.594 p < 0.001 
F1, 50 = 38.151 
p < 0.001 
F1, 50 = 0.040 
p = 0.842 
% Fat 54 F1, 50 = 6.494 p = 0.014 
F1, 50 = 51.438 
p < 0.001 
F1, 50 = 0.053 
p = 0.818 
% Lean 54 F1, 50 = 4.942 p = 0.031 
F1, 50 = 50.711 
p < 0.001 
F1, 50 = 0.042 
p = 0.839 
% Change in Mass 53 F1, 49 = 7.414 p = 0.009 
F1, 49 = 37.680 
p < 0.001 
F1, 49 = 16.525 
p < 0.001 
% Change in % Fat 53 F1, 49 = 4.128 p = 0.048 
F1, 49 = 2.212 
p = 0.143 
F1, 49 = 8.603 
p = 0.005 
% Change in % Lean 53 F1, 49 = 5.763 p = 0.020 
F1, 49 = 40.322 
p < 0.001 
F1, 49 = 0.410 
p = 0.525 
~Day 549     
Body mass (g) 53 F1, 49 = 80.383 p < 0.001 
F1, 49 = 42.233 
p < 0.001 
F1, 49 = 0.073 
p = 0.789 
% Fat 53 F1, 49 = 4.164 p = 0.047 
F1, 49 = 74.067 
p < 0.001 
F1, 49 = 0.771 
p = 0.384 
% Lean 53 F1, 49 = 2.503 p = 0.120 
F1, 49 = 71.116 
p < 0.001 
F1, 49 = 0.313 
p = 0.578 
% Change in Mass 52 F1, 48 = 0.226 p = 0.637 
F1, 48 = 2.763 
p = 0.103 
F1, 48 = 0.449 
p = 0.506 
% Change in % Fat 52 F1, 48 = 0.135 p = 0.715 
F1, 48 = 0.060 
p = 0.807 
F1, 48 = 0.178 
p =0.675 
% Change in % Lean 52 F1, 48 = 2.975 p =0.091 
F1, 48 = 60.021 
p < 0.001 
F1, 48 = 0.258 
p = 0.614 
~Day 606     
Body mass (g) 53 F1, 49 = 55.311 p < 0.001 
F1, 49 = 40.734 
p < 0.001 
F1, 49 = 0.417 
p = 0.521 
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Statistical significance was judged at P < 0.05 (in bold), and all P‐values presented are two‐
tailed. 
  
% Fat 53 F1, 49 = 0.502 p = 0.482 
F1, 49 = 51.737 
p < 0.001 
F1, 49 = 0.199 
p = 0.657 
% Lean 53 F1, 49 = 0.091 p = 0.764 
F1, 49 = 44.899 
p < 0.001 
F1, 49 = 0.277 
p = 0.601 
% Change in Mass 53 F1, 49 = 6.902 p = 0.011 
F1, 49 = 0.539 
p = 0.466 
F1, 49 = 6.539 
p = 0.014 
% Change in % Fat 53 F1, 49 = 8.162 p = 0.006 
F1, 49 = 0.383 
p = 0.539 
F1, 49 = 11.721 
p = 0.001 
% Change in % Lean 53 F1, 49 = 0.696 p = 0.408 
F1, 49 = 45.924 
p < 0.001 
F1, 49 = 0.023 
p = 0.880 
~Day 669     
Body mass (g) 51 F1, 47 = 31.317 p < 0.001 
F1, 47 = 27.705 
p < 0.001 
F1, 47 = 0.029 
p = 0.866 
% Fat 51 F1, 47 = 3.458 p = 0.069 
F1, 47 = 51.524 
p < 0.001 
F1, 47 = 0.442 
p = 0.509 
% Lean 51 F1, 47 = 3.438 p = 0.070 
F1, 47 = 43.578 
p < 0.001 
F1, 47 = 0.026 
p = 0.873 
% Change in Mass 51 F1, 47 = 2.240 p = 0.141 
F1, 47 = 7.599 
p = 0.008 
F1, 47 = 0.704 
p = 0.406 
% Change in % Fat 51 F1, 47 = 13.176 p = 0.001 
F1, 47 = 1.476 
p = 0.231 
F1, 47 = 1.226 
p = 0.274 
% Change in % Lean 51 F1, 47 = 1.306 p = 0.259 
F1, 47 = 53.151 
p < 0.001 
F1, 47 = 0.162 
p = 0.689 
~Day 731     
Body mass (g) 49 F1, 45 = 8.647 p = 0.005 
F1, 45 = 16.183 
p < 0.001 
F1, 45 = 1.515 
p = 0.225 
% Fat 49 F1, 45 = 11.882 p = 0.001 
F1, 45 = 31.040 
p < 0.001 
F1, 45 = 2.794 
p = 0.225 
% Lean 49 F1, 45 = 13.721 p = 0.001 
F1, 45 = 25.857 
p < 0.001 
F1, 45 = 2.409 
p = 0.128 
% Change in Mass 49 F1, 45 = 18.171 p < 0.001  
F1, 45 = 0.512 
p = 0.478 
F1, 45 = 12.510 
p = 0.001 
% Change in % Fat 49 F1, 45 = 17.647 p < 0.001 
F1, 45 = 0.225 
p = 0.638 
F1, 45 = 0.216 
p = 0.644 
% Change in % Lean 49 F1, 45 = 10.069 p = 0.003 
F1, 45 = 35.749 
p < 0.001 
F1, 45 = 3.765 




Table 2.2.  
Effects of sex (male vs. female) and exercise (wheel vs. no wheel) on metabolic parameters. 
Measures were taken at ~1 year (prior to running wheel exposure), ~1.5, and ~2 years of age 
Statistical significance was judged at P < 0.05 (in bold), and all P‐values presented are two‐
tailed. 
  
Trait N Sex Wheel Access Interaction Activity Batch 
~Day 372       
VO2 (ml/kg/h) 59 
F1, 53 = 189.696 
p < 0.001 
F1, 53 = 0.036 
p = 0.850 
F1, 53 = 2.991 
p = 0.090 
F1, 53 = 2.614 
p = 0.112 
F1, 53 = 0.007 
p = 0.936 
VCO2 (ml/kg/h) 59 
F1, 53 = 114.856 
p < 0.001 
F1, 53 = 0.027 
p = 0.651 
F1, 53 = 0.264 
p = 0.610 
F1, 53 = 1.482 
p = 0.229 
F1, 53 = 0.144 
p = 0.706 
RER (VCO2/VO2) 59 
F1, 53 = 2.642 
p = 0.110 
F1, 53 = 0.552 
p = 0.461 
F1, 53 = 1.486 
p = 0.228 
F1, 53 = 0.106 
p = 0.746 
F1, 53 = 0.049 
p = 0.826 
~Day 549       
VO2 (ml/kg/h) 44 
F1, 38 = 93.906 
p < 0.001 
F1, 38 = 1.390 
p = 0.246 
F1, 38 = 0.006 
p = 0.939 
F1, 38 = 1.553 
p = 0.220 
F1, 38 = 0.085 
p = 0.772 
VCO2 (ml/kg/h) 44 
F1, 38 = 55.383 
p < 0.001 
F1, 38 = 6.102 
p = 0.018 
F1, 38 = 4.703 
p = 0.036 
F1, 38 = 0.010 
p = 0.921 
F1, 38 = 0.070 
p = 0.793 
RER (VCO2/VO2) 44 
F1, 38 = 2.863 
p = 0.099 
F1, 38 = 9.835 
p = 0.003 
F1, 38 = 14.044 
p = 0.001 
F1, 38 = 3.037 
p = 0.089 
F1, 38 = 0.041 
p = 0.840 
~Day 731       
VO2 (ml/kg/h) 45 
F1, 39 = 5.351 
p = 0.026 
F1, 39 = 0.446 
p = 0.508 
F1, 39 = 3.864 
p = 0.056 
F1, 39 = 7.405 
p = 0.010 
F1, 39 = 1.054 
p = 0.311 
VCO2 (ml/kg/h) 45 
F1, 39 = 9.370 
p = 0.004 
F1, 39 = 0.038 
p = 0.846 
F1, 39 = 5.137 
p = 0.029 
F1, 39 = 4.147 
p = 0.049 
F1, 39 = 0.050 
p = 0.824 
RER (VCO2/VO2) 45 
F1, 39 = 5.473 
p = 0.025 
F1, 39 = 3.430 
p = 0.072 
F1, 39 = 1.521 
p = 0.225 
F1, 39 = 0.402 
p = 0.530 
F1, 39 = 3.071 





Effects of sex (male vs. female) and exercise (wheel vs. no wheel) on home cage activity. 
Measures were taken at ~1 year (prior to running wheel exposure), ~1.5, and ~2 years of age 
Statistical significance was judged at P < 0.05 (in bold), and all P‐values presented are two‐
tailed. 
  
Trait Trans N Sex Wheel Access Interaction Batch 
~Day 372       
Home Cage Activity  59 F1, 54 = 26.973 p < 0.001 
F1, 54 = 0.170 
p = 0.682 
F1, 54 = 0.025 
p = 0.874 
F1, 54 = 0.035 
p = 0.852 
Food Consumption  59 F1, 54 = 15.459 p < 0.001 
F1, 54 = 0.055 
p = 0.815 
F1, 54 = 0.416 
p = 0.521 
F1, 54 = 0.281 
p = 0.598 
Water Consumption lg10 59 F1, 54 = 9.912 p = 0.003 
F1, 54 = 0.253 
p = 0.617 
F1, 54 = 7.284 
p = 0.009 
F1, 54 = 0.249 
p = 0.620 
~Day 549       
Home Cage Activity  44 F1, 39 = 6.070 p = 0.018 
F1, 39 = 1.166 
p = 0.287 
F1, 39 = 10.402 
p = 0.003 
F1, 39 = 9.860 
p = 0.003 
Food Consumption  44 F1, 39 = 13.352 p = 0.001 
F1, 39 = 11.025 
p = 0.002 
F1, 39 = 8.609 
p = 0.006 
F1, 39 = 0.724 
p = 0.400 
Water Consumption  43 F1, 38 = 10.837 p = 0.002 
F1, 38 = 9.618 
p = 0.004 
F1, 38 = 0.792 
p = 0.379 
F1, 38 = 4.231 
p = 0.047 
~Day 731       
Home Cage Activity  45 F1, 40 = 32.582 p < 0.001 
F1, 40 = 9.624 
p = 0.004 
F1, 40 = 1.815 
p = 0.186 
F1, 40 = 9.831 
p = 0.003 
Food Consumption  45 F1, 40 = 3.232 p = 0.080 
F1, 40 = 5.452 
p = 0.025 
F1, 40 = 1.869 
p = 0.179 
F1, 40 = 1.858 
p = 0.180 
Water Consumption  44 F1, 39 = 14.398 p = 0.001 
F1, 39 = 4.002 
p = 0.052 
F1, 39 = 0.009 
p = 0.926 
F1, 39 = 0.437 





Pearson partial correlations for mean running traits during week 1, week 25, and week 51 of 
wheel access and metabolic traits measured immediately prior to each time point. Approximate 
age of individuals is one year, 1.5, and 2 years 
 
Pearson partial correlations (r; controlling for sex) are shown. NA (Not Applicable) represents 
correlations that cannot be calculated since the measurements depend on a prior experimental 
time point. *P < 0.05. **P < 0.001. 
  
  Age 





Distance:Time 0.932** 0.943** 0.938** 
Distance:Speed 0.793** 0.827** 0.706** 
Distance:VO2 0.04 -0.097 -0.127 
Distance:VCO2 -0.002 0.049 0.26 
Distance:RER -0.042 0.165 0.538* 
Time:Speed 0.554* 0.661* 0.439* 
Time:VO2 0.011 -0.067 -0.184 
Time:VCO2 0.04 0.211 0.192 
Time:RER 0.07 0.374 0.486* 
Speed:VO2 0.075 -0.059 0.108 
Speed:VCO2 -0.005 -0.058 0.314 
Speed:RER -0.095 -0.024 0.387 
VO2:VCO2 0.837** 0.753** 0.745* 
VO2:RER 0.088 0.162 0.037 





Pearson partial correlations for mean running traits during week 1, 7, 21, 25, 33, 42, 51 of wheel 
access and body composition measured immediately prior to each time point. 
 
 Age 











Distance:Time 0.923** 0.857** 0.942** 0.917** 0.918** 0.880** 0.930** 
Distance:Speed 0.762** 0.877** 0.834** 0.804** 0.857** 0.834** 0.683** 
Distance:Mass -0.108 -0.366 -0.456* -0.266 -0.24 -0.276 -0.166 
Distance:% Fat 0.042 -0.266 -0.544* -0.267 -0.338 -0.322 -0.232 
Distance:% 
Lean 0.002 0.029 0.483
* 0.272 0.293 0.271 0.109 
Distance:% Δ in 
Mass NA -0.515
* -0.278 -0.122 0.023 -0.257 0.23 
Distance:% Δ in 
%Fat NA -0.487
* -0.381 0.157 -0.088 -0.103 -0.004 
Distance:% Δ in 
% Lean NA 0.004 0.515
* 0.412* 0.282 0.322 0.172 
Time:Speed 0.492* 0.567* 0.642** 0.579* 0.605* 0.504* 0.39 
Time:Mass -0.15 -0.431* -0.454* -0.186 -0.205 -0.119 -0.026 
Time:% Fat 0.005 -0.336 -0.529* -0.128 -0.19 -0.049 -0.093 
Time:% Lean 0.035 0.099 0.447* 0.118 0.143 0.006 -0.006 
Time:% Δ in 
Mass NA -0.302 -0.157 -0.055 0.001 -0.097 0.308 
Time:% Δ in 
%Fat NA -0.575
* -0.311 0.163 0.032 0.075 0.002 
Time:% Δ in % 
Lean NA 0.067 0.484
* 0.235 0.161 0.067 0.04 
Speed:Mass -0.026 -0.356 -0.421* -0.453* -0.307 -0.412* -0.396 
Speed:% Fat 0.037 -0.352 -0.529* -0.563* -0.554* -0.558* -0.488* 
Speed:% Lean -0.001 0.126 0.479* 0.570* 0.525* 0.509* 0.383 
Speed:% Δ in 
Mass NA -0.620
** -0.269 -0.05 0.105 -0.31 0.043 
Speed:% Δ in 
%Fat NA -0.345 -0.311 0.167 -0.17 -0.225 -0.099 
Speed:% Δ in % 
Lean NA 0.126 0.511
* 0.662** 0.494* 0.548* 0.445* 
Mass:% Fat 0.752** 0.882** 0.824** 0.868** 0.800** 0.799** 0.739** 
Mass:% Lean -0.766** -0.619** -0.833** -0.866** -0.784** -0.802** -0.751** 
Mass:% Δ in 
Mass NA 0.16 0.463
* 0.197 0.248 0.301 0.189 
Mass:% Δ in 
%Fat NA 0.332 0.12 0.056 0.084 0.238 0.148 
Mass:% Δ in % 
Lean NA -0.706
** -0.774** -0.743** -0.783** -0.817** -0.777** 
% Fat:% Lean -0.986** -0.700** -0.792** -0.950** -0.981** -0.992** -0.969** 
% Fat:% Δ in 
Mass NA 0.224 0.403




Pearson partial correlations (r; controlling for sex) are shown. NA (Not Applicable) represents 
correlations that cannot be calculated since the measurements depend on a prior experimental 
time point. *P < 0.05. **P < 0.001. 
  
% Fat:% Δ in 
%Fat NA 0.396
* 0.419* 0.165 0.118 0.416* 0.497* 
% Fat:% Δ in % 
Lean NA -0.791
** -0.797** -0.821** -0.946** -0.990** -0.989** 
% Lean:% Δ in 
Mass NA -0.411
* -0.406* -0.231 -0.136 -0.207 -0.091 
% Lean:% Δ in 
%Fat NA -0.408
* -0.16 -0.117 -0.198 -0.398* -0.527* 
% Lean:% Δ in 
% Lean NA 0.961
** 0.890** 0.857** 0.950** 0.990** 0.989** 
% Δ in Mass:% 
Δ in %Fat NA 0.591
* 0.567* 0.459* 0.653** 0.536* 0.202 
% Δ in Mass:% 
Δ in % Lean NA -0.299 -0.33 -0.091 -0.123 -0.164 -0.069 
% Δ in %Fat:% 






Pearson partial correlations for mean body composition traits and metabolic traits measured 
immediately prior to wheel access. 
 
Pearson partial correlations (r; controlling for sex) are shown. NA (Not Applicable) represents 
correlations that cannot be calculated since the measurements depend on a prior experimental 
time point. *P < 0.05. **P < 0.001.
 1 
  Age 
Traits ~1 year ~1.5 years ~2 years 
Mass:% Fat 0.776** 0.911** 0.884** 
Mass:% Lean -0.763** -0.894** -0.879** 
Mass:% Δ in Mass NA 0.343* 0.567** 
Mass:% Δ in % Fat NA 0.108 0.401* 
Mass:% Δ in % Lean NA -0.869** -0.895** 
Mass:VO2 -0.511
** -0.655** -0.558** 
Mass:VCO2 -0.632
** -0.600** -0.512* 
Mass:RER -0.504** -0.376* -0.031 
% Fat:% Lean -0.984** -0.991** -0.986** 
% Fat:% Δ in Mass NA  0.320* 0.504* 
% Fat:% Δ in % Fat NA 0.181 0.580** 
% Fat:% Δ in % Lean NA  -0.921** -0.973** 
% Fat:VO2 -0.654
** -0.619** -0.499* 
% Fat:VCO2 -0.735
** -0.567** -0.492* 
% Fat:RER -0.471** -0.345* -0.12 
% Lean:% Δ in Mass NA  -0.316* -0.483* 
% Lean:% Δ in % Fat NA  -0.175 -0.602** 
% Lean:% Δ in % Lean NA  0.925** 0.974** 
% Lean:VO2 0.644
** 0.633** 0.478* 
% Lean:VCO2 0.709** 0.549** 0.448* 
% Lean:RER 0.436** 0.302* 0.053 
% Δ in Mass:% Δ in % Fat NA  0.528** 0.424* 
% Δ in Mass:% Δ in % Lean NA  -0.221 -0.480* 
% Δ in Mass:VO2 NA  -0.299 -0.616** 
% Δ in Mass:VCO2 NA  -0.25 -0.605** 
% Δ in Mass:RER NA  -0.109 -0.139 
% Δ in % Fat:% Δ in % Lean NA  0.064 -0.480* 
% Δ in % Fat:VO2 NA  -0.036 -0.247 
% Δ in % Fat:VCO2 NA  -0.088 -0.202 
% Δ in % Fat:RER NA  -0.121 0.041 
% Δ in % Lean:VO2 NA  0.587** 0.508* 
% Δ in % Lean:VCO2 NA  0.458* 0.487* 
% Δ in % Lean:RER NA  0.211 0.087 
VO2:VCO2 0.850** 0.818** 0.923** 
VO2:RER 0.229 0.320* 0.117 
VCO2:RER 0.701** 0.799** 0.486* 
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CHAPTER 3: THE COLLABORATIVE CROSS POPULATION IS A SYSTEM GENETICS 
RESOURCE TO STUDY EXERCISE AND EXERCISE-RELATED TRAITS 
3.1 Introduction 
Exercise and subsequent physiological responses are highly variable, complex traits 
influenced by genomics, environment and their interactions. Exercise has numerous health 
benefits and is commonly used as a therapeutic and preventative for a variety of chronic 
diseases (15, 16). Despite the known benefits of exercise, there is still individual variability 
in physiological adaptations to exercise (16, 18, 19, 45, 54). In order to fully understand 
genomic and molecular mechanisms driving variation and complexity in exercise and 
exercise-related traits, a systems genetics based approach needs to be utilized. Human 
studies are often confounded by numerous variables making it difficult to identify underlying 
genetic mechanisms of exercise-related phenotypes. Animal models are valuable for 
dissecting the genetic and molecular mechanism of exercise-induced adaptations due to 
the ability to control genetic background, standardize phenotypic measurements and 
regulate environmental variables (41, 52, 54). The Collaborative Cross (CC) offers a 
systems genetics based platform to dissect complex traits. It overcomes the limited range 
of phenotypic and genotypic diversity in common murine models since the CC is derived 
from eight founder strains from the three Mus musculus subspecies. The CC enables 
improved accuracy of phenotypic measurement and data integration across a variety of 
factors (e.g. exercise type, age, sex, diet, etc) in the same genetic backgrounds due to 
inbred nature of the CC strains and the genomic tools available for analysis of CC strains 
(54, 55, 58). Mathes et al. (2011) examined exercise and exercise related traits in pre-CC 
mice (partially inbred). The pre-CC study demonstrated high phenotypic diversity in
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exercise and exercise related traits. A subset of ~17% of pre-CC mice had an adverse body 
fat response to exercise suggesting the CC population could be a rich source of adverse 
physiological adaption models (66). The purpose of this study was to demonstrate the CC 
population is a useful system genetics resource for studying exercise and exercise-related 
traits. In order to understand the exercise abilities and responder types present in the CC 
population, we screened 50 CC strains for forced endurance abilities and 43 corresponding 
CC strains for voluntary exercise abilities and subsequent body mass and composition 
responses. As expected we observed phenotypic variability in exercise and exercise-
related traits across the CC strains. We demonstrated the CC population to be a useful 
source for identifying model strains for human exercise-related traits. In particular, 
CC027/GeniUnc females were identified as a potential model for adverse body composition 
response to voluntary exercise. 
3.2 Materials and Methods 
3.2.1 Mice 
Female mice from 50 CC strains were obtained from another project (National 
Institutes of Health U19AI100625) or from the System Genetics Core at UNC-Chapel Hill. 
The female mice in the experiment were all retired breeders and varied in life history (e.g. 
number of litters, most recent litter, etc) and age. Prior to and during the experiment, all 
mice had ad libitum access to standard laboratory chow (Envigo 2920 irradiated chow) and 
water in a temperature controlled (23° +/- 1°C) and humidity-monitored vivarium with a 
standard 12:12 h light:dark cycle (lights on at 0700h). All CC strains were at least 85% 
inbred (determined by genotyping of the most recent common ancestor born in 2011-2013) 
with 41 strains ~90% (or greater) inbred. Additional information regarding the CC strains 
can be found at http://csbio.unc.edu/CCstatus/index.py (55, 59). All procedures performed 
within this experiment were approved by the University of North Carolina – Chapel Hill 




3.2.2 Body mass and composition measurements 
Body composition was assessed using whole body MRI (EchoMRI 3-in-1 Body 
Composition Analyzer, EchoMRI, Houston, TX) to determine fat and lean mass content (in 
grams) for each animal. Body mass (g) was recorded at the time of each MRI. Body fat 
percentage and lean mass percentage were calculated relative to body mass at each time 
point. All measurements were collected in the morning between 0700 and 1200h. 
3.2.3 Forced Endurance Cohort 
Forced endurance distance was measured in 50 CC strains (total of 232 aged mice; 
age range: 4.27-18.23 months; age mean: 10.39 months) across 26 treadmill batches 
starting in February 2015 and ending in June 2016. Mice in the forced endurance cohort 
were group housed with mice from the same strain in standard laboratory cages. Forced 
endurance was measured on Exer-3/6 treadmill (Columbus Instruments, Columbus, OH) 
after three adaptation days (Table 3.7) followed by one maximal performance day (Table 
3.7) that measured distance traveled. Max forced endurance distance was recorded when 
the individual mouse failed to run either from the inability to continue treadmill running or 
the refusal to continue running despite extra stimulus from the shock grid and prodding. For 
treadmill protocols refer to Table 3.7. Body mass and composition was collected prior to the 
start of day 1 of treadmill acclimation. 
3.2.4 Forced Endurance Cohort—Statistical Analysis 
A summary of descriptive statistics (mean, variance, standard deviation, standard 
error) for each CC strain across all traits can be found in Table 3.1. All statistical analyses 
were conducted in the R environment (CRAN). Linear models were generated to assess 
the variance in endurance distance and contribution from strain (genetic background) 
and/or each potential mediator (age, baseline body mass, baseline body fat percentage, 
and baseline lean mass percentage). Base linear models (only one mediator as a fixed 
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effect; “Model F#a”), additive models (mediator and Strain; “Model F#b”) or interaction 
models (mediator and Strain; “Model F#c”) were generated. Nested ANOVA analysis was 
performed to assess statistical significance of model fit for adding additional explanatory 
variables. Models are as follows: 
Model F1a: distance ~ Strain 
Model F2a: distance ~ Age 
Model F2b: distance ~ Age + Strain 
Model F2c: distance ~ Age*Strain 
Model F3a: distance ~ Body Mass 
Model F3b: distance ~ Body Mass + Strain 
Model F3c: distance ~ Body Mass*Strain 
Model F4a: distance ~ Body Fat % 
Model F4b: distance ~ Body Fat % + Strain 
Model F4c: distance ~ Body Fat %*Strain 
Model F5a: distance ~ Lean Mass % 
Model F5b: distance ~ Lean Mass % + Strain 
Model F5c: distance ~ Lean Mass %*Strain 
3.2.5 Voluntary Exercise Cohort 
Aged female mice (n = 186; age range: 5.27 – 22.50 months; age mean: 11.28 
months) across 43 CC strains were exposed to one month of voluntary exercise in 17 
batches starting in August 2015 and ending in September 2016. Mice in the voluntary 
exercise cohort were individually housed in standard laboratory cages with attached 
running wheels (1.1m circumference; Lafayette Industries Lafayette, IN). Mice were allowed 
ad libitum access to running wheels for a month (~28 days). Voluntary wheel running data 
was recorded continuously in 1-min intervals (as number of revolutions) over the month 
using an automated activity wheel monitoring program (AWM, Lafayette Industries, 
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Lafayette, IN). Food was weighed prior to the start of the experiment, two weeks after the 
start of the experiment and at the end of the experiment (one month). Any food spillage was 
collected and weighed (113). Body mass and composition was measured and recorded 
prior to the experiment, mid experiment (two weeks) and at the end of the experiment (one 
month). All measurements were collected in the morning between 07:00 and 12:00. 
3.2.6 Voluntary Exercise Cohort – Calculations 
Three body mass and composition responses were calculated: total response (one 
month), response 1 (week1-2), and response 2 (week3-4). Body mass response was 
calculated as [((Post body mass – Pre body mass)/ Pre body mass)*100%]. Body 
composition (body fat % and lean mass %) response was calculated as [((Post %– Pre %)/ 
Pre %)*100%]. Food intake (FI) was calculated as [Pre food weight – post food weight] for 
both week1-2 and week3-4. Adjusted food intake (FIa) was calculated as [FI/Pre Body 
Mass]. 
The following physical activity measurements were obtained for each day of wheel 
access: distance (total revolutions x 1.1 m), duration (cumulative 1-min intervals in which at 
least 1 revolution was recorded), and average speed (total revolutions/total duration) (96). 
For week1-2 (days1-14), week3-4 (days15-28), month (days1-28) of wheel access the 
following were calculated using the calculated daily physical activity measurements: total 
distance (km), total duration (min) and average speed (m/min).  
3.2.7 Voluntary Exercise Cohort – Statistical analysis 
A summary of descriptive statistics (mean, variance, standard deviation, standard 
error) for each trait across all CC strains can be found in Tables 3.2 and Table 3.3. Linear 
models were generated to assess the variance in response (body mass, body fat and lean 
mass response) and contribution from strain (genetic background) and/or each potential 
mediator (distance, duration, speed, food intake). Base linear models (only one mediator as 
a fixed effect; “Model V2a”), additive models (mediator and Strain; “Model V2b”) or 
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interaction models (mediator and Strain; “Model V2c”) were generated. Nested ANOVA 
framework analysis was performed to assess statistical significance of model fit for adding 
additional explanatory variables. Models are as follows: 
Model V1a: Response ~ Strain 
Model V2a: Response ~ Mediator 
Model V2b: Response ~ Mediator + Strain 
Model V2c: Response ~ Mediator*Strain 
Phenotypic pearson’s correlations and statistical significance of each correlation was 
obtained using the Hmisc package and are provided in Table 3.6. 
3.2.8 Data Availability 
All raw data for both the forced endurance and voluntary exercise experiment are 
publically available at https://phenome.jax.org. Forced endurance data set is Mouse 
Phenome Database (MPD): McMullan1. Voluntary exercise data sets are MPD: McMullan2 
and McMullan3. In addition for both forced endurance and voluntary exercise experiments, 
tables containing general descriptive statistics for each trait are located in Table 3.1, 3.2 
and 3.3. 
3.3 Results 
3.3.1 Forced endurance distance varied by 16.5 fold across 50 CC strains. 
Forced endurance distance was measured in 232 mice across 50 CC strains. 
Genetic background had a significant effect on forced endurance distance (p<2.2x10-6; 
Model F1a). The strain mean endurance distance in the CC population varied 16.5 fold 
ranging from 275m to 4,819m. Thirteen CC strains had a mean endurance distance above 
2,371m with CC001/Unc having the greatest strain mean endurance distance of 4,819.33m. 
Eleven strains had a mean endurance distance below 1,038m. Furthermore, endurance 
distance across the CC population had a large population variance and variance within 
each CC strain differed based on CC strain (Figure 3.1, Table 3.1).  
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 Baseline body mass and composition varied significantly by genetic background 
(p<2.2x10-16). Strain means for baseline body mass ranged from 18.97g to 36.02g across 
the 50 CC strains with an overall mean of 27.75g. Baseline body fat percentage ranged 
from a strain mean of 0.90% to 31.96% with an overall mean of 14.70%. CC strain means 
for baseline lean mass percentage ranged from 63.42% to 91.32% with an overall mean of 
78.08%. Genetic background contributed more to forced endurance distance than any 
baseline body mass or composition mediator alone (Model F3a vs F3b p<2.2x10-6; Model 
F4a vs F4b p<2.2x10-6; Model F5a vs F5b p<2.2x10-6) signifying genetic background was 
driving forced endurance distance. Thus, baseline body mass, body fat percentage, and 
lean mass percentage did not have a significant effect on forced endurance distance 
(Figure 3.2 A-C, Table 3.1). Although, there were significant correlations between 
endurance distance and baseline body mass (r=-0.372, p=4.87x10-09), body fat percentage 
(r=-0.298, p=3.80x10-06) and lean mass percentage (r=0.302, p=2.80x10-06). Age also 
varied across the forced endurance cohort (Figure 3.2 D, Table 3.1). There was a 
significant genetic background by age interaction on endurance distance (Model F2a vs 
F2b p<2.2x10-6; Model F2c vs F2b p=0.00816). In addition, there was a significant negative 
correlation between age and endurance distance (r=-0.269, p=3.3x10-05) indicating older 
mice had lower forced endurance distance. 
3.3.2 The CC population is a source of potential model strains for adverse body 
composition responses induced by voluntary exercise 
Genetic background had a significant effect on body fat percentage response at 
each time point (1 month p=6.09x10-09; week1-2 p=6.32x10-08; week3-4 p=6.096x10-09). 
Body fat percentage response to one month of voluntary exercise ranged from ranged from 
-64.5% to 91.0% across CC strain means with an overall mean of -17.95%. Twelve CC 
strains (of 43) had an adverse fat response to a month of voluntary exercise. In the first two 
weeks of exercise (week1-2), strain means ranged from -67.8% to 50.5% with an overall 
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mean of -22.8%. Five of the 43 CC strains had an adverse fat response to week1-2 of 
exercise. However, in the second two weeks of exercise (week3-4), fat response ranged 
from -23.4% to 54.4% with an overall mean of 7.3%. Interestingly, 27 of the 43 CC strains 
had an adverse fat response to week3-4 of exercise. This suggests that as voluntary 
exercise is continued, there is a greater chance of an adverse fat response. CC063/Unc, 
CC070/TauUnc and CC027/GeniUnc were the only strains with consistent adverse fat 
responses means at week1-2, week3-4 and the month (Figure 3.3, Table 3.2).  
Genetic background had a significant effect on lean mass percentage response at 
each time point (1 month p=3.4x10-04; week1-2 p=7.44x10-10; week3-4 p=3.4x10-04). Strain 
means for lean mass percentage response to a month of voluntary exercise ranged from -
7.6% to 23.1% across the 43 CC strains with an overall mean of 5.5%. Seven CC strains 
had an adverse lean mass response (loss of lean mass) to one month of exercise. Lean 
mass response ranged from -3.2% to 20.6% (overall mean 5.6%) for week1-2 and from -
13.7% to 14.3% (overall mean of -0.1%) for week3-4. There were six CC strains with 
adverse lean mass response to week1-2 of exercise and 20 CC strains with adverse lean 
mass response to week3-4 of exercise, thus in most strains there was a pattern of lean 
muscle response that mirrored body fat response over the course of the exercise. 
CC063/Unc, CC070/TauUnc, CC027/GeniUnc and CC040/TauUnc were the only strains 
with consistent adverse lean mass responses means at week1-2, week3-4 and one month 
(Figure 3.4, Table 3.2).  
Finally, genetic background had a significant effect on body mass response at each 
time point (1 month p=0.01388; week1-2 p=1.15x10-08; week3-4 p=0.013). Body mass 
response was measured for voluntary exercise in CC strains and during one month of 
exercise ranged from -19.4% to 23.1% across the 43 CC strains with an overall mean of -
5.5%. Eight CC strains had an adverse body mass response (gain of body mass) to one 
month of exercise. Body mass response ranged from -20.0% to 23.2% (overall mean of -
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5.6%) for week1-2 and from -19.9% to 28.6% (overall mean of 0.6%) for week3-4. There 
were six CC strains with adverse body mass response to week1-2 of exercise and 27 CC 
strains with adverse body mass response to week3-4 of exercise. CC052/GeniUnc, 
CC070/TauUnc, CC027/GeniUnc and CC040/TauUnc were the only strains with consistent 
adverse body mass responses means at week1-2, week3-4 and one month (Figure 3.5, 
Table 3.2).  
Both baseline body mass and composition and adjusted food intake varied across 
the 43 CC strains in the voluntary cohort (Table 3.2, Figures 3.6 and 3.7). 
3.3.3 Voluntary physical activity levels vary extensively across 43 CC strains 
Over a month of voluntary exercise, total distance ranged from 6.9 to 232.9 km 
(Figure 3.8 A), cumulative duration ranged from 2,191 to 13,829 (Figure 3.9 A) and average 
speed ranged from 2.7 to 19.7 m/min (Figure 3.10 A) for CC strain means. 
Total distance ranged from 4.0 to 112.2 km for week1-2 (Figure 3.8 B) and 2.8 to 117.4 km 
for week3-4 (Figure 3.8 C), cumulative duration ranged from 1,279 to 6,887 for week1-2 
(Figure 3.9 B) and 881.3 to 6,806 for week3-4 (Figure 3.9 C) and average speed ranged 
from 2.6 to 20.1 m/min for week1-2 (Figure 3.10 B) and 2.7 to 21.1 m/min for week3-4 
(Figure 3.10 C) for CC strain means (Table 3.3). This suggests that while there is strain 
variation for the three measures of physical activity (Figure 3.8, Figure 3.9, Figure 3.10), the 
amount of exercise is consistent across the measured time points. 
3.3.4 Genetic background has a more significant contribution to body mass and 
composition response to one month of voluntary exercise than physical activity 
levels, food intake or age alone 
In the voluntary exercise cohort, all mediators (distance, duration, speed, and 
adjusted food intake) were under genetic control at each time point (1 month, week1-2, and 
week3-4) (Table 3.4). To determine if these potential mediators alone can explain any of 
the responses, linear models of the mediator alone were compared to additive models 
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(mediator + genetic background) for each body mass and composition response at every 
time point. Then, interaction models (mediator*genetic background) were compared to the 
additive models for each body mass and composition response to determine if any 
interactions had a significant effect on observed responses. Genetic background 
contributed more than each mediator (distance, duration, speed, adjusted food intake) 
alone for body mass response. There was a significant genetic background by mediator 
(distance, duration, speed, adjusted food intake) interaction on body mass response at 
week1-2. For both body fat percentage and lean mass percentage response at 1 month 
and week1-2, genetic background had a more significant contribution than each mediator 
alone (distance, duration, speed, adjusted food intake) alone. Whereas, genetic 
background did not have a significant additive effect on body fat percentage and lean mass 
percentage response at week3-4 compared to the mediators alone (distance, duration, 
speed, adjusted food intake). This observation indicates that genetic background does not 
add any additional information for body composition response during week3-4, although all 
mediators were genetically regulated during week3-4. Interestingly, there were significant 
genetic background by mediator (distance, duration, speed, and adjusted food intake) 
interactions (at some or all of the time points) on body fat percentage response. Genetic 
background contributed more to all responses at each time point (with the exception of 
body fat percentage and lean mass percentage response at week3-4) than age alone 
(Table 3.5). Overall, genetic background drives body mass and composition responses to 
voluntary exercise in the CC. During week3-4, genetic background did not add any more 
additional information than the genetically regulated mediators.  
All phenotypic correlations and their significance are located in Table 3.6. There 
were no significant correlations between physical activity traits and body mass and 
composition responses with each time point with the exception of fat response. Fat 
response during week1-2 was significantly and negatively correlated with duration (week1-
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2; r=-0.18, p=0.015) and speed (week1-2; r=-0.15, p=0.042). Fat response during week3-4 
was significantly and positively correlated with duration (week3-4; r=0.17, p=0.02). Food 
intake was also significantly correlated with some body mass and composition responses 
(Table 3.6). Therefore, lower duration and speed during week1-2 resulted in greater fat 
gain; whereas, greater duration during week3-4 was associated with greater fat gain. 
3.4 Discussion 
3.4.1 CC027/GeniUnc as a potential model for voluntary exercise-induced adverse 
body composition response 
As expected based on exercise studies performed in the pre-CC population (66) and 
studies of other traits performed in the CC (60-63), the CC population has a broad 
phenotypic range for exercise and responses to exercise along with the presence of 
extreme outlier strains. It is likely that the genetic diversity of the eight founder inbred 
strains of the CC and unique combinations of alleles makes the CC population a rich 
source of new models of human disease traits. This dataset in particular is useful for 
selecting potential CC strains for model development of different exercise related traits. 
CC027/GeniUnc is a potential model for adverse body fat and lean mass response induced 
by voluntary exercise (at all time points). CC027/GeniUnc had an overall strain mean body 
fat percentage response of 93.8% to one month of voluntary exercise (46.9% week1-2; 
32.1% week3-4). Additionally, CC027/GeniUnc had the highest voluntary exercise distance 
over one month (232.9 km strain mean). Food intake and food composition are important 
for body composition regulation post exercise (114). One possible reason for the observed 
muscle mass breakdown and fat mass build up could be due to extensive aerobic activity 
combined with the lack of appropriate (amount and/or nutritional content) food intake 
(resulting in reduced resting metabolic rate). Other possible reasons include preferential 
metabolic breakdown of carbs and proteins over fats or altered cortisol levels. These 
reasons are all speculative and future studies will be necessary to determine the genetic 
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and molecular mechanism driving the adverse body composition responses in 
CC027/GeniUnc. Identifying genetic and molecular architecture of physiological adaptations 
to exercise will be valuable in deriving personalized exercise recommendations for 
individuals and particular populations. 
This dataset is useful for selecting CC strains for model development for other 
exercise-related traits such as physical inactivity. For example, CC010/GeniUnc, 
CC028/GeniUnc and CC059/TauUnc had mean total distance less than 15km over a month 
of voluntary exercise. These CC strains could be useful for studying motivation to engage in 
exercise (via voluntary exercise) and genetic mechanisms regulating physical activity. 
Potential CC model strains will be important in future research for identifying the underlying 
genetic and biological mechanisms regulating physical activity and subsequent adaptations 
in order to improve health and physical activity (115). 
While this dataset is useful for selecting potential model strains, it is important to 
note this dataset contains confounding caveats. All mice in the dataset were female, varied 
in older age and were retired breeders. Additionally, the voluntary exercise dataset does 
not have a control (no exercise) cohort to compare body mass and composition responses 
alongside. Thus, future studies may not replicate these findings in different sexes, ages and 
life histories. Still, this dataset provides valuable information on a large number of CC 
strains and can be used to identify potential model strains for a variety of exercise-related 
phenotypes. 
3.4.2 Increased presence of adverse responders during week 3-4 of voluntary 
exercise 
Interestingly, more strains with exercise-induced adverse body fat responses were 
observed during week3-4 measurements (27 strains) than week1-2 measurements (5 
strains). There were significant correlations between fat response week3-4 and duration 
and food intake. It is unlikely that duration is driving the adverse fat responses during 
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week3-4 since duration at week1-2 and week3-4 are highly correlated (r=0.79). Food intake 
was also significantly and positively correlated with fat response week3-4 thus could 
potentially explain the increase in adverse responder strains observed (Table 3.6). It is 
common for individuals to exhibit compensatory behaviors, such as increased food intake 
especially increased carbohydrate intake, in response to exercise. Increased food intake in 
response to exercise can reduce health benefits of exercise (16). Previous studies in mice 
have observed positive correlation between food intake and running distance (19). 
3.4.3 The presence and magnitude of individual variation differs across CC strains 
As this dataset demonstrated there is extensive phenotypic range in exercise and 
exercise-related traits observed in the CC population. It is important to note that while the 
strain means reported for each phenotype are informative, it is vital to examine the 
individual measurements for each individual within a strain. We observed a range of 
individual variation for each trait measurement and CC strain (variance within strains is 
reported in Table 3.1-3.3). Some CC strains had very little variance while other CC strains 
had large variance. For example, CC028/GeniUnc had little within strain variance for total 
voluntary exercise distance over one month (var=5.05, n=4) and CC055/TauUnc had large 
within strain variation (var=9,276, n=8) (Figure 3.8 A, Table 3.3). Thus, individual variation 
was observed in genetically homogeneous CC strains and variance levels fluctuated across 
strains and traits. While this study demonstrates genetic background is important for each 
of these exercise and exercise-related traits, other potential factors are influencing the 
same traits. It is likely environmental differences and genetic background-by-environment 
interactions are driving some of the observed individual variation not accounted for in these 
studies. CC population is ideal for dissection of complex traits due to its reproducible nature 
and genetic diversity. 
 
54 
3.4.4 Forced endurance and voluntary exercise are two distinct but complementary 
traits 
Both forced and voluntary exercise programs are used in rodents as a method to 
measure exercise performance and other exercise-related traits. In rodents, voluntary 
exercise by means of running wheel is believed to model voluntary exercise as observed in 
human populations. Voluntary exercise is a self-rewarding behavior and a complex trait that 
not only captures physical activity habits but also represents engagement in neural and 
physiological mechanisms required for the behavior. While both forced and voluntary 
depend on common variables (e.g. physiological systems, organ function), there are distinct 
factors to each program including: psychological desire to run, fear, pain perception, shock 
avoidance, etc (116), (78), (51). In this study there was a significant and positive correlation 
between CC strains mean forced endurance distance and voluntary exercise distance 
(r=0.316, p=0.044). However, some strains did not have correlated forced endurance and 
voluntary exercise distances. For example, CC011/Unc has a strain mean of ~150km of 
voluntary exercise over a month yet has a low strain mean for forced endurance distance 
(~440m). Thus this observation indicates there are distinct factors to the voluntary and 
forced programs for CC011/Unc. While CC011/Unc has the physical ability to engage in 
exercise, it is likely a unique factor distinct to forced endurance (treadmills) preventing the 
strain from achieving a greater distance. Whereas, CC059/TauUnc had a strain mean of 
1,864m for forced endurance but low voluntary exercise levels over a month (6.9km). Most 
likely, CC059/TauUnc lacks the motivation to engage in voluntary exercise or doesn’t find 
the behavior self-rewarding; while the strain has the ability to exercise as demonstrated by 






Figure 3.1. Forced Endurance Distance (m) across 50 CC strains. 
Each dot represents an individual mouse within a CC strain. Data is ordered by the CC 







































































































































































































































































































































































































































































































































































































Figure 3.2. Baseline traits in the forced endurance cohort. 
Baseline body mass (g) (A), baseline body fat percentage (B), baseline lean mass 
percentage (C) and age (m) at the start of the experiment (D) for all mice in the forced 
endurance cohort. Each dot represents an individual mouse within a CC strain. Data is 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.3. Body fat response to voluntary exercise in 43 CC strains. 
Body fat response (%) to one month (A), week1-2 (B), and week3-4 (C) of voluntary 
exercise. Each dot represents an individual mouse within a CC strain. Data above 0 
represents an adverse fat response and data below 0 represents a standard response. 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.4. Lean mass response to voluntary exercise in 43 CC strains. 
Lean mass response (%) to one month (A), week1-2 (B), and week3-4 (C) of voluntary 
exercise. Each dot represents an individual mouse within a CC strain. Data above 0 
represents a standard response and data below 0 represents an adverse lean mass 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.5. Body mass response to voluntary exercise in 43 CC strains. 
Body mass response (%) to one month (A), week1-2 (B), and week3-4 (C) of voluntary 
exercise. Each dot represents an individual mouse within a CC strain. Data above 0 
represents an adverse body mass response and data below 0 represents a standard 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.6. Baseline body mass and composition traits in the voluntary exercise cohort. 
Baseline body mass (g) (A), baseline body fat percentage (B), baseline lean mass 
percentage (C) prior to exercise in the voluntary exercise cohort. Each dot represents an 
individual mouse within a CC strain. Data is ordered by the CC strain median for total 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.7. Adjusted food intake during voluntary exercise. 
Adjusted food intake during week1-2 (A) and week3-4 (B) of voluntary exercise. Each dot 
represents an individual mouse within a CC strain. Data is ordered by the CC strain median 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.8. Voluntary exercise distance in 43 CC strains. 
Total distance (km) during one month (A), week1-2 (B), and week3-4 (C) of voluntary 
exercise. Each dot represents an individual mouse within a CC strain. Data is ordered by 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.9. Voluntary exercise duration in 43 CC strains. 
Total duration (1-min intervals) during one month (A), week1-2 (B), and week3-4 (C) of 
voluntary exercise. Each dot represents an individual mouse within a CC strain. Data is 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.10. Voluntary exercise speed in 43 CC strains. 
Mean speed (m/min) during one month (A), week1-2 (B), and week3-4 (C) of voluntary 
exercise. Each dot represents an individual mouse within a CC strain. Data is ordered by 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.11. Correlation between voluntary exercise distance and forced endurance 
distance in 43 CC strains. 
Total distance (m) is represented as a strain mean for both voluntary exercise (VE) and 
forced endurance. The blue line represents the best-fitted linear model between the two 
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Table 3.1. Descriptive statistics for CC strains in the forced endurance experiment. 
CC Strain n 
















































CC001/Unc 3 10.1 0.7 0.9 0.5 4,819.3 721,014.3 849.1 
490.
2 25.9 13.7 3.7 2.1 13.9 9.1 3.0 1.7 79.8 6.8 2.6 1.5 
CC002/Unc 6 11.9 0.2 0.4 0.2 1,812.7 582,051.9 762.9 
311.
5 27.9 36.6 6.1 2.5 16.7 103.2 10.2 4.1 75.7 88.2 9.4 3.8 




0 28.6 12.9 3.6 2.1 7.4 2.3 1.5 0.9 84.5 1.5 1.2 0.7 
CC004/TauUn
c 3 11.9 2.5 1.6 0.9 
1,911.
7 966,204.3 983.0 
567.
5 32.7 59.2 7.7 4.4 18.7 263.9 16.2 9.4 71.0 101.1 10.1 5.8 
CC005/TauUn
c 3 14.0 0.0 0.0 0.0 
2,388.
0 677,389.0 823.0 
475.
2 27.5 1.9 1.4 0.8 11.8 4.9 2.2 1.3 79.8 6.5 2.5 1.5 
CC006/TauUn






2 28.2 36.7 6.1 2.7 16.9 116.9 10.8 4.8 75.6 93.0 9.6 4.3 
CC007/Unc 6 10.3 0.7 0.8 0.3 1,014.2 29,631.8 172.1 70.3 35.0 35.6 6.0 2.4 27.0 73.6 8.6 3.5 65.8 63.0 7.9 3.2 
CC008/GeniU
nc 3 7.7 0.0 0.1 0.1 
1,937.
0 7,441.0 86.3 49.8 30.1 0.9 1.0 0.5 13.8 6.5 2.6 1.5 79.0 4.3 2.1 1.2 
CC009/Unc 8 12.2 4.0 2.0 0.7 962.0 88,426.0 297.4 105.1 34.3 15.1 3.9 1.4 31.0 57.9 7.6 2.7 63.4 49.4 7.0 2.5 
CC010/GeniU
nc 5 6.2 0.1 0.3 0.1 577.0 96,028.0 309.9 
138.
6 30.6 6.8 2.6 1.2 19.8 8.6 2.9 1.3 72.0 14.1 3.8 1.7 
CC011/Unc 4 11.0 3.5 1.9 0.9 439.8 18,922.9 137.6 68.8 29.6 18.2 4.3 2.1 8.6 3.0 1.7 0.9 83.4 2.2 1.5 0.7 
CC013/GeniU
nc 4 10.1 2.7 1.6 0.8 
1,345.
8 187,002.9 432.4 
216.
2 34.4 31.3 5.6 2.8 16.2 58.9 7.7 3.8 75.1 35.6 6.0 3.0 
CC014/Unc 3 15.2 0.3 0.5 0.3 1,143.0 70,129.0 264.8 
152.
9 25.2 0.4 0.6 0.4 9.5 1.5 1.2 0.7 82.7 2.5 1.6 0.9 




5 23.7 4.2 2.1 1.0 7.6 14.7 3.8 1.9 82.3 12.2 3.5 1.7 
CC017/Unc 3 10.8 1.8 1.3 0.8 3,434.0 554,971.0 745.0 
430.
1 25.1 3.0 1.7 1.0 9.3 0.2 0.5 0.3 83.9 0.4 0.7 0.4 
CC019/TauUn
c 6 8.3 0.0 0.1 0.1 
1,967.
5 184,250.7 429.2 
175.
2 22.0 2.5 1.6 0.7 4.0 0.9 0.9 0.4 89.4 0.8 0.9 0.4 
CC021/Unc 4 10.6 9.6 3.1 1.6 3,406.3 314,113.6 560.5 
280.
2 24.3 17.9 4.2 2.1 11.2 38.1 6.2 3.1 80.8 41.1 6.4 3.2 
CC022/GeniU
nc 3 11.3 0.5 0.7 0.4 
3,232.
3 503,226.3 709.4 
409.
6 23.6 3.5 1.9 1.1 12.9 6.5 2.5 1.5 79.8 4.8 2.2 1.3 
CC023/GeniU






4 32.2 81.0 9.0 3.7 21.6 94.0 9.7 4.0 70.9 105.6 10.3 4.2 
CC024/GeniU
nc 4 9.4 3.7 1.9 1.0 
1,393.
8 190,288.3 436.2 
218.
1 30.0 0.6 0.8 0.4 9.1 7.4 2.7 1.4 85.2 5.1 2.3 1.1 
CC025/GeniU
nc 3 7.1 0.5 0.7 0.4 
3,206.
0 557,452.0 746.6 
431.
1 21.4 3.9 2.0 1.1 10.3 11.9 3.5 2.0 81.3 9.6 3.1 1.8 
CC026/GeniU
nc 3 14.0 1.2 1.1 0.6 275.0 378.3 19.4 11.2 32.2 11.8 3.4 2.0 23.5 24.2 4.9 2.8 70.7 26.0 5.1 2.9 
CC027/GeniU
nc 6 9.9 4.2 2.1 0.8 
2,257.
2 449,595.8 670.5 
273.




3 9.9 1.8 1.3 0.4 754.2 97,080.0 311.6 86.4 36.0 33.5 5.8 1.6 28.2 74.9 8.7 2.4 65.4 64.8 8.0 2.2 
CC029/Unc 3 12.3 2.8 1.7 1.0 1,104.7 194,420.3 440.9 
254.
6 24.1 3.3 1.8 1.1 15.6 0.7 0.8 0.5 76.8 3.3 1.8 1.0 
67 
CC030/GeniUnc 3 8.4 0.0 0.0 0.0 1,738.3 615,484.3 784.5 452.9 19.1 10.3 3.2 1.9 0.9 2.5 1.6 0.9 91.3 2.4 1.5 0.9 
CC032/GeniUnc 5 8.0 5.1 2.3 1.0 1,951.2 359,650.7 599.7 268.2 31.8 28.5 5.3 2.4 18.6 47.1 6.9 3.1 74.7 49.1 7.0 3.1 
CC033/GeniUnc 3 10.1 0.0 0.1 0.0 2,684.3 347,942.3 589.9 340.6 24.1 2.8 1.7 1.0 14.2 25.2 5.0 2.9 78.7 15.7 4.0 2.3 
CC035/Unc 5 9.0 5.8 2.4 1.1 2,049.0 1,197,057.0 1,094.1 489.3 24.8 9.2 3.0 1.4 15.6 93.8 9.7 4.3 77.7 86.9 9.3 4.2 
CC037/TauUnc 5 7.1 8.0 2.8 1.3 2,397.0 189,637.0 435.5 194.7 31.4 11.8 3.4 1.5 11.0 14.2 3.8 1.7 82.0 12.7 3.6 1.6 
CC039/Unc 6 11.2 5.8 2.4 1.0 2,454.8 490,916.2 700.7 286.0 25.0 9.0 3.0 1.2 15.3 83.3 9.1 3.7 76.4 63.9 8.0 3.3 
CC040/TauUnc 4 9.2 0.0 0.1 0.1 1,472.8 55,540.3 235.7 117.8 30.9 6.6 2.6 1.3 16.8 2.5 1.6 0.8 76.6 1.1 1.0 0.5 
CC041/TauUnc 3 11.0 0.4 0.6 0.3 920.0 19,629.0 140.1 80.9 33.9 8.3 2.9 1.7 15.9 8.9 3.0 1.7 75.8 10.9 3.3 1.9 
CC042/GeniUnc 3 10.1 0.0 0.0 0.0 3,047.3 530,122.3 728.1 420.4 26.4 15.8 4.0 2.3 19.6 134.0 11.6 6.7 74.3 111.1 10.5 6.1 
CC043/GeniUnc 12 11.4 1.6 1.2 0.4 1,467.1 390,101.2 624.6 180.3 24.0 4.1 2.0 0.6 14.0 15.9 4.0 1.2 79.2 10.1 3.2 0.9 
CC044/Unc 3 9.2 5.6 2.4 1.4 956.7 126,622.3 355.8 205.4 23.4 7.6 2.8 1.6 6.7 0.5 0.7 0.4 86.4 0.8 0.9 0.5 
CC045/GeniUnc 9 10.8 1.7 1.3 0.4 3,210.2 483,484.2 695.3 231.8 23.0 13.0 3.6 1.2 12.1 17.2 4.1 1.4 81.2 17.0 4.1 1.4 
CC046/Unc 4 12.5 3.2 1.8 0.9 1,334.0 221,672.0 470.8 235.4 25.3 8.0 2.8 1.4 13.7 18.2 4.3 2.1 79.7 19.3 4.4 2.2 
CC051/TauUnc 3 16.5 7.2 2.7 1.5 714.7 74,105.3 272.2 157.2 35.6 14.7 3.8 2.2 32.0 44.2 6.6 3.8 64.1 44.7 6.7 3.9 
CC052/GeniUnc 4 14.8 0.5 0.7 0.4 2,139.8 975,848.3 987.9 493.9 21.7 3.2 1.8 0.9 13.7 6.7 2.6 1.3 79.7 6.1 2.5 1.2 
CC055/TauUnc 3 13.5 0.0 0.1 0.0 1,016.3 1,822,966.2 1,350.2 779.5 29.6 1.5 1.2 0.7 17.5 20.8 4.6 2.6 75.4 18.6 4.3 2.5 
CC058/Unc 7 10.7 1.2 1.1 0.4 781.6 35,497.6 188.4 71.2 29.3 13.2 3.6 1.4 28.1 92.6 9.6 3.6 67.9 60.9 7.8 2.9 
CC059/TauUnc 6 7.9 13.1 3.6 1.5 1,864.0 1,582,164.8 1,257.8 513.5 32.8 126.0 11.2 4.6 17.6 160.0 12.6 5.2 76.4 135.3 11.6 4.7 
CC060/Unc 6 8.6 3.3 1.8 0.7 1,919.5 414,479.5 643.8 262.8 28.8 2.8 1.7 0.7 15.0 15.8 4.0 1.6 77.6 15.2 3.9 1.6 
CC065/Unc 4 12.7 0.2 0.5 0.2 971.3 153,642.9 392.0 196.0 26.3 23.8 4.9 2.4 12.3 95.3 9.8 4.9 81.3 96.7 9.8 4.9 
CC068/TauUnc 3 11.7 0.0 0.1 0.1 959.3 126,889.6 356.2 205.7 24.3 7.3 2.7 1.6 3.3 2.0 1.4 0.8 88.4 2.3 1.5 0.9 
CC070/TauUnc 3 9.0 2.9 1.7 1.0 1,136.3 12,641.3 112.4 64.9 26.8 1.3 1.2 0.7 11.9 3.2 1.8 1.0 81.0 1.9 1.4 0.8 
CC071/TauUnc 6 8.7 0.4 0.6 0.2 2,516.5 681,457.1 825.5 337.0 19.0 0.4 0.7 0.3 7.7 6.3 2.5 1.0 83.9 7.1 2.7 1.1 
CC072/TauUnc 3 12.3 0.2 0.4 0.2 1,761.3 556,066.3 745.7 430.5 32.1 40.4 6.4 3.7 18.1 33.5 5.8 3.3 75.2 20.3 4.5 2.6 





Table 3.2. Descriptive statistics for responses to voluntary exercise in CC strains. 
CC Strain n 
Body Mass Response (%) - Month Body Mass Response (%) - Week1-2 Body Mass Response (%) - Week3-4 
Mean Variance Std Deviation 
Std 









CC001/Unc 5 -6.91 4.13 2.03 0.91 -9.56 4.63 2.15 0.96 2.98 10.20 3.19 1.43 
CC003/Unc 4 -6.86 15.75 3.97 1.98 -20.05 111.13 10.54 5.27 18.62 465.23 21.57 10.78 
CC004/Unc 4 -11.99 28.14 5.30 2.65 -15.51 15.65 3.96 1.98 4.18 21.83 4.67 2.34 
CC005/TauUnc 3 -4.48 2.03 1.43 0.82 -5.16 16.27 4.03 2.33 0.78 7.74 2.78 1.61 
CC006/TauUnc 7 -12.23 39.60 6.29 2.38 -13.37 22.00 4.69 1.77 1.28 14.11 3.76 1.42 
CC007/Unc 3 -12.28 16.23 4.03 2.33 -8.33 9.36 3.06 1.77 -4.34 2.29 1.51 0.87 
CC008/GeniUnc 6 -5.00 5.73 2.39 0.98 -5.46 1.65 1.28 0.52 0.50 6.40 2.53 1.03 
CC009/Unc 5 -13.12 33.18 5.76 2.58 -14.54 32.53 5.70 2.55 1.69 7.87 2.81 1.25 
CC010/GeniUnc 5 -8.64 21.43 4.63 2.07 -6.89 10.04 3.17 1.42 -1.85 22.05 4.70 2.10 
CC011/Unc 3 -10.98 7.27 2.70 1.56 -8.52 13.83 3.72 2.15 -2.64 5.66 2.38 1.37 
CC013/GeniUnc 7 -8.78 15.40 3.92 1.48 -7.98 15.80 3.97 1.50 -0.79 17.81 4.22 1.60 
CC014/Unc 3 -10.44 3.06 1.75 1.01 -8.55 20.85 4.57 2.64 -4.51 20.60 4.54 2.62 
CC015/Unc 4 23.13 3,031.11 55.06 27.53 -4.82 24.64 4.96 2.48 28.57 2,918.10 54.02 27.01 
CC017/Unc 3 -4.22 28.33 5.32 3.07 23.19 510.05 22.58 13.04 -19.89 389.56 19.74 11.40 
CC019/TauUnc 5 -3.08 16.52 4.06 1.82 -3.54 23.87 4.89 2.18 0.62 27.40 5.23 2.34 
CC021/Unc 3 1.08 8.22 2.87 1.66 -1.60 1.26 1.12 0.65 2.75 15.75 3.97 2.29 
CC022/GeniUnc 4 -9.26 25.70 5.07 2.53 -10.70 17.13 4.14 2.07 1.65 20.91 4.57 2.29 
CC023/GeniUnc 3 -11.94 25.85 5.08 2.94 -11.95 39.03 6.25 3.61 0.09 7.22 2.69 1.55 
CC024/GeniUnc 5 -11.61 315.30 17.76 7.94 -0.53 4.51 2.12 0.95 -11.32 282.20 16.80 7.51 
CC025/GeniUnc 3 -3.01 308.20 17.56 10.14 -4.72 158.85 12.60 7.28 1.58 87.66 9.36 5.41 
CC027/GeniUnc 9 1.63 27.52 5.25 1.75 0.78 19.34 4.40 1.47 0.90 19.53 4.42 1.47 
CC028/GeniUnc 4 -10.19 8.74 2.96 1.48 -6.76 2.98 1.73 0.86 -3.68 7.87 2.81 1.40 
CC029/Unc 3 0.09 12.11 3.48 2.01 -1.34 68.98 8.31 4.80 1.73 26.60 5.16 2.98 
CC032/GeniUnc 2 -0.88 4.96 2.23 1.58 -3.68 7.52 2.74 1.94 2.91 0.38 0.62 0.44 
CC035/Unc 5 -19.36 63.54 7.97 3.56 -15.38 33.87 5.82 2.60 -4.64 55.80 7.47 3.34 
CC040/TauUnc 5 5.57 102.00 10.10 4.52 1.81 147.95 12.16 5.44 3.96 16.75 4.09 1.83 
CC043/GeniUnc 6 -1.45 76.77 8.76 3.58 0.42 39.01 6.25 2.55 -1.98 13.79 3.71 1.52 
CC044/Unc 3 -3.48 0.26 0.51 0.29 -3.97 1.38 1.18 0.68 0.52 1.57 1.25 0.72 
CC045/GeniUnc 5 -4.94 71.04 8.43 3.77 -4.76 74.13 8.61 3.85 -0.10 18.73 4.33 1.94 
CC046/Unc 3 -4.21 7.47 2.73 1.58 -6.84 290.89 17.06 9.85 5.02 327.21 18.09 10.44 
CC051/TauUnc 4 -10.92 36.20 6.02 3.01 -8.11 50.23 7.09 3.54 0.69 48.27 6.95 3.47 
CC052/GeniUnc 3 6.68 325.97 18.05 10.42 4.98 195.88 14.00 8.08 1.35 25.32 5.03 2.91 
CC055/TauUnc 8 -13.61 117.36 10.83 3.83 -14.25 92.94 9.64 3.41 0.70 21.65 4.65 1.65 
CC058/Unc 7 -6.69 34.82 5.90 2.23 -6.56 23.42 4.84 1.83 -0.16 9.83 3.13 1.18 
CC059/TauUnc 3 -4.06 6.65 2.58 1.49 -4.70 4.01 2.00 1.16 0.70 10.27 3.21 1.85 
CC060/Unc 6 -11.06 106.99 10.34 4.22 -8.00 53.48 7.31 2.99 -2.87 18.38 4.29 1.75 
CC062/Unc 5 -3.30 11.06 3.33 1.49 -6.94 22.79 4.77 2.13 3.99 4.58 2.14 0.96 
CC063/Unc 4 1.95 17.97 4.24 2.12 -0.77 11.49 3.39 1.69 2.76 10.67 3.27 1.63 
CC065/Unc 5 -13.20 320.99 17.92 8.01 -5.61 43.60 6.60 2.95 -8.49 238.06 15.43 6.90 
CC068/TauUnc 4 -6.44 119.68 10.94 5.47 -5.12 157.33 12.54 6.27 -0.63 170.80 13.07 6.53 
CC070/TauUnc 3 0.72 14.51 3.81 2.20 2.59 33.00 5.74 3.32 -1.76 3.14 1.77 1.02 
CC071/TauUnc 4 -4.93 7.40 2.72 1.36 -7.56 3.56 1.89 0.94 2.86 5.81 2.41 1.21 




Body Fat % Response (%) - Month Body Fat % Response (%) - Week1-2 Body Fat % Response (%) - Week3-4 
Mean Variance Std Deviation 
Std 









CC001/Unc -26.33 759.67 27.56 12.33 -43.71 197.99 14.07 6.29 26.85 592.99 24.35 10.89 
CC003/Unc -28.54 42.68 6.53 3.27 -34.75 773.14 27.81 13.90 27.78 3,435.93 58.62 29.31 
CC004/Unc -21.38 63.71 7.98 3.99 -33.62 17.95 4.24 2.12 18.34 61.87 7.87 3.93 
CC005/TauUnc -35.13 4.92 2.22 1.28 -37.94 469.71 21.67 12.51 11.98 1,821.71 42.68 24.64 
CC006/TauUnc -27.41 397.35 19.93 7.53 -36.27 129.50 11.38 4.30 12.79 282.27 16.80 6.35 
CC007/Unc -28.99 193.52 13.91 8.03 -14.24 115.29 10.74 6.20 -17.57 81.25 9.01 5.20 
CC008/GeniUnc -15.88 592.33 24.34 9.94 -23.02 253.68 15.93 6.50 9.85 662.33 25.74 10.51 
CC009/Unc -22.10 211.57 14.55 6.50 -28.98 116.23 10.78 4.82 9.30 44.67 6.68 2.99 
CC010/GeniUnc -25.12 122.26 11.06 4.94 -23.24 199.71 14.13 6.32 -1.76 56.53 7.52 3.36 
CC011/Unc -46.85 59.99 7.75 4.47 -40.95 42.81 6.54 3.78 -9.42 206.31 14.36 8.29 
CC013/GeniUnc -27.37 275.31 16.59 6.27 -25.82 190.43 13.80 5.22 -0.85 440.23 20.98 7.93 
CC014/Unc -45.71 67.94 8.24 4.76 -42.46 196.52 14.02 8.09 -16.62 299.63 17.31 9.99 
CC015/Unc -51.95 193.16 13.90 6.95 -67.36 24.04 4.90 2.45 54.36 4,365.43 66.07 33.04 
CC017/Unc 54.76 18,754.15 136.95 79.07 50.50 11,582.59 107.62 62.14 -4.73 280.77 16.76 9.67 
CC019/TauUnc -9.27 785.78 28.03 12.54 -15.86 1,880.91 43.37 19.40 22.42 2,046.33 45.24 20.23 
CC021/Unc 5.55 1,010.65 31.79 18.35 -13.04 789.83 28.10 16.23 21.95 37.61 6.13 3.54 
CC022/GeniUnc -27.98 617.59 24.85 12.43 -25.74 115.05 10.73 5.36 -4.58 490.14 22.14 11.07 
CC023/GeniUnc -36.66 508.42 22.55 13.02 -39.19 377.43 19.43 11.22 4.65 322.02 17.95 10.36 
CC024/GeniUnc 31.72 5,824.93 76.32 34.13 -8.29 496.14 22.27 9.96 38.92 2,637.82 51.36 22.97 
CC025/GeniUnc 12.70 7,818.27 88.42 51.05 -20.73 2,811.84 53.03 30.62 38.87 1,799.88 42.42 24.49 
CC027/GeniUnc 90.99 4,152.44 64.44 21.48 49.61 2,638.56 51.37 17.12 28.91 214.28 14.64 4.88 
CC028/GeniUnc -18.57 97.84 9.89 4.95 -8.78 17.02 4.13 2.06 -10.89 71.33 8.45 4.22 
CC029/Unc 8.58 229.64 15.15 8.75 -4.00 372.09 19.29 11.14 14.17 133.10 11.54 6.66 
CC032/GeniUnc -2.69 8.03 2.83 2.00 -15.96 62.83 7.93 5.60 16.15 57.49 7.58 5.36 
CC035/Unc -61.67 764.67 27.65 12.37 -54.91 278.24 16.68 7.46 -20.91 2,509.00 50.09 22.40 
CC040/TauUnc 24.32 792.45 28.15 12.59 -0.58 889.99 29.83 13.34 27.48 355.07 18.84 8.43 
CC043/GeniUnc 1.11 1,732.19 41.62 16.99 -0.36 1,244.99 35.28 14.40 0.73 494.80 22.24 9.08 
CC044/Unc 13.96 3,230.85 56.84 32.82 -17.31 487.62 22.08 12.75 33.02 1,010.84 31.79 18.36 
CC045/GeniUnc -33.85 613.92 24.78 11.08 -36.13 624.68 24.99 11.18 8.63 873.96 29.56 13.22 
CC046/Unc -58.25 661.59 25.72 14.85 -27.06 971.65 31.17 18.00 -22.40 5,454.99 73.86 42.64 
CC051/TauUnc -17.83 190.57 13.80 6.90 -0.22 1,429.84 37.81 18.91 1.31 224.60 14.99 7.49 
CC052/GeniUnc 0.35 183.67 13.55 7.82 6.86 1,023.92 32.00 18.47 -2.62 311.00 17.64 10.18 
CC055/TauUnc -58.81 398.72 19.97 7.06 -50.41 605.26 24.60 8.70 -15.59 255.61 15.99 5.65 
CC058/Unc -31.03 287.16 16.95 6.40 -31.11 314.80 17.74 6.71 1.36 287.72 16.96 6.41 
CC059/TauUnc -11.54 29.38 5.42 3.13 -10.79 10.16 3.19 1.84 -0.78 42.51 6.52 3.76 
CC060/Unc -64.13 590.68 24.30 9.92 -48.90 139.42 11.81 4.82 -23.43 2,211.86 47.03 19.20 
CC062/Unc -34.34 221.48 14.88 6.66 -41.06 79.47 8.91 3.99 13.22 815.63 28.56 12.77 
CC063/Unc 9.12 17.76 4.21 2.11 1.97 9.37 3.06 1.53 7.03 10.97 3.31 1.66 
CC065/Unc -13.92 3,917.77 62.59 27.99 -19.14 1,236.40 35.16 15.73 -10.75 3,608.98 60.07 26.87 
CC068/TauUnc -38.69 1,124.03 33.53 16.76 -28.08 2,705.30 52.01 26.01 -5.05 2,304.84 48.01 24.00 
CC070/TauUnc 16.11 1,563.72 39.54 22.83 11.41 1,429.90 37.81 21.83 4.35 73.54 8.58 4.95 
CC071/TauUnc -64.50 53.87 7.34 3.67 -67.81 16.67 4.08 2.04 9.43 98.55 9.93 4.96 






Lean Mass % Response (%) - Month Lean Mass % Response (%) - Week1-2 Lean Mass % Response (%) - Week3-4 
Mean Variance Std Deviation 
Std 









CC001/Unc 5.63 42.90 6.55 2.93 8.99 19.35 4.40 1.97 -3.15 5.33 2.31 1.03 
CC003/Unc 6.25 12.25 3.50 1.75 7.52 7.23 2.69 1.34 -1.18 4.78 2.19 1.09 
CC004/Unc 12.54 14.08 3.75 1.88 18.65 6.57 2.56 1.28 -5.16 2.56 1.60 0.80 
CC005/TauUnc 2.38 1.03 1.01 0.58 1.32 2.20 1.48 0.86 1.07 6.15 2.48 1.43 
CC006/TauUnc 11.33 74.21 8.61 3.26 12.12 43.10 6.57 2.48 -0.78 6.78 2.60 0.98 
CC007/Unc 12.10 89.65 9.47 5.47 7.81 40.93 6.40 3.69 3.88 7.02 2.65 1.53 
CC008/GeniUnc 4.10 10.74 3.28 1.34 4.46 10.65 3.26 1.33 -0.32 4.23 2.06 0.84 
CC009/Unc 10.99 39.85 6.31 2.82 14.12 19.62 4.43 1.98 -2.78 7.93 2.82 1.26 
CC010/GeniUnc 8.24 21.26 4.61 2.06 7.03 17.48 4.18 1.87 1.12 0.80 0.89 0.40 
CC011/Unc 11.73 5.60 2.37 1.37 9.08 22.57 4.75 2.74 2.52 14.10 3.76 2.17 
CC013/GeniUnc 7.37 24.61 4.96 1.88 6.34 22.14 4.71 1.78 1.01 10.92 3.30 1.25 
CC014/Unc 3.69 3.25 1.80 1.04 3.43 2.74 1.66 0.96 1.16 1.78 1.33 0.77 
CC015/Unc -7.63 900.68 30.01 15.01 7.01 4.00 2.00 1.00 -13.68 779.77 27.92 13.96 
CC017/Unc 0.49 57.51 7.58 4.38 -1.51 31.62 5.62 3.25 1.96 5.97 2.44 1.41 
CC019/TauUnc 1.82 13.62 3.69 1.65 1.77 16.04 4.01 1.79 0.08 3.15 1.77 0.79 
CC021/Unc 0.42 5.92 2.43 1.40 1.14 14.01 3.74 2.16 -0.68 2.72 1.65 0.95 
CC022/GeniUnc 8.29 177.77 13.33 6.67 6.64 36.31 6.03 3.01 1.29 48.72 6.98 3.49 
CC023/GeniUnc 13.05 42.44 6.51 3.76 15.19 77.22 8.79 5.07 -1.72 18.71 4.33 2.50 
CC024/GeniUnc 14.70 746.46 27.32 12.22 0.67 8.19 2.86 1.28 14.33 875.43 29.59 13.23 
CC025/GeniUnc 3.02 348.87 18.68 10.78 7.47 239.93 15.49 8.94 -4.29 62.81 7.93 4.58 
CC027/GeniUnc -5.22 16.77 4.10 1.37 -3.22 14.74 3.84 1.28 -2.06 2.69 1.64 0.55 
CC028/GeniUnc 10.61 8.82 2.97 1.49 5.77 2.26 1.50 0.75 4.59 8.11 2.85 1.42 
CC029/Unc -2.94 16.32 4.04 2.33 1.15 28.89 5.38 3.10 -3.98 6.08 2.47 1.42 
CC032/GeniUnc -1.10 0.10 0.31 0.22 2.24 0.22 0.47 0.33 -3.27 0.02 0.14 0.10 
CC035/Unc 23.14 109.92 10.48 4.69 20.62 72.64 8.52 3.81 2.04 13.93 3.73 1.67 
CC040/TauUnc -5.66 32.40 5.69 2.55 -0.20 40.64 6.38 2.85 -5.40 12.54 3.54 1.58 
CC043/GeniUnc 1.73 18.02 4.24 1.73 1.72 15.20 3.90 1.59 0.03 6.15 2.48 1.01 
CC044/Unc 0.18 5.43 2.33 1.35 1.26 2.89 1.70 0.98 -1.07 0.44 0.66 0.38 
CC045/GeniUnc 6.05 26.36 5.13 2.30 6.46 24.66 4.97 2.22 -0.37 4.97 2.23 1.00 
CC046/Unc 9.51 7.65 2.77 1.60 4.74 35.59 5.97 3.44 4.82 58.60 7.65 4.42 
CC051/TauUnc 10.54 87.21 9.34 4.67 6.51 46.88 6.85 3.42 0.79 23.81 4.88 2.44 
CC052/GeniUnc 0.10 9.62 3.10 1.79 -1.21 34.46 5.87 3.39 1.45 11.66 3.41 1.97 
CC055/TauUnc 15.32 155.14 12.46 4.40 15.81 136.12 11.67 4.12 -0.41 17.84 4.22 1.49 
CC058/Unc 8.56 23.95 4.89 1.85 7.59 32.05 5.66 2.14 0.97 7.76 2.78 1.05 
CC059/TauUnc 5.72 18.87 4.34 2.51 5.25 3.20 1.79 1.03 0.43 11.43 3.38 1.95 
CC060/Unc 13.77 173.05 13.15 5.37 9.17 99.58 9.98 4.07 2.94 8.71 2.95 1.20 
CC062/Unc 4.10 1.65 1.29 0.58 2.62 5.42 2.33 1.04 1.49 11.28 3.36 1.50 
CC063/Unc -6.77 9.00 3.00 1.50 -2.41 5.45 2.33 1.17 -4.46 7.14 2.67 1.34 
CC065/Unc 3.46 130.80 11.44 5.11 2.26 33.99 5.83 2.61 1.02 47.47 6.89 3.08 
CC068/TauUnc 3.67 15.76 3.97 1.98 2.88 23.38 4.84 2.42 0.81 2.44 1.56 0.78 
CC070/TauUnc -2.50 31.75 5.63 3.25 -2.24 33.14 5.76 3.32 -0.26 1.24 1.11 0.64 
CC071/TauUnc 5.57 0.71 0.84 0.42 6.87 0.30 0.55 0.27 -1.21 1.15 1.07 0.54 





Table 3.3. Descriptive statistics for exercise traits in CC strains from the voluntary endurance experiment. 
CC Strain n 
Distance - Month (km) Distance - Week1-2 (km) Distance - Week3-4 (km) 
Mean Variance Std Deviation 
Std 









CC001/Unc 5 150.69 2,077.50 45.58 20.38 74.93 219.85 14.83 6.63 75.04 1,056.14 32.50 14.53 
CC003/Unc 4 96.87 3,981.46 63.10 31.55 43.91 835.91 28.91 14.46 51.36 1,232.44 35.11 17.55 
CC004/Unc 4 179.32 686.58 26.20 13.10 74.22 244.80 15.65 7.82 95.72 186.54 13.66 6.83 
CC005/TauUnc 3 45.92 1,084.97 32.94 19.02 29.18 374.61 19.35 11.17 16.52 232.99 15.26 8.81 
CC006/TauUnc 7 147.34 1,566.83 39.58 14.96 44.29 93.25 9.66 3.65 95.42 1,033.13 32.14 12.15 
CC007/Unc 3 107.79 8,745.14 93.52 53.99 37.89 500.17 22.36 12.91 67.60 4,786.73 69.19 39.94 
CC008/GeniUnc 6 33.94 1,402.30 37.45 15.29 12.12 289.43 17.01 6.95 21.37 844.98 29.07 11.87 
CC009/Unc 5 141.63 2,178.14 46.67 20.87 60.38 240.46 15.51 6.93 78.34 979.95 31.30 14.00 
CC010/GeniUnc 5 12.31 66.12 8.13 3.64 5.79 19.07 4.37 1.95 6.34 15.08 3.88 1.74 
CC011/Unc 3 149.84 4,072.64 63.82 36.84 49.95 1,105.34 33.25 19.20 97.21 1,118.28 33.44 19.31 
CC013/GeniUnc 7 34.32 319.89 17.89 6.76 14.12 21.68 4.66 1.76 19.58 167.69 12.95 4.89 
CC014/Unc 3 42.78 1,954.95 44.21 25.53 23.70 299.21 17.30 9.99 18.45 743.55 27.27 15.74 
CC015/Unc 4 146.78 3,602.36 60.02 30.01 86.09 705.90 26.57 13.28 58.97 1,333.44 36.52 18.26 
CC017/Unc 3 99.92 6,543.12 80.89 46.70 48.05 1,475.41 38.41 22.18 51.73 1,942.19 44.07 25.44 
CC019/TauUnc 5 130.36 3,001.98 54.79 24.50 54.66 733.07 27.08 12.11 72.76 923.18 30.38 13.59 
CC021/Unc 3 112.22 803.78 28.35 16.37 42.96 127.35 11.28 6.52 64.95 364.03 19.08 11.02 
CC022/GeniUnc 4 157.60 5,235.83 72.36 36.18 65.33 674.15 25.96 12.98 87.92 2,099.35 45.82 22.91 
CC023/GeniUnc 3 109.84 3,497.77 59.14 34.15 46.08 406.39 20.16 11.64 60.87 1,968.28 44.37 25.61 
CC024/GeniUnc 4 163.38 4,250.05 65.19 32.60 76.39 750.65 27.40 13.70 84.45 1,396.36 37.37 18.68 
CC025/GeniUnc 3 101.25 2,902.19 53.87 31.10 42.72 615.72 24.81 14.33 56.27 879.15 29.65 17.12 
CC027/GeniUnc 6 232.88 450.14 21.22 8.66 112.23 129.03 11.36 4.64 117.43 196.52 14.02 5.72 
CC028/GeniUnc 4 8.21 5.05 2.25 1.12 4.66 1.65 1.28 0.64 3.42 0.99 1.00 0.50 
CC029/Unc 3 158.55 2,380.04 48.79 28.17 65.80 439.68 20.97 12.11 89.24 879.70 29.66 17.12 
CC032/GeniUnc 2 83.99 12.62 3.55 2.51 42.86 63.91 7.99 5.65 39.43 13.16 3.63 2.57 
CC035/Unc 4 68.89 1,504.01 38.78 19.39 35.11 162.78 12.76 6.38 32.51 613.76 24.77 12.39 
CC040/TauUnc 5 116.26 9,703.59 98.51 44.05 59.16 2,308.85 48.05 21.49 57.11 2,555.53 50.55 22.61 
CC043/GeniUnc 6 57.29 5,574.80 74.66 30.48 22.80 1,152.26 33.94 13.86 34.17 1,942.98 44.08 18.00 
CC044/Unc 3 25.88 108.93 10.44 6.03 13.58 39.78 6.31 3.64 12.15 19.62 4.43 2.56 
CC045/GeniUnc 5 161.93 8,240.56 90.78 40.60 59.98 1,113.09 33.36 14.92 90.12 2,927.43 54.11 24.20 
CC046/Unc 3 70.58 5,220.54 72.25 41.72 44.06 2,113.46 45.97 26.54 26.41 753.28 27.45 15.85 
CC051/TauUnc 4 38.51 2,481.80 49.82 24.91 18.10 594.72 24.39 12.19 19.67 629.42 25.09 12.54 
CC052/GeniUnc 3 17.81 14.28 3.78 2.18 8.29 7.61 2.76 1.59 8.96 18.16 4.26 2.46 
CC055/TauUnc 8 156.89 9,276.81 96.32 34.05 60.43 1,643.16 40.54 14.33 92.43 3,112.21 55.79 19.72 
CC058/Unc 7 44.22 862.96 29.38 11.10 17.30 102.94 10.15 3.83 24.07 414.34 20.36 7.69 
CC059/TauUnc 3 6.88 18.83 4.34 2.51 4.02 9.27 3.05 1.76 2.80 1.60 1.27 0.73 
CC060/Unc 6 115.30 274.64 16.57 6.77 50.59 542.73 23.30 9.51 63.73 181.02 13.45 5.49 
CC062/Unc 5 94.68 277.84 16.67 7.45 41.49 148.04 12.17 5.44 51.87 164.06 12.81 5.73 
CC063/Unc 4 40.87 1,367.22 36.98 18.49 18.93 214.81 14.66 7.33 21.26 487.20 22.07 11.04 
CC065/Unc 5 122.59 7,168.89 84.67 37.87 61.86 1,034.22 32.16 14.38 58.73 3,303.24 57.47 25.70 
CC068/TauUnc 4 72.58 2,017.26 44.91 22.46 31.90 351.07 18.74 9.37 40.53 696.37 26.39 13.19 
CC070/TauUnc 3 48.94 6,154.92 78.45 45.30 21.93 1,095.34 33.10 19.11 26.41 1,966.78 44.35 25.60 
CC071/TauUnc 4 163.81 783.58 27.99 14.00 76.36 211.04 14.53 7.26 83.35 186.13 13.64 6.82 




Duration - Month (min) Duration - Week1-2 (min) Duration - Week3-4 (min) 
Mean Variance Std Deviation 
Std 









CC001/Unc 9,772.00 3,875,192.50 1,968.55 880.36 4,965.20 287,583.70 536.27 239.83 4,492.20 1,302,589.70 1,141.31 510.41 
CC003/Unc 6,704.50 13,212,955.00 3,634.96 1,817.48 3,152.25 2,715,792.25 1,647.97 823.98 3,462.00 3,996,860.67 1,999.22 999.61 
CC004/Unc 9,401.50 762,157.67 873.02 436.51 3,962.00 251,900.00 501.90 250.95 4,950.25 370,850.92 608.98 304.49 
CC005/TauUnc 4,413.00 8,770,483.00 2,961.50 1,709.82 3,206.33 4,352,092.33 2,086.17 1,204.45 1,179.00 1,047,652.00 1,023.55 590.95 
CC006/TauUnc 8,517.29 1,953,445.90 1,397.66 528.26 3,262.43 123,123.62 350.89 132.62 4,848.14 1,190,424.14 1,091.07 412.38 
CC007/Unc 8,772.67 13,965,206.33 3,737.00 2,157.56 4,696.00 3,131,167.00 1,769.51 1,021.63 3,932.00 3,627,696.00 1,904.65 1,099.65 
CC008/GeniUnc 4,078.33 16,589,837.47 4,073.06 1,662.82 1,709.83 4,831,481.77 2,198.06 897.36 2,320.17 6,599,706.97 2,568.99 1,048.79 
CC009/Unc 11,952.20 18,524,760.70 4,304.04 1,924.83 6,845.60 6,333,351.30 2,516.62 1,125.46 4,928.60 3,103,047.30 1,761.55 787.79 
CC010/GeniUnc 3,670.20 1,650,226.20 1,284.61 574.50 1,742.80 1,090,781.70 1,044.40 467.07 1,866.40 100,456.30 316.95 141.74 
CC011/Unc 8,864.67 3,177,590.33 1,782.58 1,029.17 3,640.00 990,327.00 995.15 574.55 5,066.33 925,600.33 962.08 555.46 
CC013/GeniUnc 5,914.29 1,345,372.57 1,159.90 438.40 2,835.43 235,744.95 485.54 183.52 2,988.29 561,558.24 749.37 283.24 
CC014/Unc 4,538.67 10,082,185.33 3,175.25 1,833.23 2,728.00 1,317,199.00 1,147.69 662.62 1,733.67 4,415,736.33 2,101.37 1,213.22 
CC015/Unc 11,302.00 13,834,408.67 3,719.46 1,859.73 6,408.00 2,583,519.33 1,607.33 803.67 4,747.00 4,592,059.33 2,142.91 1,071.45 
CC017/Unc 7,222.33 23,133,602.33 4,809.74 2,776.90 3,534.00 5,054,812.00 2,248.29 1,298.05 3,666.67 7,631,476.33 2,762.51 1,594.94 
CC019/TauUnc 8,795.60 7,059,313.30 2,656.94 1,188.22 4,327.20 2,786,259.20 1,669.21 746.49 4,285.80 1,022,137.70 1,011.01 452.14 
CC021/Unc 11,036.00 687,817.00 829.35 478.82 4,444.67 773,810.33 879.66 507.87 5,767.67 1,349,062.33 1,161.49 670.59 
CC022/GeniUnc 11,439.75 8,081,473.58 2,842.79 1,421.40 5,337.50 1,443,109.67 1,201.29 600.65 5,793.75 2,919,116.92 1,708.54 854.27 
CC023/GeniUnc 8,744.33 10,569,150.33 3,251.02 1,876.98 4,077.67 1,412,465.33 1,188.47 686.16 4,456.00 5,132,836.00 2,265.58 1,308.03 
CC024/GeniUnc 11,784.25 10,599,678.25 3,255.71 1,627.86 6,887.00 2,190,874.00 1,480.16 740.08 4,757.25 2,836,402.92 1,684.16 842.08 
CC025/GeniUnc 11,197.33 6,311,817.33 2,512.33 1,450.50 5,182.33 1,932,966.33 1,390.31 802.70 5,768.33 1,294,126.33 1,137.60 656.79 
CC027/GeniUnc 13,829.33 1,236,704.27 1,112.07 454.00 6,723.00 367,536.80 606.25 247.50 6,806.17 397,349.37 630.36 257.34 
CC028/GeniUnc 3,051.25 549,164.92 741.06 370.53 1,707.50 216,902.33 465.73 232.86 1,288.00 92,756.67 304.56 152.28 
CC029/Unc 7,834.00 2,942,092.00 1,715.25 990.30 3,480.33 614,122.33 783.66 452.45 4,175.67 937,769.33 968.38 559.10 
CC032/GeniUnc 9,387.50 747,864.50 864.79 611.50 5,056.50 519,180.50 720.54 509.50 4,163.00 42,050.00 205.06 145.00 
CC035/Unc 5,262.75 4,841,028.25 2,200.23 1,100.12 2,960.75 459,986.92 678.22 339.11 2,225.50 2,136,693.67 1,461.74 730.87 
CC040/TauUnc 7,995.60 17,302,151.30 4,159.59 1,860.22 3,989.00 3,200,816.00 1,789.08 800.10 4,006.60 6,003,568.30 2,450.22 1,095.77 
CC043/GeniUnc 3,942.00 12,859,929.60 3,586.07 1,464.01 1,748.83 3,209,700.17 1,791.56 731.40 2,163.00 3,996,139.60 1,999.03 816.10 
CC044/Unc 4,967.67 776,986.33 881.47 508.92 2,529.33 323,857.33 569.08 328.56 2,385.67 131,844.33 363.10 209.64 
CC045/GeniUnc 12,006.60 31,674,265.30 5,627.99 2,516.91 5,108.40 4,549,311.30 2,132.91 953.87 5,778.20 8,108,422.20 2,847.53 1,273.45 
CC046/Unc 6,269.00 21,273,147.00 4,612.28 2,662.90 3,825.00 9,090,237.00 3,015.00 1,740.71 2,430.67 3,089,590.33 1,757.72 1,014.82 
CC051/TauUnc 3,358.00 10,000,310.00 3,162.33 1,581.16 1,769.75 3,059,714.92 1,749.20 874.60 1,514.00 1,988,798.00 1,410.25 705.12 
CC052/GeniUnc 3,879.33 103,842.33 322.25 186.05 1,924.00 60,781.00 246.54 142.34 1,859.67 160,384.33 400.48 231.22 
CC055/TauUnc 11,064.50 13,015,752.57 3,607.74 1,275.53 5,462.25 4,225,703.36 2,055.65 726.78 5,388.00 3,133,178.29 1,770.08 625.82 
CC058/Unc 4,939.14 3,905,083.81 1,976.13 746.91 2,345.29 542,727.24 736.70 278.45 2,301.57 1,077,151.95 1,037.86 392.27 
CC059/TauUnc 2,190.67 1,143,882.33 1,069.52 617.49 1,279.00 507,484.00 712.38 411.29 881.33 112,272.33 335.07 193.45 
CC060/Unc 7,913.50 970,537.10 985.16 402.19 3,839.33 1,534,460.27 1,238.73 505.71 3,776.67 199,673.87 446.85 182.43 
CC062/Unc 8,792.00 1,537,556.50 1,239.98 554.54 4,293.40 334,467.80 578.33 258.64 4,397.00 603,143.50 776.62 347.32 
CC063/Unc 4,005.50 3,223,729.67 1,795.47 897.74 2,173.25 674,072.25 821.02 410.51 1,777.75 923,468.92 960.97 480.49 
CC065/Unc 8,942.00 25,263,338.00 5,026.26 2,247.81 4,832.00 2,475,916.50 1,573.50 703.69 3,997.20 14,082,068.70 3,752.61 1,678.22 
CC068/TauUnc 7,038.25 10,784,023.58 3,283.90 1,641.95 3,458.75 2,230,000.92 1,493.32 746.66 3,237.75 1,719,922.25 1,311.46 655.73 
CC070/TauUnc 4,402.67 27,946,546.33 5,286.45 3,052.13 2,217.00 3,806,992.00 1,951.15 1,126.50 2,140.67 10,959,160.33 3,310.46 1,911.30 
CC071/TauUnc 11,595.75 1,038,284.92 1,018.96 509.48 5,697.75 211,796.25 460.21 230.11 5,618.25 323,669.58 568.92 284.46 








































Mean Speed - Month (m/min) Mean Speed - Week1-2 (m/min) Mean Speed - Week3-4 (m/min) 
Mean Variance Std Deviation 
Std 









CC001/Unc 15.22 5.56 2.36 1.05 14.61 3.74 1.93 0.86 16.16 12.74 3.57 1.60 
CC003/Unc 12.53 28.64 5.35 2.68 12.31 21.56 4.64 2.32 12.72 38.38 6.19 3.10 
CC004/Unc 19.73 9.14 3.02 1.51 20.21 11.48 3.39 1.69 19.41 9.87 3.14 1.57 
CC005/TauUnc 9.87 19.16 4.38 2.53 9.31 9.76 3.12 1.80 9.25 68.31 8.26 4.77 
CC006/TauUnc 17.26 6.57 2.56 0.97 15.25 11.62 3.41 1.29 19.22 8.54 2.92 1.10 
CC007/Unc 11.78 42.56 6.52 3.77 9.06 11.21 3.35 1.93 14.37 90.41 9.51 5.49 
CC008/GeniUnc 5.15 19.50 4.42 1.80 3.64 9.47 3.08 1.26 5.86 30.68 5.54 2.26 
CC009/Unc 13.19 0.32 0.56 0.25 10.69 1.12 1.06 0.47 15.46 2.29 1.51 0.68 
CC010/GeniUnc 2.92 1.96 1.40 0.63 2.60 2.54 1.59 0.71 3.09 2.46 1.57 0.70 
CC011/Unc 15.51 13.87 3.72 2.15 12.14 22.04 4.69 2.71 18.77 9.49 3.08 1.78 
CC013/GeniUnc 5.29 3.66 1.91 0.72 4.70 1.25 1.12 0.42 5.87 7.40 2.72 1.03 
CC014/Unc 7.01 19.69 4.44 2.56 7.57 16.06 4.01 2.31 6.17 30.22 5.50 3.17 
CC015/Unc 12.59 10.72 3.27 1.64 13.29 4.44 2.11 1.05 11.99 23.49 4.85 2.42 
CC017/Unc 11.65 40.92 6.40 3.69 10.93 37.67 6.14 3.54 12.30 45.79 6.77 3.91 
CC019/TauUnc 14.29 14.02 3.74 1.67 12.32 20.52 4.53 2.03 16.25 20.92 4.57 2.05 
CC021/Unc 10.95 4.89 2.21 1.28 11.11 8.71 2.95 1.70 11.08 1.61 1.27 0.73 
CC022/GeniUnc 13.26 15.87 3.98 1.99 12.51 8.44 2.90 1.45 14.09 26.46 5.14 2.57 
CC023/GeniUnc 11.53 9.12 3.02 1.74 10.30 9.51 3.08 1.78 12.61 13.29 3.65 2.11 
CC024/GeniUnc 15.76 4.11 2.03 1.01 14.33 3.63 1.91 0.95 17.02 7.50 2.74 1.37 
CC025/GeniUnc 9.19 22.18 4.71 2.72 8.21 16.95 4.12 2.38 10.11 28.22 5.31 3.07 
CC027/GeniUnc 16.65 0.81 0.90 0.37 16.36 0.77 0.87 0.36 17.17 1.08 1.04 0.42 
CC028/GeniUnc 2.69 0.05 0.23 0.11 2.75 0.06 0.25 0.13 2.66 0.04 0.21 0.10 
CC029/Unc 19.48 4.83 2.20 1.27 17.89 2.84 1.68 0.97 21.10 12.22 3.50 2.02 
CC032/GeniUnc 8.99 0.33 0.57 0.41 8.45 0.11 0.32 0.23 9.47 2.03 1.42 1.01 
CC035/Unc 12.04 9.68 3.11 1.56 11.45 2.32 1.52 0.76 12.54 21.44 4.63 2.32 
CC040/TauUnc 12.66 83.74 9.15 4.09 12.29 79.29 8.90 3.98 13.02 88.50 9.41 4.21 
CC043/GeniUnc 8.18 41.08 6.41 2.62 6.72 42.81 6.54 2.67 9.60 53.81 7.34 2.99 
CC044/Unc 4.85 1.61 1.27 0.73 4.87 1.99 1.41 0.81 4.99 2.26 1.50 0.87 
CC045/GeniUnc 11.36 20.03 4.48 2.00 9.79 15.96 3.99 1.79 13.11 33.75 5.81 2.60 
CC046/Unc 8.98 15.04 3.88 2.24 9.73 27.77 5.27 3.04 8.25 12.85 3.58 2.07 
CC051/TauUnc 7.46 29.66 5.45 2.72 6.25 21.73 4.66 2.33 8.47 41.93 6.48 3.24 
CC052/GeniUnc 4.23 0.35 0.59 0.34 3.88 0.24 0.49 0.28 4.47 1.17 1.08 0.62 
CC055/TauUnc 13.36 37.43 6.12 2.16 10.91 29.58 5.44 1.92 15.62 49.50 7.04 2.49 
CC058/Unc 7.77 7.47 2.73 1.03 6.53 5.11 2.26 0.85 8.94 13.33 3.65 1.38 
CC059/TauUnc 2.98 0.16 0.40 0.23 2.94 0.41 0.64 0.37 3.07 0.06 0.24 0.14 
CC060/Unc 13.82 1.47 1.21 0.49 12.28 7.60 2.76 1.13 15.51 9.65 3.11 1.27 
CC062/Unc 10.73 4.88 2.21 0.99 9.46 5.93 2.44 1.09 11.82 8.49 2.91 1.30 
CC063/Unc 8.52 13.79 3.71 1.86 7.60 6.63 2.58 1.29 9.54 28.79 5.37 2.68 
CC065/Unc 13.12 10.60 3.26 1.46 11.94 5.19 2.28 1.02 13.21 56.30 7.50 3.36 
CC068/TauUnc 10.62 22.83 4.78 2.39 9.26 15.75 3.97 1.98 12.18 32.17 5.67 2.84 
CC070/TauUnc 6.41 52.35 7.24 4.18 5.97 47.38 6.88 3.97 7.03 56.37 7.51 4.33 
CC071/TauUnc 13.98 1.84 1.36 0.68 13.11 2.14 1.46 0.73 14.79 1.63 1.28 0.64 
CC075/Unc 12.48 42.56 6.52 3.26 13.53 38.27 6.19 3.09 11.90 52.03 7.21 3.61 
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Table 3.4. Genetic background has a significant effect on all potential mediators of 
exercise-induced body composition response to voluntary exercise. 
P-values from ANOVAs of linear models measuring the effect of genetic background on 
each potential mediator (distance, duration, speed, and adjusted food intake) at all three 
time points (1 month; week1-2; week3-4). Statistical significance: p<0.05. 
Mediator Time point 
Month Week 1-2 Week 3-4 
Total Distance 3.09x10-12 3.25x10-12 6.64x10-10 
Total Duration 2.57x10-12 9.16x10-14 5.097x10-09 
Average Speed 5.08x10-13 3.37x10-14 1.167x10-09 





Table 3.5. Nested ANOVA analysis of potential mediators and genetic background on body mass and composition response to 
voluntary exercise. Base models included a mediator as a fixed effect. Additive models included a mediator and genetic 
background as additive effects. Full models included a mediator effect, genetic background effect and their interaction. Grey 
boxes represent significant p values. 
Mediator Response Time point 
Base vs 
Additive model 
Additive vs Full 













Month 0.045 0.759 
Week 1-2 1.32x10-08 9.27x10-04 Week 1-2 3.45x10-08 0.0054 
Week 3-4 0.0236 0.9127 Week 3-4 0.0355 0.763 
Body Fat % 
Month 6.61x10-10 0.022 
Body Fat % 
Month 9.933x10-08 0.01839 
Week 1-2 1.152x10-08 0.0129 Week 1-2 4.936x10-07 0.00102 
Week 3-4 0.09038 0.0204 Week 3-4 0.0404 0.213 
Lean Mass 
% 
Month 3.7x10-04 0.7551 
Lean Mass 
% 
Month 0.00345 0.6629 
Week 1-2 9.77x10-10 0.261 Week 1-2 5.416x10-08 0.319 




Month 0.0106 0.999 
Baseline Age 
Body Mass 
Month 0.1172 0.9871 
Week 1-2 1.88x10-08 0.026 Week 1-2 1.25x10-08 0.7791 
Week 3-4 0.0286 0.996 Week 3-4 0.037 0.7117 
Body Fat % 
Month 7.83x10-10 0.05196 
Body Fat % 
Month 1.216x10-8 0.9751 
Week 1-2 1.569x10-08 0.0283 Week 1-2 4.99x10-08 0.991 
Week 3-4 0.1289 0.1219 Week 3-4 0.0967 0.872 
Lean Mass 
% 
Month 3.55x10-04 0.9806 
Lean Mass 
% 
Month 0.00329 0.6741 
Week 1-2 7.79x10-10 0.4224 Week 1-2 9.705x10-10 0.8715 




Month 0.01659 0.9907 
 
Week 1-2 5.049x10-09 9.54x10-04 
Week 3-4 0.01502 0.3612 
Body Fat % 
Month 2.418x10-09 0.009836 
Week 1-2 4.98x10-08 0.001293 
Week 3-4 0.08204 0.2008 
Lean Mass 
% 
Month 4.316x10-04 0.9908 
Week 1-2 2.187x10-09 0.346 
Week 3-4 0.1283 0.8192 
 
76 
Table 3.6. Phenotypic correlations and significance between body mass and 
composition responses and potential mediators in the voluntary exercise cohort. 
Grey boxes represent significant correlations. 
Time Point Mediator 
Body Mass 
Response 
Body Fat % 
Response 
Lean Mass % 
Response 
cor p cor p cor p 
Month Age -0.0881 0.2425 -0.0674 0.3712 0.1082 0.1506 
Week 1-2 Age -0.0704 0.3467 0.0384 0.6078 0.0231 0.7578 
Week 3-4 Age -0.0104 0.8906 -0.1048 0.1639 0.1037 0.1684 
Month Distance - month -0.0721 0.3374 -0.0111 0.8830 0.0260 0.7294 
Week 1-2 Distance - month -0.0865 0.2455 -0.1322 0.0752 0.1464 0.0486 
Week 3-4 Distance - month -0.0067 0.9293 0.1377 0.0660 -0.1032 0.1690 
Month Distance - week 1-2 0.0476 0.5269 0.0264 0.7257 -0.0853 0.2563 
Week 1-2 Distance - week 1-2 -0.0067 0.9282 -0.1084 0.1451 0.0629 0.3988 
Week 3-4 Distance - week 1-2 0.0615 0.4137 0.1755 0.0188 -0.1707 0.0223 
Month Distance - week 3-4 -0.1505 0.0443 -0.0299 0.6911 0.0978 0.1926 
Week 1-2 Distance - week 3-4 -0.1325 0.0746 -0.1354 0.0683 0.1875 0.0113 
Week 3-4 Distance - week 3-4 -0.0559 0.4573 0.1061 0.1576 -0.0476 0.5267 
Month Duration - month -0.0651 0.3869 -0.0322 0.6687 0.0279 0.7112 
Week 1-2 Duration - month -0.1035 0.1645 -0.1803 0.0149 0.1597 0.0312 
Week 3-4 Duration - month 0.0081 0.9140 0.1679 0.0247 -0.1108 0.1397 
Month Duration - week 1-2 -0.0304 0.6861 -0.0362 0.6302 0.0108 0.8858 
Week 1-2 Duration - week 1-2 -0.0718 0.3355 -0.1793 0.0155 0.1257 0.0908 
Week 3-4 Duration - week 1-2 0.0187 0.8035 0.1537 0.0400 -0.0955 0.2035 
Month Duration - week 3-4 -0.0889 0.2369 -0.0135 0.8581 0.0283 0.7066 
Week 1-2 Duration - week 3-4 -0.1168 0.1164 -0.1559 0.0356 0.1649 0.0261 
Week 3-4 Duration - week 3-4 -0.0034 0.9635 0.1725 0.0210 -0.1197 0.1106 
Month Food Intake - week 1-2 0.1766 0.0180 0.3762 0.0000 -0.2933 0.0001 
Week 1-2 Food Intake - week 1-2 0.4026 0.0000 0.3211 0.0000 -0.4190 0.0000 
Week 3-4 Food Intake - week 1-2 -0.1147 0.1264 0.1572 0.0356 0.0280 0.7096 
Month Adj Food Intake - week 1-2 0.4427 0.0000 0.3185 0.0000 -0.5065 0.0000 
Week 1-2 Adj Food Intake - week 1-2 0.6243 0.0000 0.2534 0.0006 -0.6140 0.0000 
Week 3-4 Adj Food Intake - week 1-2 -0.0149 0.8426 0.2051 0.0059 -0.0734 0.3286 
Month Food Intake - week 3-4 -0.1515 0.0429 0.0413 0.5833 0.1450 0.0528 
Week 1-2 Food Intake - week 3-4 -0.1427 0.0561 -0.1046 0.1623 0.2869 0.0001 
Week 3-4 Food Intake - week 3-4 -0.0303 0.6870 0.2248 0.0025 -0.0795 0.2899 
Month Adj Food Intake - week 3-4 0.0739 0.3253 -0.0510 0.4975 -0.0736 0.3275 
Week 1-2 Adj Food Intake - week 3-4 -0.1063 0.1555 -0.2583 0.0005 0.0960 0.2000 
Week 3-4 Adj Food Intake - week 3-4 0.1779 0.0172 0.3668 0.0000 -0.1901 0.0108 
Month Speed - month -0.1070 0.1539 -0.0454 0.5466 0.0836 0.2659 
Week 1-2 Speed - month -0.0731 0.3268 -0.1552 0.0364 0.1717 0.0205 
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Week 3-4 Speed - month -0.0529 0.4819 0.1084 0.1487 -0.0450 0.5498 
Month Speed - week 1-2 -0.0143 0.8496 -0.0357 0.6352 0.0005 0.9944 
Week 1-2 Speed - week 1-2 -0.0289 0.6984 -0.1503 0.0428 0.1258 0.0907 
Week 3-4 Speed - week 1-2 0.0144 0.8483 0.1233 0.1002 -0.1127 0.1332 
Month Speed - week 3-4 -0.1713 0.0219 -0.0519 0.4900 0.1395 0.0626 
Week 1-2 Speed - week 3-4 -0.1038 0.1632 -0.1521 0.0403 0.1949 0.0084 





Table 3.7. Treadmill protocols for acclimation days and forced endurance testing. 
Acclimation Day 1 











this step (m) 
Total distance 
accumulated after 
this step (m) 
Total Running 
Time (at end of 
this step; min) 
1 0 3 30 0.75 0.75 0.5 
2 3 6 90 6.75 7.5 2 
3 6 9 180 22.5 30 5 
4 9 9 600 90 120 15 
5 9 0 120 9 129 17 
Acclimation Day 2 











this step (m) 
Total distance 
accumulated after 
this step (m) 
Total Running 
Time (at end of 
this step; min) 
1 0 3 30 0.75 0.75 0.5 
2 3 6 90 6.75 7.5 2 
3 6 9 180 22.5 30 5 
4 9 9 600 90 120 15 
5 9 16 120 25 145 17 
6 16 16 120 32 177 19 
7 16 0 60 8 185 20 
Acclimation Day 3 











this step (m) 
Total distance 
accumulated after 
this step (m) 
Total Running 
Time (at end of 
this step; min) 
1 0 3 30 0.75 0.75 0.5 
2 3 6 90 6.75 7.5 2 
3 6 9 180 22.5 30 5 
4 9 9 60 9 39 6 
5 9 16 60 12.5 51.5 7 
6 16 16 180 48 99.5 10 
7 16 18 180 51 150.5 13 
8 18 18 120 36 186.5 15 
9 18 20 180 57 243.5 18 
10 20 20 120 38 281.5 20 
11 18 0 60 9 290.5 21 
Endurance Test Day 











this step (m) 
Total distance 
accumulated after 
this step (m) 
Total Running 
Time (at end of 
this step; min) 
1 0 6 120 6 6.0 2.0 
2 6 13 720 114.0 120.0 14.0 
3 13 13 360 78.0 198.0 20.0 
4 13 14 30 6.8 204.8 20.5 
5 14 14 360 84.0 288.8 26.5 
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6 14 15 30 7.3 296.0 27.0 
7 15 15 360 90.0 386.0 33.0 
8 15 16 30 7.8 393.8 33.5 
9 16 16 720 192.0 585.8 45.5 
10 16 17 30 8.3 594.0 46.0 
11 17 17 720 204.0 798.0 58.0 
12 17 18 60 17.5 815.5 59.0 
13 18 18 720 216.0 1031.5 71.0 
14 18 19 60 18.5 1050.0 72.0 
15 19 19 720 228.0 1278.0 84.0 
16 19 20 180 58.5 1336.5 87.0 
17 20 20 999 333.0 1669.5 103.7 
18 20 20 999 333.0 2002.5 120.3 
19 20 20 999 333.0 2335.5 137.0 
20 20 21 999 341.3 2676.8 153.6 
21 21 21 999 349.7 3026.5 170.3 
22 21 21 999 349.7 3376.1 186.9 
23 21 22 999 358.0 3734.1 203.6 
24 22 22 999 366.3 4100.4 220.2 
25 22 22 999 366.3 4466.7 236.9 
26 22 23 999 374.6 4841.3 253.5 
27 23 23 999 383.0 5224.3 270.2 
28 23 23 999 383.0 5607.2 286.8 
29 23 24 999 391.3 5998.5 303.5 
30 24 24 999 399.6 6398.1 320.1 
31 24 24 999 399.6 6797.7 336.8 
32 24 24 999 399.6 7197.3 353.4 
33 24 18 120 42.0 7239.3 355.4 
34 18 6 120 24.0 7263.3 357.4 





CHAPTER 4: CC002/Unc FEMALES ARE MOUSE MODELS OF EXERCISE-INDUCED 
ADVERSE FAT RESPONSE6 
4.1 Overview 
Exercise results in beneficial health outcomes and protects against a variety of chronic 
diseases. However, U.S. exercise guidelines recommend identical exercise programs for 
everyone, despite individual variation in responses to these programs, including paradoxical fat 
gain. Experimental models of exercise-induced adverse outcomes may enable the dissection of 
underlying physiological mechanisms as well as the evaluation of potential interventions. 
Whereas several studies have identified individual mice exhibiting adverse fat gain following 
exercise, no systematic effort has been conducted to identify and characterize models of 
adverse response. Strains from the Collaborative Cross (CC) genetic reference population were 
used due to its high levels of genetic variation, its reproducible nature, and the observation that 
the CC is a rich source of novel disease models, to assess the impact genetic background has 
on exercise responses. We identified the strain CC002/Unc as a robust exercise-induced 
adverse fat response model in a controlled voluntary exercise study across multiple ages in 
female mice. We also found sex and genetic differences were consistent with this pattern in a 
study of forced exercise programs. These results provide a novel model for studies to determine 
the mechanisms behind paradoxical adverse metabolic responses to exercise, and enable 
development of more rational personalized exercise recommendations based on factors such as 
age, sex, and genetic background.
                                               
6 This work was submitted to Physiological Genomics and is under review. The work 
described has been completed in collaboration with Martin T. Ferris, Timothy A. Bell, Vineet 
D. Menachery, Ralph S. Baric, Kunjie Hua, Daniel Pomp, Abbie E. Smith-Ryan and 





Exercise is known to have numerous positive health benefits, plays a role in weight 
management and obesity prevention, and has the potential to reduce morbidity associated 
with chronic diseases (16, 117). Although exercise reduces health risks, the effects on body 
composition are still unknown. Exercise is expected to reduce body mass and fat, but 
exercise-induced weight loss is often less than expected (16). In both human and rodent 
populations, individual variation across a multitude of exercise-induced responses occurs, 
with some individuals experiencing adverse responses (45, 47, 49, 118-122). Even when 
exercise doses and energy expenditures are controlled, there is large individual variation in 
body mass and composition responses to exercise programs (19, 49, 79). In fact, some 
humans gain weight (16, 48) and gain body fat (49) in response to exercise; and similar 
adverse responses have been observed in outbred mice (19). This observed variation can 
be partially attributed to insufficient exercise dose, lack of adherence, and physiological and 
behavioral compensatory adaptations (e.g. energy intake, habitual activity levels, metabolic 
adaptations) (16, 123). Furthermore, the individual variation in response to exercise 
treatments suggests genetic variation contributes to differences in exercise-induced 
responses (8, 49, 83, 121, 124-127). Initial studies in humans (121, 124, 125, 127, 128) and 
rodents (19, 83, 126, 129) have suggested that genetics contributes to exercise-induced 
body mass and composition responses.  
U.S. guidelines for physical activity recommend the same exercise programs despite 
age or sex (21). A moderate intensity continuous training (MICT) program consists of 
continuous exercise at a moderate intensity and closely resembles recommended physical 
activity guidelines. Alternatively, exercise programs can vary in intensity, such as high 
intensity interval training (HIIT), which consists of exercising at intervals of high intensity 
followed by short periods of low intensity or rest. HIIT programs are time-efficient 




(26, 130). Initial studies have demonstrated HIIT can efficiently and effectively reduce body 
fat (29, 30) and increase lean mass (34, 35). However, individual variability in body 
composition responses with the presence of responders and non-responders has been 
observed in HIIT, MICT and other exercise programs making it difficult to determine 
effective personalized exercise programs. Furthermore, initial evidence in humans suggests 
that physiological outcomes as a result of HIIT may be sex specific (43). It is unclear if or 
how genetics influences body composition in response to HIIT and MICT exercise 
programs (22-29, 35).  
Given the complex interactions between physical activity, energy intake, body 
composition, as well as other variables, it is difficult to determine causal factors and 
successful exercise regimes that elicit beneficial responses to exercise in the human 
population. Sets of genetically distinct inbred mouse strains can be used to assess the 
impact of genetic responses for all of these traits while controlling environmental variables 
(51, 54). Even though it is common in human studies, especially in women, to observe 
exercise-induced body fat gain, no inbred mouse models exist which recapitulate these 
phenotypes. Most mouse studies (83, 90, 126, 129) have only observed a standard 
response (body fat loss) to exercise, with the exception of some outbred mice presenting 
adverse responses (19). A previous study used incipient Collaborative Cross (pre-CC) mice 
to examine exercise-related traits and observed ~17% of the pre-CC lines had an adverse 
response to voluntary exercise (66). Since biological replicates within each pre-CC line 
were not tested, it remains unknown whether the observed adverse body composition 
responses were due to genetics, experimental noise or another underlying mechanism. 
We utilized the CC population (53, 55, 57-59) to determine if there are inbred strains with 
consistent adverse fat response to exercise. The CC was selected because of 1) the 
previously reported exercise-induced adverse responses in the pre-CC (66); 2) its high 




replicates; and 4) it has proven to be a rich source for novel human disease models (64, 
65). We expected variation in exercise phenotypes among CC strains to be comparable to 
variation observed in the human population (54), and to provide strain(s) that can serve as 
models of exercise-induced adverse fat response.  
Here we report the results of three independent but related experiments in CC mice: 
a screen for variability in responses to voluntary exercise; validation of strain CC002/Unc as 
a model for adverse response; and finally, an evaluation of metabolic response for two 
different exercise programs. These studies aimed to identify potential CC strains with 
exercise-induced adverse body composition response for model development and for 
understanding genetic background contribution on physiological responses to different 
exercise programs. 
4.3 Materials & Methods 
Each section is divided into subsections for the following experiments: 1) Voluntary 
Exercise Screen; 2) CC002/Unc Model Validation; 3) Exercise Program Evaluation.  
4.3.1 Mice & Exercise Treatment 
All mice were purchased from the Systems Genetics Core Facility 
(http://csbio.unc.edu/CCstatus/index.py) and housed in the Division of Comparative 
Medicine facilities at the University of North Carolina at Chapel Hill. All procedures 
performed within this experiment were approved by the University of North Carolina – 
Chapel Hill Institutional Animal Care and Use Committee (IACUC #15-015). Mice were 
housed in a temperature controlled (23° +/- 1° C) and humidity controlled vivarium with a 
standard 12:12h light:dark cycle (lights on at 0700h). Mice were allowed ad libitum access 
to standard laboratory chow (Envigo 2920 irradiated chow) and water. 
1) Voluntary Exercise Screen. Female mice (n=173 total mice; ~9 months +/- 4 weeks) from 
13 CC strains were used in this screen and are also part of an ongoing aging study at UNC. 




April to October 2015). Females were selected due to the need to group house the mice 
during the aging process. Mice were assigned to experimental (voluntary exercise; n=93) or 
control (no exercise; n=80) treatment cohorts prior to the start of the experiment (n=4-8 per 
strain and treatment). The experiment was performed in six batches spaced approximately 
one month apart each. During the experiment two mice died of unrelated causes, one 
CC040/TauUnc from the control cohort and one CC030/GeniUnc from the experimental 
cohort (these mice were only used in the baseline phenotypic analysis).  
Mice in the experimental cohort were individually housed in standard laboratory 
cages with ad libitum access to attached running wheels (1.1m circumference; Lafayette 
Industries Lafayette, IN; (134)). Wheel running data was recorded continuously in 1-min 
intervals over a two-week period using an automated activity wheel monitoring program 
(AWM, Lafayette Industries, Lafayette, IN). The following physical activity measurements 
were obtained for each day of wheel access: distance (total revolutions x 1.1 m), duration 
(cumulative 1-min intervals in which at least 1 revolution was recorded), and average speed 
(total distance/total duration; m/min) (96). For days 11-12 of wheel access, the mean total 
distance, duration and average speed were calculated for each mouse. Mice in the control 
cohort were group housed (or single housed in select cases when all other cage mates 
were assigned to the experimental cohort) for the two weeks.  
2) CC002/Unc Model Validation. Female mice (n=12 per strain; born September to October 
2016) from CC002/Unc and CC037/TauUnc were used to assess robustness of the 
CC002/Unc model at a younger age (~4 months +/- 2 weeks). Mice were assigned to 
control (CC002/Unc n=3; CC037/TauUnc n=5) or experimental (CC002/Unc n=9; 
CC037/TauUnc n=7) cohort. Both cohorts were acclimated for two weeks to single housing 
with attached wheels in same vivarium room but without access to wheels. After 
acclimation, mice in the experimental cohort were given ad libitum access to running 




Experimental procedures for running wheel data collection and physical activity calculations 
follow those detailed in the “Voluntary Exercise Screen” section above. Total weekly 
distance, total weekly duration and average weekly speed were calculated for each two 
week interval of wheel access and were labeled 1, 2, 3 and 4 (respectively: weeks 1-2, 
weeks 3-4, weeks 5-6, weeks 7-8 of wheel access). 
3) Exercise Program Evaluation  
Strain selection: Four strains were selected based on the following criteria: 1) ability to run 
on treadmills, 2) fat response type to voluntary exercise, 3) endurance ability (MPD 
datasets: McMullan1, McMullan2, McMullan3; Experiment “Voluntary Exercise Screen”; all 
data was collected in older females). Selected strains were: CC002/Unc adverse fat 
responder, low endurance; CC027/GeniUnc adverse fat responder, high endurance; 
CC013/GeniUnc standard fat responder, low endurance; and CC037/TauUnc standard fat 
responder, high endurance. 
Maximum endurance speed: To assess maximum endurance speed, mice from the 
selected strains (n=3 per sex and strain) were group housed with the same sex and strain. 
Mice were acclimated to the treadmill (Exer 3/6, Columbus Instruments, Columbus, Ohio) 
over three days (Supporting Table 1). Then, mice were run to exhaustion using the 
following endurance protocol performed at 20° inclination: initial speed was 4 m/min, 
increased by 2 m/min every two minutes then at 12 m/min the speed increased by 1 m/min 
every minute. The endurance protocol was performed twice on each mouse on two 
separate days and maximum speed (m/min) was recorded for both days. Maximum speed 
was defined as the last speed the mouse was able to maintain steady treadmill running 
before failure. Failure was defined as the inability or refusal to run on the treadmill despite 
stimulus via shock grid or prodding. The mean maximum speed was calculated for each 




Exercise program protocol design: Strain and sex specific training protocols (HIIT and 
MICT) were designed based on the measured mean maximum speeds. There were five 
separate exercise groups: 1) CC002/Unc females; 2) CC013/GeniUnc females; 3) 
CC027/GeniUnc and CC037/TauUnc females; 4) CC002/Unc and CC013/GeniUnc males; 
and 5) CC027/GeniUnc and CC037/TauUnc males. The HIIT protocols consisted of five 
intervals with 80% max speed for four minutes, 20% max speed for one min, and ten 30 
second transitions to decrease and increase speed between the different intensities. The 
MICT protocols were distance matched to the HIIT protocols and consisted of ~43 min 
duration at 50% max speed (Supporting Table 2-3). 
Exercise program evaluation: Mice (n=252 total mice; n=minimum 8 per sex, strain and 
exercise treatment combination; age: 8-10 weeks at start; born between March to August 
2016 and February to March 2017) from CC002/Unc, CC013/GeniUnc, CC027/GeniUnc 
and CC037/TauUnc were housed with the same strains and sex in groups of three. The 
experiment was performed in five batches. Every strain, sex, exercise program combination 
was represented at least once in each batch for batches 1-4. In order to increase biological 
replicates, an additional batch (batch 5) was added. Batch 5 consisted of CC002/Unc 
females, CC027/GeniUnc females, CC037/TauUnc females, CC027/GeniUnc males, and 
CC037/TauUnc males (for females HIIT n=8 & MICT n=8 per strain; for males HIIT n=3 & 
MICT n=3 per strain). Across all batches, within each home cage, there was one mouse 
randomly assigned to each of the three exercise programs (HIIT, MICT, and no exercise 
[NE]) to avoid confounding cage effects with exercise program effects (with the exception of 
batch 5 which consisted of only HIIT and MICT programs). In five cases (for batches 1-4) 
more than three mice were group housed in one cage.  
Mice completed five weeks of exercise training on the Exer-3/6 treadmills (Columbus 
Instruments, Columbus, Ohio). Mice assigned to both HIIT and MICT training protocols 




After acclimation, HIIT and MICT mice completed four weeks of training, three times a week 
of their respective training protocol (Supporting Table 3). All training occurred in the 
morning and mice were randomly assigned to a treadmill lane each training day. 
Compliance was tracked over the full 15 days of exercise training and mice with 50% or 
more non-compliant days were removed from statistical analysis. A mouse was considered 
non-compliant if it refused or was not able to continue regular treadmill running despite 
extra stimulus from shock and/or prodding. Ten non-compliant mice were removed from the 
study (two CC002/Unc females HIIT; two CC002/Unc males HIIT; three CC013/GeniUnc 
females HIIT; two CC027/GeniUnc females HIIT; one CC027/GeniUnc female MICT). Five 
mice died during the experiment and were removed from the analysis (one CC013/GeniUnc 
female HIIT; one CC027/GeniUnc male MICT; one CC027/GeniUnc female HIIT; two 
CC037/TauUnc females HIIT).  
4.3.2 Metabolic measurements 
In all experiments, body composition was assessed (during mornings 0700-1200h) 
using whole body MRI (EchoMRI 3-in-1 Body Composition Analyzer, EchoMRI, Houston, 
TX) to determine fat and lean mass content (in grams) for each animal. 
1) Voluntary Exercise Screen. Body mass and composition were measured immediately 
prior to the start of the experiment, and following the two-week experiment for all cohorts. 
Food was weighed prior to and after the experiment for the experimental cohort. To prevent 
variation in food intake due to food wastage, any food spillage was collected and weighed 
(113). Food intake for the control cohort was not tracked as a result of group housing. 
2) CC002/Unc Model Validation. Body mass and composition were measured every two 
weeks over the 10 weeks of the experiment for all cohorts. Food was weighed at the same 
time points as body composition for both control and experimental cohorts. 
3) Exercise Program Evaluation. Metabolic measurements and body mass and composition 




training. Metabolic measurements were assessed by indirect calorimetry (PhenoMaster, 
TSE systems, Chesterfield, MO). For each batch, mice were randomly assigned to a 
calorimetry batch (A, B, or C) and calorimetry cage (1-24). Calorimetry data recorded 
included: oxygen consumption (VO2; ml/h/kg), carbon dioxide output (VCO2; ml/h/kg), 
activity (counts), food weight (g), water volume (ml) and heat production (kcal/h/kg). 
Respiratory exchange ratio (RER; VCO2/VO2) was calculated at each collection point. To 
acclimate to single housing, mice were individually housed for 24 hours prior to the start of 
the indirect calorimetry. Mice were then individually housed in calorimetry cages for 24 
hours and data was recorded every ~50 minutes for each calorimetry cage. After, mice 
were returned to their assigned group housing. 
4.3.3 Metabolic Calculations 
Body fat and lean mass percentages were calculated relative to body mass at each 
time point in every experiment. Body mass response was calculated as [(Post-mass – pre-
mass)/pre-mass] x 100. Body composition percentage response was calculated as [(post-
measurement % - pre-measurement %)/pre-measurement %] x 100. Body mass and 
composition responses for individual mice in the experimental cohort (or HIIT, MICT) were 
adjusted to the mean strain (or strain-by-sex) responses in the control cohort (or NE) to 
account for experimental variability between cohorts (e.g. adjusted body mass response = 
[individual body mass response – control cohort strain mean body mass response]; 
adjusted body fat % response = [individual body fat % response – control cohort strain 
mean body fat % response]). Negative values represent a loss and positive values 
represent a gain in response to treatment. Food intake was calculated as the differential 
between baseline and post exercise food weights (g). Adjusted food intake was calculated 




1) Voluntary Exercise Screen. Body mass and composition responses for both cohorts 
were calculated for the two weeks of treatment. Adjusted body mass and composition 
responses were calculated for the experimental cohort.  
2) CC002/Unc Model Validation. For each mouse, cumulative body mass and composition 
responses were calculated for every experimental time point interval (1, 2, 3, 4; 
respectively: weeks 0-2, weeks 0-4, weeks 0-6 and weeks 0-8 of treatment). Adjusted 
cumulative body mass and composition responses were calculated for the experimental 
cohort at each time point interval. Adjusted food intake was calculated for each interval. 
3) Exercise Program Evaluation. Body mass and composition responses were calculated 
for the five weeks of exercise program treatment. Adjusted body mass and composition 
responses were calculated for HIIT and MICT mice. Calorimetry data collected from 0700-
1100h (day) and 1900-2300h (nocturnal) was used to calculate the following traits for each 
mouse for both day and nocturnal values (at baseline and post treatment): mean VO2 
intake, mean VCO2 output, mean RER, total activity, mean heat production, food intake and 
water intake. 
4.3.4 Statistical Analysis 
All statistical analyses were performed in the R programming environment 
(https://cran.r-project.org). Descriptive statistics (mean, variance, coefficient of variance, 
standard deviation and standard error) were calculated for phenotypes across CC strain 
(Supporting Table 4-8). Pearson’s correlations were calculated for the relationship between 
body mass and composition responses and potential mediators (physical activity traits and 
adjusted food intake). Heritability of body mass and composition response in the voluntary 
exercise screen was measured by inter-class correlation (icc) and the coefficient of genetic 
determination (cgd) (135). In order to determine potential mediators of the physiological 




explanatory variables (e.g. treatment, genetic background, sex, metabolic responses), 
which robustly explain variation in the physiological responses. 
4.3.5 Data Availability 
All data are publically available at the Mouse Phenome Database (https://phenome.jax.org). 
CC strain information is located at: http://csbio.unc.edu/CCstatus/index.py (55, 59). 
4.4 Results 
4.4.1 Screen for voluntary exercise-induced adverse body composition responders in 
aged CC females 
In a screen of 13 CC strains, body mass and composition responses to two weeks of 
treatment (control or experimental) were measured in ~9 month old females. Exercise had 
a significant effect on body mass and composition responses (p<1.0x10-05), but genetic 
background had a greater contribution (Table 4.1). All responses were heritable (cgd=31.0%, 
icc=47.4% body mass response; cgd=22.4%, icc=36.8% body fat response; and cgd=26.3%, 
icc=41.7% lean mass response). Furthermore, there were significant genetic background-by-
treatment interactions on body mass, body fat and lean mass responses (p=5.1x10-11, 
p=3.5x10-07, and p=1.9x10-09, respectively, Table 4.1). 
In the control cohort (no exercise), three strains had a significant standard body 
mass response (lost body mass), two strains had a significant standard body fat response 
(lost body fat) and three strains had a significant standard lean mass response (gained lean 
mass). In the experimental cohort (voluntary exercise), six CC strains had a significant body 
mass loss, seven strains had a significant standard body fat response and nine CC strains 
had a significant standard lean mass response (Figure 4.1, Supporting Table 4). In order to 
determine the effect of exercise independent of aging, the responses in the experimental 
cohort were adjusted to the mean strain responses in the control cohort. In the 
experimental cohort, six strains had a significant standard adjusted body mass response 




exercise treatment. CC072/TauUnc had no significant change in mean body fat as there 
was great individual variability within the strain. CC002/Unc had a significant adverse 
adjusted fat response (mean: 25.6%; range: -5.78% to +82.06%) (Figure 4.2B). Eight CC 
strains had a significant standard adjusted lean mass response and one strain, CC002/Unc, 
had a significant adverse adjusted lean mass response (Figure 4.2C, Supporting Table 4). 
Other traits varied significantly by genetic background (running distance p=0.0025; 
duration p=0.018; speed p<2.7x10-06; adjusted food intake p=0.0001) (Supporting Figure 1-
2, Supporting Table 5). Therefore, phenotypic correlations were used to assess whether 
these potential mediators were associated with body mass and composition responses. 
Running duration was significantly and negatively correlated with body mass (r=-0.211) and 
body fat response (r=-0.223). Mean speed was significantly correlated with body fat 
response (r=-0.206). All physical activity traits had significant positive correlations with lean 
mass response (distance r=0.244, duration r=0.266, speed r=0.278). Adjusted food intake 
was significantly correlated with body mass response (r=0.755), although this is not 
surprising since adjusted food intake is calculated by dividing food intake by baseline body 
mass. Adjusted food intake was also significantly correlated with lean mass response (r=-
0.665) and body fat response (r=0.411) (Table 4.2). While potential mediators were 
correlated with responses, genetic background had a more significant contribution than any 
mediator alone to body mass and composition responses. There was a significant genetic 
background-by-adjusted food intake interaction on fat response (p=0.018, Table 4.3). 
4.4.2 Further characterization of CC002/Unc as a model for exercise-induced adverse 
fat response 
To determine whether the CC002/Unc model of exercise-induced adverse body 
composition response extended beyond aged females, the robustness of the model was 
tested in younger females. The experiment was performed in ~4 month old females from 




There was no significant effect of treatment, genetic background or genetic background-by-
treatment interaction on body mass or body composition response to two weeks of 
treatment in young CC002/Unc and CC037/TauUnc females. Despite the lack of statistical 
significance, the direction and magnitude of fat response to two weeks of exercise was 
consistent between young and old CC002/Unc females. Young CC002/Unc females in the 
experimental cohort had a 28.94% mean unadjusted gain of body fat (range: -14.7% to 
70.7%) and a 19.73% mean adjusted gain of body fat (range: -23.9% to 61.5%). 
CC002/Unc mice had a lower baseline body fat percentage in young (mean 10.4%) 
compared to old (mean 16.8%) females. Additionally, adjusted food intake was greater in 
young females (mean 2.2) than old females (mean 1.85). Younger CC002/Unc mice ran 
approximately the same mean distance (4.51 km), but at lower mean speed (15.7 m/min) 
and greater mean duration (279.1 min) than old mice (mean distance 4.49 km, speed 17.8 
m/min, duration 248.6 min) on days 11-12. Initial body fat response to two weeks of 
voluntary exercise in young CC037/TauUnc females was not the same direction or 
magnitude as body fat response observed in old females (young: 6.68% unadjusted, -
1.93% adjusted; old: -43.64% unadjusted, -37.85% adjusted mean body fat response) 
(Supporting Figure 3, Supporting Table 4-6). 
Cumulative body mass and composition response was also measured over eight 
weeks of treatment to assess the effect of additional exercise on physiological responses. 
For cumulative body mass response, there was no significant effect of time point, 
treatment, genetic background and all their interactions. There was a significant additive 
effect of time point and genetic background on cumulative fat response (p=0.0018) and 
cumulative lean mass response (p=0.0471) demonstrating body composition responses 
varied by time point and genetic background. There was no significant effect of treatment 
on cumulative fat or lean mass response over time. Young experimental CC002/Unc 




a mean unadjusted cumulative fat response of 28.9, 20.3%, 25.6% and 32.0% for weeks 0-
2, 0-4, 0-6 and 0-8. In the CC002/Unc control cohort, mean unadjusted cumulative fat 
response increased over time intervals (9.2%, 16.9%, 23.6% and 30.9%). CC037/Tau 
mean cumulative fat response fluctuated over eight weeks in experimental females (6.68%, 
-5.6%, 17.9% and 0.19% for weeks 0-2, 0-4, 0-6 and 0-8) and in control females (8.65%, -
0.77%, 19.04% and 14.8%) (Figure 4.3, Supporting Figure 4, Supporting Table 6). 
Total distance and duration in the CC002/Unc experimental females decreased 
during weeks 1-4 to weeks 4-8. Mean speed remained stable over eight weeks of wheel 
access. CC037/TauUnc experimental females had stable running duration, but increased in 
mean speed and distance during the eight weeks of exercise (Supporting Figure 5, 
Supporting Table 7). Adjusted food intake increased during the first two weeks of wheel 
access in both cohorts and strains relative to food intake during single housing acclimation. 
Fluctuations in food intake were observed over the course of treatment in both cohorts and 
strains (Supporting Figure 6). The fluctuations in physical activity levels and food intake 
over the course of treatment are important since energy expenditure and energy intake 
contribute to body mass and composition responses. 
4.4.3 Effect of exercise program on body composition response across both sexes 
and different genetic backgrounds 
We selected four CC strains (see materials and methods) to measure the effects of 
genetic background, sex and two types of forced exercise programs (HIIT and MICT) on 
exercise-induced metabolic responses. Overall, exercise programs, HIIT and MICT, 
significantly reduced body mass relative to NE programs (p=6.82x10-12; HIIT-NE 
padj<1.0x10-07; MICT-NE padj=3.0x10-07). Body mass response in mice exposed to HIIT 
was not significantly different from body mass response in mice exposed to MICT. Genetic 
background-by-exercise program had a significant interaction on body mass response 




genetic background. Body mass response was not significantly modified by sex; thus, both 
males and females had similar mass response (Figure 4.4A, Figure 4.5A, Supporting Table 
8). 
Exercise programs were suggestive of body fat percentage response (p=0.063), but 
the interaction between exercise program and sex had a significant effect on body fat 
percentage response (p=0.039). Specifically, body fat response varied between HIIT and 
MICT programs among females (padj=0.01). Furthermore, there was a significant genetic 
background-by-exercise program-by-sex interaction effect on body fat percentage response 
(p=0.0002). CC002/Unc females had a significant standard adjusted fat response to HIIT 
(mean -24.37%, p=0.002) but no significant change in adjusted fat response to MICT 
(mean -1.0%, p=0.906). CC027/GeniUnc females had a significant adverse adjusted fat 
response to MICT (mean 38.01%, p=0.028) but no significant adjusted fat response to HIIT 
(mean 6.55%, p=0.571). Unlike females, males demonstrated similar fat responses to both 
HIIT and MICT programs (Figure 4.4B, Figure 4.5B, Supporting Table 8). 
Exercise program (p=0.011), and the interaction between exercise program and sex 
(p=0.0109), had a significant effect on lean mass percentage response. Again, the 
differences in lean mass response to HIIT and MICT programs in females were driving this 
significant interaction (padj=6.97x10-04). There was a significant genetic background-by-
exercise program-by-sex interaction on lean mass percentage response (p=0.009). 
CC027/GeniUnc females had a significant adverse lean mass response to both HIIT 
(adjusted mean -1.70%, p=0.004) and MICT (adjusted mean -2.78%, p=0.0002) programs 
(Figure 4.4C, Figure 4.5C, Supporting Table 8). 
All baseline metabolic variables (RER, VO2, VCO2, activity, heat, food intake and 
water intake) during both nocturnal and daytime were under genetic control (p<0.05). 
Baseline metabolic variables were not more predictive than genetic background for body 




activity and nocturnal water intake were as predictive as genetic background for body fat 
response (Table 4.4). Pearson’s correlations revealed baseline nocturnal activity was 
positively and significantly correlated with body fat response (r=0.185, p=0.0035). These 
observations indicate baseline nocturnal activity levels are predictive of fat response to 
exercise. Whereas, baseline nocturnal water intake was not significantly correlated with 
body fat response (r=-0.067, p=0.29) indicating that water intake is not likely casual of body 
fat response to exercise and instead may be confounded. After exercise training, metabolic 
variables during both nocturnal and day time were under genetic control (p<0.05) with the 
exception of nocturnal RER (p=0.459), day VO2 (p=0.069) and day heat production 
(p=0.056). In some cases post metabolic traits were just as predictive as genetic 
background for body fat response (Table 4.4). This observation is likely due to the fact that 
the metabolic traits are genetically regulated. 
4.5 Discussion 
4.5.1 CC002/Unc is a model for exercise-induced adverse body composition 
response 
One previous study that reported an exercise-induced adverse response in 17% of 
partially inbred mice (66), only examined one individual mouse per genotype in the pre-CC 
population, which limited the ability to assess genetic control of this trait. In contrast, our 
study used replicate inbred animals from the CC population with both sedentary control and 
voluntary exercise cohorts. The most significant finding was that CC002/Unc, one of the 13 
CC strains screened in the initial study, had a voluntary exercise-induced adverse body 
composition response among old females. It is possible that CC002/Unc overcompensates 
with food intake in response to exercise driving the observed adverse response, but this 
may not be only factor or driving factor contributing to the adverse response. Food intake 
varied significantly by genetic background and there was a significant genetic background-




background, including food intake, are driving the adverse response in old CC002/Unc 
females. For example, a standard response was observed in CC042/GeniUnc, which had 
similar levels of adjusted food intake and physical activity. Furthermore, a standard 
response occurred in CC039/Unc, even though CC039/Unc had similar adjusted food 
intake levels but lower physical activity levels than CC002/Unc. 
Young CC002/Unc females had consistent direction and magnitude of fat response 
to two weeks of voluntary exercise with old CC002/Unc females; however the treatment 
effect was not statistically significant at ~4 months. This is likely due to the variability 
present in the control and experimental treatment groups leading to overlap in the body 
composition response measurements between the groups in the younger mice. 
Interestingly, there was higher variance in body fat responses at ~4 months than at ~9 
months. The higher levels of variability could be due to the ongoing alterations in body 
composition occurring at this age. The younger CC002/Unc females had a lower baseline 
body fat percentage than the older mice (mean 10.4% and 16.8%, respectively). This is not 
surprising, as it is known that aging typically results in increased body fat, alterations in 
body composition and redistribution of fat (68, 134). The younger CC002/Unc females could 
have been undergoing alterations in body composition associated with aging over the eight 
weeks of treatment. Other factors could have contributed to the higher level of variability in 
the young mice and lack of significant effect. Unlike the older control mice, the young 
control cohort was housed in the same vivarium and cages as the experimental cohort. The 
control cohort for the young CC002/Unc and CC037/TauUnc females could have been 
exposed to stress or other factors impacting body composition responses confounded in 
the experiment.  
Young CC002/Unc females exposed to forced exercise programs (HIIT and MICT) 
did not have an adverse body composition response, as observed in the old and young 




significant standard adjusted fat response to HIIT and no significant change in adjusted fat 
response to MICT. It is important to note the forced endurance programs were performed 
three times a week over the course of four weeks and totaled ~480m per session for 
CC002/Unc females; whereas, CC002/Unc females in the voluntary exercise treatment 
were running ~4.5km on days 11-12 of wheel access. Thus, CC002/Unc females exposed 
to voluntary exercise had a greater frequency, duration and distance and varying intensity 
of exercise over two weeks than the females exposed to forced exercise programs. In 
rodents, both forced and voluntary exercise programs are used as a method to measure 
exercise abilities, exercise performance and other exercise-related traits. Voluntary 
exercise is a self-rewarding behavior and a complex trait that not only captures physical 
activity habits but also represents engagement in neural and physiological mechanisms 
required for the behavior (51). While both forced and voluntary depend on common 
variables (e.g. physiological systems, organ function), there are distinct factors to each 
program including: psychological desire to run, fear, pain perception, shock avoidance, etc 
(51, 78, 116). Factors unique to voluntary exercise and their interaction with the CC002/Unc 
genetic background could be driving the observed exercise-induced adverse body 
composition response. In conclusion, CC002/Unc females are a novel model mouse strain 
for voluntary exercise-induced adverse body composition response. These findings strongly 
suggest that this response is due to unique physiological and metabolic conditions under 
genetic control. 
4.5.2 Females have different body composition responses depending on exercise 
program and genetic background 
Body composition responses to HIIT, MICT and NE programs were examined in 
both males and females in four different genetic backgrounds. There was a significant 
genetic background-by-sex-by-exercise program interaction on both body fat and lean 




programs, and the response further varied by genetic background. This finding indicates 
genetic background, sex and exercise factors (e.g. intensity, duration) should be 
considered in design of exercise programs for humans. From this study, additional CC 
strains as potential models of adverse body composition responses to exercise were 
identified. In particular, both CC027/GeniUnc and CC037/TauUnc females had a significant 
adverse adjusted fat response to MICT programs. Additional studies utilizing these 
identified models of adverse responders and non-responders will be necessary to identify 
underlying mechanistic pathways and genetic biomarkers predicting response to particular 
exercise programs. These studies will be important for informing the design of effective 
exercise programs for particular genetic populations and individuals. 
In addition, the current study demonstrated that baseline metabolism, including 
RER, did not predict body mass and composition response. Genetic background instead 
predicted body mass and composition response in the four CC strains. RER is commonly 
used to indirectly determine the contribution of carbohydrates and lipids to energy 
expenditure. The contribution of these fuels can be affected by diet, muscle glycogen 
presence, exercise factors (intensity, duration) and training status (111, 120). Individual 
variation in substrate oxidation during exercise has been observed in both trained and 
untrained individuals. In this study, baseline RER was not associated body composition 
response to exercise supporting prior findings in humans (118). 
4.5.3 Within strain individual variability was observed across phenotypes 
Even though these studies were performed in mouse strains that were almost fully 
inbred (55), variance in all phenotypes and variability in levels of variance across CC strains 
was observed (Supporting Table 4-8). This is not surprising since individual variability in 
exercise-related phenotypes in inbred strains has previously been observed (66, 116). In 
particular, large individual variability in body fat percentage response, physical activity 




differences in adjusted food intake, in combination with the differences in physical activity 
levels were driving the observed differences in fat response. In addition, CC072/TauUnc 
may be more susceptible to environmental influences (e.g. life history) or epigenetic 
influence (e.g. in utero environment) that were unaccounted for in the study design. The 
large individual variability observed in CC072/TauUnc was unlikely caused by segregating 
regions of the strain’s genome since the only 0.8% of the genome was segregating in this 
strain two years ago (55). 
4.5.4 Concluding Remarks 
Despite significant health burdens and public interest in understanding and 
optimizing exercise regimes within the human population, relatively little is known about the 
genetic architecture and control of the diverse behavioral, metabolic and physiological 
responses that converge to drive successful response to exercise. This study used mouse 
strains from the CC population to identify and develop mouse model(s) of exercise-induced 
adverse fat responders. Genetic variation in the CC resulted in phenotypic diversity in 
exercise-related traits. The presence of extreme outliers in body composition response to 
exercise in a small subset of CC strains, further supports that the CC population is a rich 
source for new models of human traits (54, 64).  
CC002/Unc was identified as a model for adverse body composition response under 
certain conditions (females, voluntary exercise, significance of effect varies by age). 
Voluntary exercise-induced body mass and composition responses were driven by genetic 
background independent of physical activity levels further supporting the importance of 
genetic background on exercise-induced responses (126). Lastly, this study demonstrated a 
significant genetic background-by-sex-by-exercise program interaction on body composition 
response. Specifically, HIIT elicited more beneficial body composition responses than MICT 












Figure 4.1. Body mass and composition response to two weeks of treatment in aged 
females across 13 CC strains. Body mass response (%) (A), body fat percentage response 
(%) (B) and lean mass percentage response (%) (C) over two weeks of treatment in both 
control and experimental treatment cohorts. Each dot represents an individual female 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.2. Exercise-induced body mass and composition response  
in aged females across 13 CC strains. Adjusted body mass response (%) (A), adjusted 
body fat percentage response (%) (B) and adjusted lean mass percentage response (%) 
(C) to two weeks of wheel access in the experimental cohort. Responses are adjusted to 
strain mean responses in the control cohort. Each dot represents an individual female 






















































































































































































































































































































































































































































































































































































































Figure 4.3. Cumulative body mass and composition response to treatment over 8 weeks in 
CC002/Unc and CC037/TauUnc. Body mass response (%) (A), body fat percentage 
response (%) (B) and lean mass percentage response (%) (C) for each two week interval of 
the experiment in both control and experimental treatment cohorts. Each dot represents an 
individual female mouse. Each response is calculated for a two week interval. Responses 
are represented as timepoint intervals: timepoint 0 (single housing acclimation), 1 (weeks 0-


































































































































































































































































































































































Figure 4.4. Body mass and composition response to exercise programs in four CC strains. 
Body mass response (%) (A), body fat percentage response (%) (B) and lean mass 
percentage response (%) (C) to five weeks of exercise program training. Top panels are 
























































































































































































































































































































































































































































































































































































































































Figure 4.5. Adjusted body mass and composition response to exercise programs in four CC 
strains. Adjusted body mass response (%) (A), adjusted body fat percentage response (%) 
(B) and adjusted lean mass percentage response (%) (C) to five weeks of exercise program 
training. Exercise programs include HIIT (high intensity interval training) and MICT 
(moderate intensity continuous training). Responses are adjusted to mean responses in 
matching strain and sex NE (no exercise) cohort. Top panels are only female mice (F) and 
bottom panels are only male mice (M). Each dot represents an individual mouse. 
































































































































































































































































































































































































































































































































Table 4.1. P-values from nested ANOVA analysis of treatment cohort and genetic 
background effect on body mass and composition response. Base models included 
treatment cohort as a fixed effect. Additive models included treatment cohort and genetic 
background as an additive effect. Full models included treatment cohort effect, genetic 
background effect and their interaction. 
    base vs additive model 
base	vs	full	
model	
additive vs full 
model 
Response 
Body Mass 1.35x10-09	 5.14x10-11	 8.18x10-04	
Body Fat % 1.19x10-06	 3.53x10-07	 0.011	







Table 4.2. Pearson’s correlations between body mass and composition response and 

















Distance (Days 11-12) -0.144 -0.202  0.244 
Duration (Days 11-12) -0.211 -0.223  0.266 
Speed (Days 11-12)  -0.17 -0.206  0.278 
Adjusted Food Intake  0.755  0.411 -0.665 
Food Intake 0.584 0.514 -0.581 
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Table 4.3. P-values from nested ANOVA analysis of potential mediators and genetic background on body mass and 
composition response within the experimental cohort. Base models included a mediator as a fixed effect. Additive models 
included a mediator and genetic background as additive effects. Full models included a mediator effect, genetic background 
effect and their interaction. 
Mediator: distance 
base vs additive model base vs full model additive vs full model 
Response 
Body Mass 2.33x10-08 3.70x10-07 0.095 
Body Fat % 7.16x10-06 0.0012 0.807 
Lean Mass % 4.325x10-07 3.56x10-05 0.42 
Mediator: duration 
base vs additive model base vs full model additive vs full model 
Response 
Body Mass 5.35x10-08 3.78x10-07 0.06 
Body Fat % 8.27x10-06 0.0019 0.889 
Lean Mass % 1.52x10-06 4.66x10-06 0.056 
Mediator: speed 
base vs additive model base vs full model additive vs full model 
Response 
Body Mass 4.697x10-08 9.53x10-07 0.126 
Body Fat % 2.633x10-05 0.0051 0.924 
Lean Mass % 5.426x10-07 1.39x10-05 0.219 
Mediator: adjusted food intake 
base vs additive model base vs full model additive vs full model 
Response 
Body Mass 4.45x10-08 9.30x10-06 0.498 
Body Fat % 6.09x10-07 5.90x10-07 0.018 
Lean Mass % 1.606x10-09 5.19x10-06 0.905 
109
9
Table 4.4. Analysis of metabolic traits and genetic background on body mass and composition response. P-values from partial 
F tests of a nested ANOVA analysis was performed comparing the best fit model with each metabolic variable subbed in for 
genetic background vs the best fit model including each metabolic variable. Best fit model are as follows: exercise 
program*genetic background (body mass response) or exercise program*sex*genetic background (body fat and lean mass 
response). Grey boxes represent non-significant p-values (p>0.05). 




















RER nocturnal 0.0048 0.0034 5.15x10-05 RER nocturnal 0.0176 0.0004 5.558x10-10 
RER day 0.0068 0.0034 0.0001 RER day 0.0150 0.3552 0.0862 
VO2 nocturnal 0.0017 0.0002 0.0001 VO2 nocturnal 9.357x10-05 0.0024 9.512x10-05 
VO2 day 0.0171 0.0197 0.0026 VO2 day 0.0035 0.0092 8.007x10-05 
VCO2 nocturnal 0.0005 0.0044 0.0010 VCO2 nocturnal 0.0057 0.0005 6.387x10-07 
VCO2 day 0.0192 0.0121 9.226x10-05 VCO2 day 0.0144 0.1937 0.0054 
Heat nocturnal 0.0013 0.0003 0.0017 Heat nocturnal 0.0003 0.0018 4.223x10-05 
Heat day 0.0188 0.0208 0.0002 Heat day 0.0042 0.0194 0.0001 
Activity nocturnal 0.0266 0.0680 0.0006 Activity nocturnal 0.0290 0.0200 0.0051 
Activity day 0.0009 0.0170 6.118x10-07 Activity day 0.0074 0.0221 2.351x10-05 
Food intake nocturnal 0.0394 0.0100 4.452x10-05 Food intake nocturnal 0.2746 0.0003 1.174x10-07 
Food intake day 0.0007 0.0209 0.0041 Food intake day 0.0410 0.0639 0.0233 
Water intake nocturnal 0.0072 0.1074 0.0007 Water intake nocturnal 0.0040 0.1490 0.0006 





CHAPTER 5: CONCLUSIONS 
Exercise is often recommended as a health preventative and treatment. Current 
guidelines recommend the same exercise programs for every U.S. adult regardless of age, 
sex or genetics (21). These “one size fits all” public health recommendations for exercise 
and other lifestyle interventions have been insufficient for the diverse human population. A 
large diversity of response types, including adverse responders, has been observed across 
a broad range of traits to the recommended exercise program. In addition to the large 
heterogeneity in exercise-induced responses, factors contributing to heterogeneity remain 
unknown. In order to establish effective physical activity guidelines, the driving mechanism 
and sources of individual variation need to be identified (16, 136). 
5.1 Contributions to advancement of the field 
While large individual variation in exercise-induced responses is observed in the 
human population, it is difficult to determine sources of variation since it is hard to control, 
track and measure potential contributing factors (e.g. genetic background, environmental 
variables, etc). My thesis utilized a multi-parental mouse population due to the ability to 
standardize measurements, regulate environmental variables and determine contributing 
cofactors to exercise-induced responses across a wide range of genetic backgrounds. My 
thesis aimed to establish mouse models of both exercise-induced positive and adverse fat 
response and to use these models to determine the role of genetic background, sex, and 
type of exercise on body composition. 
This complete work has provided multiple mouse models for exercise-induced 
standard and adverse body composition response, highlighted the importance of genetic 





exercise-induced responses. Additionally, this work has demonstrated that body 
composition responses vary by the type of exercise program, specifically in comparing HIIT 
and MICT programs, and these responses are also dependent on sex and genetic 
background. CC002/Unc was identified as a mouse model of exercise-induced adverse 
body composition response to voluntary exercise in females and CC027/GeniUnc as a 
model of exercise-induced adverse body composition response to voluntary exercise in 
aged females and HIIT programs in young females. In addition, CC013/GeniUnc was 
identified as a model of exercise-induced standard body composition response to multiple 
exercise programs and in both sexes. The presented findings further support the utility of 
the CC population for identifying extreme phenotypic outliers in exercise response that can 
serve as natural models of human traits in response to exercise. 
Each CC strain is inbred allowing for biologic replicates, which enables studies to be 
repeated and allows for individual variables to be tested across multiple studies (54, 55). 
There are also extensive genomic and computational tools for analysis of the CC strains 
(59) enabling studies to connect genotype to phenotype in the CC. Future studies using 
these models will assist in identifying genes and metabolic pathways (identified through 
different ‘omics’ approaches) contributing to both adverse responders and standard 
responders to exercise. These models provide the opportunity to further determine the 
cofactors contributing to exercise-induced responses. Furthermore, these models will 
enable studies to test potential interventions and treatments for reversal of adverse fat 
response. 
5.2 Personalized medicine to personalized exercise approach 
Historically, medicines and treatments were designed with the intention of treating 
everyone with few exceptions. It is now accepted that diseases are heterogeneous and 
each individual’s disease is unique. Personalized medicine aims to identify specific factors, 





enable therapeutic agents or preventions to be specifically designed to an individual or a 
defined population that shares the same underlying factors. Currently, the personalized 
genomic medicine approach has been successfully utilized in the treatment of diseases in 
the fields of oncology, psychiatry, and cardiovascular conditions. There are currently three 
main objectives to personalized medicine: identifying polymorphisms contributing to certain 
adverse drug events, no response or outlier drug responses; identifying potential 
biomarkers for specific diseases; and assessing clinical response in combination with 
targeted therapeutics (137). Although, the majority of efforts to this date have focused on 
understanding heterogeneity in drug responsiveness among human populations (138). 
Personalized medicine has the potential to extend beyond drug response and is applicable 
to other forms of health management, such as exercise or diet response. 
Individual variation in responses to standard exercise programs indicates that there 
should be no single standard exercise guidelines, but instead exercise should be designed 
and utilized in the same personalized medicine approach that is used to treat the diseases 
mentioned above (48, 138). Each individual is unique due to genetic background, 
environmental factors, epigenetics, gene-by-environment interactions and more. All of 
these modify nutritional requirement, metabolism, predisposition to disease and response 
to drug or lifestyle intervention (136). Therefore, personalized exercise programs should be 
tailored to each individual based on defined factors (e.g. genetics, age, sex, prior training, 
etc). Establishment of individual tailored approaches for exercise prescription will improve 
exercise-induced health benefits across the population, minimize side effects and optimized 
efficacy (8, 16, 136, 139). Additionally, effective policies, personalized lifestyle interventions 
and exercise guidelines designed to promote healthier body composition and lifestyle not 
only will improve the obesity epidemic, but will also have an enormous economic benefit on 





5.3 Next steps for development of personalized exercise programs 
Diagnostics of adverse responders and effective intervention options need to be 
developed in order to implement personalized exercise programs. Additionally, ways to 
ensure education and adherence to programs need to be developed alongside 
personalized exercise programs. 
5.3.1 Identifying diagnostics of responder type 
The genetic and mechanistic pathways driving exercise-induced adverse body 
composition response remain unknown. Determining mechanistic pathways, driving factors 
and predictors of adverse, standard and non-responders will be vital for the development of 
diagnostics for response type. Multi-omic profiling, including genomic and metabolomics 
profiling of blood or other tissue, can be utilized for discovery of genetic or metabolic 
biomarkers. Biomarkers predictive of adverse responders and biomarkers for intervention 
program selection need to be established. Once these biomarkers are scientifically 
validated, assays and other tools can be developed and applied in a clinical setting to 
identify individuals more or less receptive to each exercise program prior to initiating 
exercise (16, 29, 47, 139, 141). Development of interventions needs to occur alongside the 
identification and development of companion biomarkers for classification of responder 
type. 
5.3.2 Intervention development and optimization 
Future studies aimed at intervention development for low and adverse responders 
are necessary for establishing personalized treatments to promote healthy outcomes. 
Exercise is one form of intervention that can be varied by multiple factors (45) and induces 
individual variation in responses. Knowledge of sources of heterogeneity in exercise 
responses and a physiological understanding of mechanisms regulating exercise 
responsiveness are necessary for designing interventions and informing clinical trials to 





frequency, duration of exercise and other factors. In order to design effective exercise 
interventions for specific individuals and populations, additional studies will be important for 
identifying the optimal mode, frequency, intensity and duration of exercise and intervention 
length for inducing beneficial responses (22, 29, 45). 
 
Other forms of intervention, such as dietary and nutrition based interventions, should 
be studied. Food intake is often a compensatory behavior in response to exercise and can 
alter exercise-induced body composition responses. Studies have demonstrated food 
composition can alter metabolism mechanism and adaptations to exercise (22) and 
exercise combined with diet interventions significantly reduce body mass (142). Evaluation 
of dietary interventions in combination with exercise will be vital for the development of 
personalized lifestyle approaches aimed to improve body composition and reduce chronic 
disease risk.  
5.3.3 Future studies utilizing Collaborative Cross models 
Based on the need to develop personalized exercise programs to ensure beneficial 
health outcomes, CC mouse models will be valuable for performing three future studies: 
biomarker identification, mechanistic pathway and intervention design. 
First, biomarkers need to be identified in both CC model strains for exercise-induced 
adverse body composition response and standard response. Metabolomics (or other omics 
platforms) performed in model strains prior to exercise exposure will enable identification of 
prognostic biomarkers unique to either standard or adverse body composition responders. 
These prognostic biomarkers may be shared between adverse responder strains or may be 
unique to one adverse responder model strain. Next studies utilizing multiple technologies 
(metabolomics, RNA-sequencing, etc) can be used to identify genetic and molecular 
pathways driving adverse responses in CC model strains. Additionally, biomarkers can be 





how the prognostic biomarkers respond to each intervention. Lastly, future studies utilizing 
the CC model strains should focus on development of intervention. Studies should examine 
exercise interventions alone, diet interventions alone and synergistic exercise-diet 
combinations in CC models before and after adverse responses have occurred. Exercise 
interventions tested should vary in mode (forced, voluntary), duration, intensity and 
intervention length. Diet interventions tested should be comparable to diets commonly 
consumed and studied in the human population such as ketogenic, Mediterranean and 
paleo. These studies will be vital for the advancement of precision medicine in the human 
population. 
5.4 Commercialization and challenges to consider 
The ultimate goal is to be able to translate scientific findings to inform the design of 
effective physical activity guidelines that improve health responses and adaptations to 
exercise across multiple populations. During the translation process, there will be 
opportunities for commercialization of genetic tests, biomarker assays and/or other tools. 
There are commercially available genetic tests (direct to consumer) for training program 
guidance and athlete selection. Thirty-nine companies exist today with direct to consumer 
genetic tests for exercise performance and injury (143). However, these commercial tests 
face numerous issues and challenges due to the rigor, robustness and reproducibility of 
scientific findings supporting the products. These challenges include reproducibility across 
studies and populations, limited sample size, small effect sizes and weak associations of 
identified genes with phenotypes. In many cases, identified association between genotype 
and training response findings have not been replicated in additional studies. Additionally, 
there are many unknowns in the complex relationship between genotype and training 
response. For example, it is unknown whether genetic variation associated with variation in 
exercise response will remain stable across different exercise programs (e.g. types of 





vs diseased populations, etc) (45, 139). Furthermore, it is unlikely that one genetic variant 
will explain a large portion of the trait. For example, ACTN3 genotype is associated with 
power performance, but only predicts a small portion of athletic performance. Additionally, 
ACTN3 genotype is not predictive or necessary for elite-level competition (139). Thus, the 
identification of multiple genetic variants predictive of training responses and with strong 
scientific evidence will be necessary for the development of genetic screening technologies 
for adverse responders. 
5.5 Implementation of personalized medicine in healthcare 
With the emergence of personalized exercise programs and other interventions it will 
be vital to incorporate the healthcare infrastructure necessary for successful 
implementation and treatment of patients. Proper healthcare infrastructure will enable large 
datasets to accurately model the biological complexity and incorporate patient specific 
factors (e.g. history, health status, etc). Computational infrastructure and complex datasets 
will be important for precise and predictive outcomes personalized to the individual patient 
(137). Additionally, health care professionals will need to be trained on how to design 
personalized exercise programs and trained to consult individuals identified as low or 
adverse responders to ensure these individuals engage in the most effective exercise 
program and experience health benefits (8, 139). 
Implementation of personalized lifestyle medicine extends beyond the health care 
and into public policy and regulatory branches. For successful implementation the following 
changes must occur: policy changes for system-wide adoption, alterations in regulatory 
policy (e.g. FDA), reimbursement policy must be established (e.g. who will pay for the costs 





APPENDIX A: SUPPLEMENTAL MATERIALS 
A-1 Chapter 2: Supporting tables 
Supporting Table 1. Estimated marginal means and standard errors corresponding to 
tests presented in Table 2.1. 
Trait Female Male 
 Control Experimental Control Experimental 
 Mean SE Mean SE Mean SE Mean SE 
~Year 1         
Body mass (g) 26.1 0.6 25.0 0.6 34.5 0.6 33.8 0.6 
% Fat 13.9 1.4 13.9 1.3 17.4 1.3 15.1 1.3 
% Lean 79.7 1.3 79.8 1.2 76.5 1.2 79.4 1.2 
~Year 1.1         
Body mass (g) 26.1 0.7 24.2 0.7 37.3 0.7 33.0 0.7 
% Fat 12.2 1.3 7.9 1.3 21.5 1.3 11.2 1.2 
% Lean 81.0 1.3 85.8 1.2 73.2 1.2 82.0 1.2 
% Change in Mass 1.5 1.4 -3.3 1.3 6.9 1.3 -1.4 1.2 
% Change in % Fat -5.8 7.6 -37.9 7.0 25.2 7.0 -23.2 6.8 
% Change in % Lean 83.1 2.0 89.9 1.9 72.3 1.9 84.2 1.8 
~Year 1.4         
Body mass (g) 31.9 1.1 25.8 0.9 41.2 0.9 35.4 0.9 
% Fat 22.5 1.8 10.3 1.6 26.4 1.6 14.9 1.6 
% Lean 70.9 1.8 82.5 1.6 67.6 1.6 78.7 1.5 
% Change in Mass 19.5 1.5 5.5 1.4 10.1 1.3 7.3 1.3 
% Change in % Fat 72.1 10.8 28.2 10.0 22.8 9.6 37.1 9.3 
% Change in % Lean 71.1 3.1 87.1 2.8 62.6 2.7 82.2 2.6 
~Year 1.5         
Body mass (g) 33.3 1.2 26.2 1.0 42.3 1.0 35.8 1.0 
% Fat 25.1 1.9 10.2 1.4 26.9 1.5 14.8 1.4 
% Lean 68.4 1.7 81.5 1.3 66.9 1.4 78.4 1.3 
% Change in Mass 1.9 0.9 1.2 0.7 2.8 0.7 1.1 0.7 
% Change in % Fat 1.9 8.5 6.6 6.8 2.2 6.8 1.0 6.6 
% Change in % Lean 62.6 3.4 86.6 2.7 59.1 2.7 80.1 2.6 
~Year 1.6         
Body mass (g) 33.0 1.3 26.5 1.0 42.1 1.1 34.2 1.0 
% Fat 23.2 2.2 11.0 1.7 25.3 1.7 11.4 1.7 
% Lean 71.9 2.0 82.4 1.6 70.5 1.6 82.7 1.6 
% Change in Mass -0.7 1.4 1.4 1.0 -0.8 1.1 -4.6 1.0 
% Change in % Fat -9.8 5.8 10.0 4.5 -7.0 4.6 -20.7 4.5 
% Change in % Lean 67.3 3.8 88.3 2.9 64.1 3.0 86.2 2.9 
~Year 1.8         
Body mass (g) 33.6 1.6 27.4 1.1 40.7 1.1 34.1 1.1 





% Lean 69.2 2.3 81.2 1.6 72.8 1.6 84.2 1.6 
% Change in Mass -2.2 1.9 3.2 1.3 -3.2 1.4 -0.3 1.3 
% Change in % Fat 1.0 6.9 13.5 4.7 -12.7 4.9 -12.1 4.7 
% Change in % Lean 60.9 4.1 85.2 2.8 65.8 2.9 87.5 2.8 
~Year 2         
Body mass (g) 35.1 1.9 27.4 1.3 37.7 1.3 33.5 1.4 
% Fat 28.6 2.8 12.6 1.9 17.3 2.0 8.7 2.0 
% Lean 67.0 2.6 80.7 1.8 77.8 1.8 85.1 1.9 
% Change in Mass 4.3 2.0 -0.1 1.3 -7.8 1.4 -1.2 1.4 
% Change in % Fat 3.6 8.7 3.6 5.9 -28.6 6.2 -22.1 6.3 






Supporting Table 2. Estimated marginal means and standard errors corresponding to 






  Control Experimental Control Experimental 
  Mean SE Mean SE Mean SE Mean SE 
~Year 1          
VO2 (ml/kg/h)  3423.5 74.5 3326.5 47.9 2537.9 56.3 2600.9 68.6 
VCO2 (ml/kg/h)  2820.5 86 2840 55.2 2069.7 64.9 2144 79.1 
RER (VCO2/VO2)  0.82 0.02 0.85 0.01 0.82 0.01 0.82 0.01 
Home Cage Activity  2501.9 185 2391.4 113.9 1802.7 139.7 1728.5 165.2 
Food Consumption  3.83 0.34 3.79 0.21 2.73 0.26 2.97 0.31 
Water Consumption lg10 0.578 0.043 0.532 0.026 0.41 0.032 0.508 0.038 
~Year 1.5          
VO2 (ml/kg/h)  3042.4 110 3174.5 60.1 2152.3 82.1 2295 83.6 
VCO2 (ml/kg/h)  2409.8 136.7 2954.5 74.7 1751.9 102 1922.9 103.9 
RER (VCO2/VO2)  0.78 0.03 0.93 0.01 0.81 0.02 0.83 0.02 
Home Cage Activity  2021.4 194.1 1931.7 132.1 1332.5 146.1 1983.1 184.8 
Food Consumption  2.88 0.49 5.88 0.33 2.54 0.37 3.85 0.46 
Water Consumption  2.95 0.4 4.8 0.27 2.28 0.31 3.71 0.37 
~Year 2          
VO2 (ml/kg/h)  2909.4 164.8 2959.9 117.7 2704.8 131.7 2410.9 131.8 
VCO2 (ml/kg/h)  2562.4 162.7 2793.4 116.2 2266.1 130 2105.2 130.1 
RER (VCO2/VO2)  0.88 0.02 0.93 0.02 0.84 0.02 0.87 0.02 
Home Cage Activity  2097 188.6 2633.6 99.6 1279.1 132.1 2103 150.4 
Food Consumption  3.67 0.46 5.27 0.24 3.51 0.32 4.4 0.37 





A-2 Chapter 4: Supporting figures 
 
Supporting Figure 1: Physical activity traits in aged females across 13 CC strains. 
Mean total distance (km) (A), mean total duration (1-min intervals) (B) and mean speed 
(m/min) (C) for days 11/12 of wheel access. Each dot represents and individual female 

























































































































































































































































































































































































































































































































































































































Supporting Figure 2: Adjusted food intake in experimental cohort across 13 CC 
strains. Adjusted food intake to two weeks of treatment in mice from the experimental 
cohort. Each dot represents an individual female mouse. Strains are ordered by median 














































































































































































































Supporting Figure 3: Adjusted body mass and composition response to two weeks 
of exercise in young and old CC002/Unc and CC037/TauUnc female mice. Adjusted 
body mass response (%) (A), adjusted body fat percentage response (%) (B) and adjusted 
lean mass percentage response (%) (C) to two weeks of wheel access in the experimental 
cohorts. Responses are adjusted to mean responses in the control cohort. Each dot 







































































































































































Supporting Figure 4: Cumulative adjusted exercise-induced body mass and 
composition response over 8 weeks in CC002/Unc and CC037/TauUnc female mice. 
Adjusted body mass response (%) (A), adjusted body fat percentage response (%) (B) and 
adjusted lean mass percentage response (%) (C) for each two week interval of the 
experiment in the experimental treatment cohort. Responses are adjusted to mean 
responses in the control cohort. Each dot represents an individual female mouse. Each 
response is calculated for a two week interval. Responses are represented as timepoint 
intervals: timepoint 0 (single housing acclimation), 1 (weeks 0-2 of treatment), 2 (weeks 2-4 































































































































































































































































































Supporting Figure 5: Physical activity traits over 8 weeks of wheel access in 
CC002/Unc and CC037/TauUnc female mice. Total distance (km) (A), total duration (1-
min intervals) (B) and mean speed (m/min) (C) are represented in two week intervals over 8 
weeks of wheel access. Each dot represents and individual female mouse. Timepoint 
intervals: timepoint 1 (weeks 0-2 of wheel access), 2 (weeks 2-4 of wheel access), 3 










































































































































































































































































Supporting Figure 6: Adjusted food intake over 10 weeks of treatment in CC002/Unc 
and CC037/TauUnc female mice. Adjusted food intake for each two week intervals of 
treatment (control or experimental). Each dot represents an individual female mouse. 
Timepoint intervals are timepoint 0 (single housing acclimation), 1 (weeks 0-2 of treatment), 


















































































































































A-3 Chapter 4: Supporting tables 
Supporting Table 1: Treadmill protocols for three days of acclimation. Interval length 
represents the length of each interval in seconds. Start speed is the speed (m/min) at which 
the interval begins at and end speed is the speed at which the interval ends. Interval 
distance is the distance (m) covered during each interval. Day 1 covers 129 m total, day 2 
covers 185m total and day 3 covers 290.5m. 
Acclimation Day 1 
Angle of 
















after this step 
(m) 
Total Running 
Time (at end of 
this step; min) 
1 0 3 30 0.75 0.75 0.5 
2 3 6 90 6.75 7.5 2 
3 6 9 180 22.5 30 5 
4 9 9 600 90 120 15 
5 9 0 120 9 129 17 
Acclimation Day 2 
Angle of 
















after this step 
(m) 
Total Running 
Time (at end of 
this step; min) 
1 0 3 30 0.75 0.75 0.5 
2 3 6 90 6.75 7.5 2 
3 6 9 180 22.5 30 5 
4 9 9 600 90 120 15 
5 9 16 120 25 145 17 
6 16 16 120 32 177 19 
7 16 0 60 8 185 20 
Acclimation Day 3 
Angle of 
















after this step 
(m) 
Total Running 
Time (at end of 
this step; min) 
1 0 3 30 0.75 0.75 0.5 
2 3 6 90 6.75 7.5 2 
3 6 9 180 22.5 30 5 
4 9 9 60 9 39 6 





6 16 16 180 48 99.5 10 
7 16 18 180 51 150.5 13 
8 18 18 120 36 186.5 15 
9 18 20 180 57 243.5 18 
10 20 20 120 38 281.5 20 
11 18 0 60 9 290.5 21 
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Supporting Table 2: Maximum endurance speed for each CC strain and sex. Max Speed (m/min) for each mouse is 
reported for both testing days. Mean strain speed (m/min) was calculated as a mean for each strain and sex across all 
maximum endurance speeds collected within the strain-by-sex groups. Protocol group represents the strains and sexes that 
will be running through exercise programs together and are matched by sex and maximum endurance speed abilities. Protocol 
group mean speed (m/min) is calculated as the mean speed for protocol groups with more than one strain. Speeds for the 
training programs are calculated using the protocol group mean speed. 
CC Strain Sex Endurance Testing Day 




Protocol Group Mean 
Speed (m/min) 
Calculated Speeds for 
Training Protocols 
Mouse 1 Mouse 2 Mouse 3 80% 20% 50% 
CC002/Unc F 
1 23 25 26 
24.17 1 24.17 19.33 4.83 12.08 
2 25 23 23 
CC013/GeniUnc F 
1 39 28 30 
33.67 2 33.67 26.93 6.73 16.83 
2 39 38 28 
CC027/GeniUnc F 
1 41 40 39 
40.50 3 
38.42 30.73 7.68 19.21 
2 43 38 42 
CC037/TauUnc F 
1 38 32 33 
36.33 3 
2 39 38 38 
CC002/Unc M 1 26 21 25 24.00 4 
25.58 20.47 5.12 12.79 
2 27 20 25 
CC013/GeniUnc M 1 27 29 29 27.17 4 
2 25 27 26 
CC027/GeniUnc M 
1 28 27 27 
27.33 5 
28.08 22.47 5.62 14.04 
2 30 23 29 
CC037/TauUnc M 
1 32 30 26 
28.83 5 
2 31 29 25 
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Supporting Table 3: Exercise Program Treadmill Protocols for HIIT and MICT for each of the 5 exercise groups. Interval 
length represents the length of each interval in seconds. Start speed is the speed (m/min) at which the interval begins at and 
end speed is the speed at which the interval ends. Interval distance is the distance (m) covered during each interval. For each 
exercise group the total time (minutes) and distance (m) is listed for both HIIT (33min) and MICT programs (42min). Total 
distance (for both HIIT and MICT programs) for each exercise group are as follows: 1) 480m; 2) 670m; 3) 764m; 4) 509m; 5) 
559m. 
HIIT Protocols 




























































60 0.00 4.83 2.42 0.00 6.73 3.37 0.00 7.68 3.84 0.00 5.12 2.56 0.00 5.62 2.81 
60 4.83 4.83 4.83 6.73 6.73 6.73 7.68 7.68 7.68 5.12 5.12 5.12 5.62 5.62 5.62 
Intervals 1 - 
5 
30 4.83 19.30 6.03 6.73 26.93 8.42 7.68 30.73 9.60 5.12 20.47 6.40 5.62 22.47 7.02 
240 19.30 19.30 77.20 26.93 26.93 107.72 30.73 30.73 122.92 20.47 20.47 81.88 22.47 22.47 89.88 
30 19.30 4.83 6.03 26.93 6.73 8.42 30.73 7.68 9.60 20.47 5.12 6.40 22.47 5.62 7.02 
60 4.83 4.83 4.83 6.73 6.73 6.73 7.68 7.68 7.68 5.12 5.12 5.12 5.62 5.62 5.62 
60 4.83 0.00 2.42 6.73 0.00 3.37 7.68 0.00 3.84 5.12 0.00 2.56 5.62 0.00 2.81 
MICT Protocols 





























































120 0.00 12.08 12.08 0.00 16.83 16.83 0.00 19.21 19.21 0.00 12.79 12.79 0.00 14.04 14.04 
2295 12.08 12.08 462.06 16.83 16.83 643.75 19.21 19.21 734.78 12.79 12.79 489.22 14.04 14.04 537.03 
60 12.08 0.00 6.04 16.83 0.00 8.42 19.21 0.00 9.61 12.79 0.00 6.40 14.04 0.00 7.02 
130
0
Supporting Table 4. Descriptive statistics for body mass and composition responses across 13 CC strains. 
Body Mass Response Body Fat % Response Lean Mass % Response 






















CC001/Unc Control 7 -4.33 6.82 -1.57 2.61 0.99 -15.64 111.94 -7.16 10.58 4.00 5.41 4.18 0.77 2.04 0.77 
CC002/Unc Control 6 -0.03 3.18 -117.97 1.78 0.73 -6.48 168.53 -26.03 12.98 5.30 2.30 9.91 4.31 3.15 1.29 
CC004/TauUnc Control 5 1.72 7.17 4.16 2.68 1.20 -3.82 34.20 -8.94 5.85 2.62 1.42 6.15 4.34 2.48 1.11 
CC030/GeniUnc Control 5 -6.37 3.71 -0.58 1.93 0.86 -30.30 157.02 -5.18 12.53 5.60 5.80 6.40 1.10 2.53 1.13 
CC032/GeniUnc Control 6 0.47 54.06 115.57 7.35 3.00 -2.96 221.58 -74.82 14.89 6.08 1.49 21.02 14.13 4.58 1.87 
CC033/GeniUnc Control 7 -4.97 10.99 -2.21 3.31 1.25 -9.23 138.09 -14.96 11.75 4.44 2.69 6.37 2.37 2.52 0.95 
CC037/TauUnc Control 6 -1.28 19.23 -15.06 4.39 1.79 -5.80 138.22 -23.85 11.76 4.80 0.75 2.89 3.86 1.70 0.69 
CC039/Unc Control 7 0.04 22.43 577.93 4.74 1.79 0.80 866.84 1080.80 29.44 11.13 -1.06 22.16 -20.90 4.71 1.78 
CC040/TauUnc Control 8 2.64 14.73 5.59 3.84 1.36 2.37 16.53 6.98 4.07 1.44 -1.06 10.19 -9.65 3.19 1.13 
CC041/TauUnc Control 4 -1.96 37.10 -18.95 6.09 3.05 -24.17 2563.64 -106.06 50.63 25.32 1.43 15.28 10.70 3.91 1.95 
CC042/GeniUnc Control 5 -2.40 6.83 -2.85 2.61 1.17 -16.82 644.75 -38.32 25.39 11.36 1.86 14.80 7.93 3.85 1.72 
CC043/GeniUnc Control 7 1.15 4.80 4.19 2.19 0.83 0.97 39.91 41.14 6.32 2.39 -0.21 1.59 -7.44 1.26 0.48 
CC072/TauUnc Control 7 3.97 40.49 10.21 6.36 2.40 3.35 136.61 40.84 11.69 4.42 -1.28 6.76 -5.29 2.60 0.98 
CC001/Unc Experimental 8 -17.15 19.63 -1.14 4.43 1.57 -50.75 141.58 -2.79 11.90 4.21 16.99 42.78 2.52 6.54 2.31 
CC002/Unc Experimental 8 -0.70 5.17 -7.43 2.27 0.80 19.17 690.32 36.02 26.27 9.29 -1.40 10.64 -7.63 3.26 1.15 
CC004/TauUnc Experimental 5 -14.32 18.76 -1.31 4.33 1.94 -38.49 227.00 -5.90 15.07 6.74 14.01 49.17 3.51 7.01 3.14 
CC030/GeniUnc Experimental 8 -7.07 10.36 -1.47 3.22 1.14 -67.54 192.33 -2.85 13.87 4.90 9.20 13.93 1.51 3.73 1.32 
CC032/GeniUnc Experimental 8 -15.55 47.25 -3.04 6.87 2.43 -29.13 159.90 -5.49 12.65 4.47 11.88 40.13 3.38 6.33 2.24 
CC033/GeniUnc Experimental 8 -15.07 68.62 -4.55 8.28 2.93 -58.86 82.49 -1.40 9.08 3.21 17.39 80.84 4.65 8.99 3.18 
CC037/TauUnc Experimental 6 -3.04 21.08 -6.92 4.59 1.87 -43.64 313.47 -7.18 17.71 7.23 7.25 16.40 2.26 4.05 1.65 
CC039/Unc Experimental 8 -6.31 61.27 -9.71 7.83 2.77 -31.03 5594.76 -180.28 74.80 26.45 10.03 109.66 10.93 10.47 3.70 
CC040/TauUnc Experimental 7 -5.37 55.68 -10.37 7.46 2.82 -24.53 177.63 -7.24 13.33 5.04 8.11 45.09 5.56 6.72 2.54 
CC041/TauUnc Experimental 6 -6.43 68.22 -10.60 8.26 3.37 -11.77 1307.25 -111.10 36.16 14.76 4.88 71.00 14.54 8.43 3.44 
CC042/GeniUnc Experimental 5 -5.21 25.76 -4.95 5.08 2.27 -49.98 470.84 -9.42 21.70 9.70 8.04 29.33 3.65 5.42 2.42 
CC043/GeniUnc Experimental 8 -3.81 28.77 -7.54 5.36 1.90 -8.23 369.16 -44.85 19.21 6.79 3.99 24.99 6.26 5.00 1.77 
CC072/TauUnc Experimental 8 4.35 173.68 39.94 13.18 4.66 19.69 5309.06 269.65 72.86 25.76 -0.95 105.86 -111.75 10.29 3.64 
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Supporting Table 5. Descriptive statistics for physical activity traits in the experimental cohort across 13 CC strains. 
Mean Distance Days 11-12 Mean Duration Days 11-12 Mean Speed Days 11-12 






















CC001/Unc Experimental 8 3.84 3.95 1.03 1.99 0.70 258.75 11,878.50 45.91 108.99 38.53 14.20 3.60 0.25 1.90 0.67 
CC002/Unc Experimental 8 4.49 2.06 0.46 1.44 0.51 248.63 4,647.84 18.69 68.18 24.10 17.79 8.07 0.45 2.84 1.00 
CC004/TauUnc Experimental 5 7.00 4.89 0.70 2.21 0.99 345.30 6,914.95 20.03 83.16 37.19 19.81 8.53 0.43 2.92 1.31 
CC030/GeniUnc Experimental 8 2.78 1.52 0.55 1.23 0.44 181.36 4,121.14 22.72 64.20 22.70 14.86 7.43 0.50 2.73 0.96 
CC032/GeniUnc Experimental 8 3.47 3.93 1.13 1.98 0.70 348.06 31,489.03 90.47 177.45 62.74 9.16 6.53 0.71 2.56 0.90 
CC033/GeniUnc Experimental 8 5.20 4.80 0.92 2.19 0.77 280.50 16,884.64 60.19 129.94 45.94 18.68 10.47 0.56 3.24 1.14 
CC037/TauUnc Experimental 6 6.65 9.81 1.47 3.13 1.28 362.33 15,623.57 43.12 124.99 51.03 17.31 19.60 1.13 4.43 1.81 
CC039/Unc Experimental 8 2.83 0.92 0.32 0.96 0.34 261.81 3,294.92 12.59 57.40 20.29 11.01 12.93 1.17 3.60 1.27 
CC040/TauUnc Experimental 7 6.49 8.85 1.36 2.98 1.12 345.36 9,620.48 27.86 98.08 37.07 18.80 32.03 1.70 5.66 2.14 
CC041/TauUnc Experimental 6 1.05 3.83 3.65 1.96 0.80 89.08 11,416.94 128.16 106.85 43.62 5.90 31.62 5.36 5.62 2.30 
CC042/GeniUnc Experimental 5 4.77 12.19 2.56 3.49 1.56 301.20 37,796.83 125.49 194.41 86.94 12.26 51.39 4.19 7.17 3.21 
CC043/GeniUnc Experimental 8 3.81 7.76 2.04 2.79 0.98 208.31 14,197.07 68.15 119.15 42.13 14.93 66.16 4.43 8.13 2.88 
CC072/TauUnc Experimental 8 4.45 19.42 4.37 4.41 1.56 284.94 57,888.53 203.16 240.60 85.07 10.32 55.86 5.41 7.47 2.64 
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Supporting Table 6. Descriptive statistics for cumulative body mass and composition response over eight weeks of treatment 
in young CC002/Unc and CC037/TauUnc females. 
Cumulative Body Mass Response Cumulative Body Fat % Response Cumulative Lean Mass % Response 

















CC002/Unc Control 1 3 4.02 2.66 0.66 1.63 0.94 9.21 763.23 82.89 27.63 15.95 -1.28 3.87 -3.02 1.97 1.14 
CC002/Unc Control 2 3 3.88 5.02 1.29 2.24 1.29 16.90 1,506.17 89.15 38.81 22.41 -2.64 12.22 -4.64 3.50 2.02 
CC002/Unc Control 3 3 4.66 9.49 2.04 3.08 1.78 23.63 1,215.70 51.44 34.87 20.13 -3.19 10.28 -3.22 3.21 1.85 
CC002/Unc Control 4 3 10.47 52.31 5.00 7.23 4.18 30.92 1,673.27 54.11 40.91 23.62 -4.46 9.63 -2.16 3.10 1.79 
CC002/Unc Experimental 1 9 2.11 13.41 6.34 3.66 1.22 28.94 1,018.77 35.21 31.92 10.64 -2.55 11.63 -4.55 3.41 1.14 
CC002/Unc Experimental 2 9 -0.11 11.02 -104.03 3.32 1.11 20.30 585.70 28.85 24.20 8.07 -2.30 5.23 -2.27 2.29 0.76 
CC002/Unc Experimental 3 9 -0.07 30.55 -467.03 5.53 1.84 25.61 1,221.03 47.68 34.94 11.65 -1.98 20.35 -10.26 4.51 1.50 
CC002/Unc Experimental 4 9 3.97 47.43 11.94 6.89 2.30 31.95 1,067.06 33.39 32.67 10.89 -2.67 12.15 -4.54 3.49 1.16 
CC037/TauUnc Control 1 5 4.09 31.29 7.64 5.59 2.50 8.65 451.28 52.20 21.24 9.50 -0.98 10.34 -10.59 3.22 1.44 
CC037/TauUnc Control 2 5 2.02 87.05 43.02 9.33 4.17 -0.77 903.66 -1,170.73 30.06 13.44 0.40 18.22 45.91 4.27 1.91 
CC037/TauUnc Control 3 5 4.35 91.65 21.05 9.57 4.28 19.04 1,393.71 73.22 37.33 16.70 -2.03 24.58 -12.08 4.96 2.22 
CC037/TauUnc Control 4 5 5.52 74.65 13.53 8.64 3.86 14.77 837.61 56.71 28.94 12.94 -1.57 22.28 -14.17 4.72 2.11 
CC037/TauUnc Experimental 1 7 4.66 39.03 8.38 6.25 2.36 6.68 296.53 44.38 17.22 6.51 -1.62 6.60 -4.08 2.57 0.97 
CC037/TauUnc Experimental 2 7 5.12 29.80 5.83 5.46 2.06 -5.60 136.33 -24.36 11.68 4.41 -0.40 4.59 -11.43 2.14 0.81 
CC037/TauUnc Experimental 3 7 5.55 18.08 3.26 4.25 1.61 17.88 706.26 39.50 26.58 10.04 -2.98 3.96 -1.33 1.99 0.75 
CC037/TauUnc Experimental 4 7 4.50 48.58 10.80 6.97 2.63 0.19 407.91 2,145.86 20.20 7.63 0.14 14.66 106.55 3.83 1.45 
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Supporting Table 7. Descriptive statistics of physical activity traits in CC002/Unc and CC037/TauUnc young females. 
Total	Distance	(km)	 Total	Duration	(1-min)	 Mean	Speed	(m/min)	






















CC002/Unc	 Experimental	 1	 9	 49.66	 415.77	 8.37	 20.39	 6.80	 3,485.89	 625,308.36	 179.38	 790.76	 263.59	 13.38	 13.50	 1.01	 3.67	 1.22	
CC002/Unc	 Experimental	 2	 9	 52.42	 770.45	 14.70	 27.76	 9.25	 3,487.44	 1,041,438.53	 298.63	 1,020.51	 340.17	 14.41	 16.65	 1.16	 4.08	 1.36	
CC002/Unc	 Experimental	 3	 9	 32.01	 111.79	 3.49	 10.57	 3.52	 2,434.67	 177,645.50	 72.97	 421.48	 140.49	 13.09	 14.19	 1.08	 3.77	 1.26	
CC002/Unc	 Experimental	 4	 9	 29.77	 220.83	 7.42	 14.86	 4.95	 2,315.56	 516,770.03	 223.17	 718.87	 239.62	 12.59	 14.42	 1.15	 3.80	 1.27	
CC037/TauUnc	 Experimental	 1	 7	 72.13	 752.68	 10.44	 27.44	 10.37	 4,297.86	 860,606.48	 200.24	 927.69	 350.63	 15.50	 18.30	 1.18	 4.28	 1.62	
CC037/TauUnc	 Experimental	 2	 7	 95.22	 660.17	 6.93	 25.69	 9.71	 4,932.43	 871,797.95	 176.75	 933.70	 352.91	 18.15	 18.54	 1.02	 4.31	 1.63	
CC037/TauUnc	 Experimental	 3	 7	 87.94	 473.71	 5.39	 21.76	 8.23	 4,319.86	 248,753.14	 57.58	 498.75	 188.51	 20.14	 13.71	 0.68	 3.70	 1.40	
CC037/TauUnc	 Experimental	 4	 7	 82.23	 349.63	 4.25	 18.70	 7.07	 3,998.43	 163,387.62	 40.86	 404.21	 152.78	 20.10	 13.06	 0.65	 3.61	 1.37	
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Supporting Table 8. Descriptive statistics for body mass and composition response across four CC strains, both sexes and 
three exercise training programs. 
Body Mass Response Body Fat % Response Lean Mass % Response 





















CC002/Unc F HIIT 14 11.68 44.22 3.79 6.65 1.78 -7.53 565.02 -75.07 23.77 6.35 0.34 11.39 33.87 3.37 0.90 
CC002/Unc F MICT 16 11.28 46.33 4.11 6.81 1.70 15.84 1,146.68 72.39 33.86 8.47 -2.25 20.83 -9.28 4.56 1.14 
CC002/Unc F NE 8 15.79 7.78 0.49 2.79 0.99 16.85 555.60 32.98 23.57 8.33 -2.27 6.91 -3.05 2.63 0.93 
CC002/Unc M HIIT 6 6.76 9.45 1.40 3.07 1.26 -15.18 471.42 -31.06 21.71 8.86 -0.70 4.23 -6.08 2.06 0.84 
CC002/Unc M MICT 8 7.54 10.80 1.43 3.29 1.16 -13.80 696.30 -50.47 26.39 9.33 0.66 1.01 1.53 1.00 0.36 
CC002/Unc M NE 7 8.64 33.43 3.87 5.78 2.19 -9.85 181.14 -18.39 13.46 5.09 0.08 4.76 62.36 2.18 0.82 
CC013/GeniUnc F HIIT 4 3.58 34.07 9.52 5.84 2.92 13.34 523.78 39.25 22.89 11.44 -1.16 2.09 -1.79 1.44 0.72 
CC013/GeniUnc F MICT 8 5.09 11.11 2.18 3.33 1.18 2.54 1,186.18 466.31 34.44 12.18 -0.71 3.65 -5.12 1.91 0.68 
CC013/GeniUnc F NE 8 12.83 15.18 1.18 3.90 1.38 47.35 3,024.06 63.87 54.99 19.44 -2.52 5.24 -2.08 2.29 0.81 
CC013/GeniUnc M HIIT 8 4.11 11.14 2.71 3.34 1.18 20.78 1,948.33 93.77 44.14 15.61 -1.53 3.30 -2.16 1.82 0.64 
CC013/GeniUnc M MICT 8 8.41 49.16 5.84 7.01 2.48 9.59 2,065.23 215.24 45.44 16.07 -1.26 6.71 -5.32 2.59 0.92 
CC013/GeniUnc M NE 8 15.83 17.08 1.08 4.13 1.46 37.52 2,054.29 54.76 45.32 16.02 -2.42 4.29 -1.78 2.07 0.73 
CC027/GeniUnc F HIIT 14 6.12 18.34 3.00 4.28 1.14 -1.69 1,782.88 -1,056.28 42.22 11.28 -1.45 3.41 -2.36 1.85 0.49 
CC027/GeniUnc F MICT 15 7.18 13.38 1.86 3.66 0.94 29.77 3,627.30 121.86 60.23 15.55 -2.54 4.74 -1.87 2.18 0.56 
CC027/GeniUnc F NE 8 15.69 24.30 1.55 4.93 1.74 -8.24 2,022.77 -245.37 44.98 15.90 0.25 2.47 9.79 1.57 0.56 
CC027/GeniUnc M HIIT 11 3.70 14.95 4.04 3.87 1.17 37.36 7,058.99 188.93 84.02 25.33 -2.40 13.20 -5.51 3.63 1.10 
CC027/GeniUnc M MICT 11 6.20 21.81 3.52 4.67 1.41 12.63 1,989.01 157.45 44.60 13.45 -1.72 10.18 -5.91 3.19 0.96 
CC027/GeniUnc M NE 8 14.61 18.06 1.24 4.25 1.50 38.68 5,447.14 140.83 73.80 26.09 -0.78 2.66 -3.43 1.63 0.58 
CC037/TauUnc F HIIT 15 3.74 38.43 10.27 6.20 1.60 13.68 2,118.10 154.83 46.02 11.88 -2.12 12.55 -5.92 3.54 0.91 
CC037/TauUnc F MICT 15 8.17 38.67 4.73 6.22 1.61 78.98 3,900.85 49.39 62.46 16.13 -8.46 23.65 -2.80 4.86 1.26 
CC037/TauUnc F NE 7 10.29 23.78 2.31 4.88 1.84 38.34 1,583.78 41.31 39.80 15.04 -3.49 12.90 -3.69 3.59 1.36 
CC037/TauUnc M HIIT 11 8.37 42.83 5.12 6.54 1.97 26.14 1,410.58 53.96 37.56 11.32 -3.36 24.44 -7.27 4.94 1.49 
CC037/TauUnc M MICT 11 9.30 19.86 2.14 4.46 1.34 36.31 1,576.17 43.41 39.70 11.97 -3.57 19.01 -5.32 4.36 1.31 
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